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Naturally occurring polyphenols in fruits and vegetables have been shown to exhibit anticancer 
characteristics. Although some roles of polyphenols in cancer prevention have been previously 
described, an involvement of mitochondrial mechanisms has not been well-studied. Also, while 
mitochondrial dysfunction has been identified in several cancer cells and is correlated with poor 
prognosis, less is known about the involvement of mitochondrial changes in carcinogenesis and 
neoplastic transformation. In an in vitro model of cancer initiation and promotion using Bhas 42 
fibroblasts, we investigated the involvement of mitochondrial changes induced by benzo[a]pyrene 
(B[a]P) and possible roles of different polyphenols in preventing carcinogenesis and neoplastic 
transformation, through inhibiting oxidative stress, inducing mitochondrial biogenesis, and 
ameliorating mitochondrial dysfunction.  
Bhas 42 mouse fibroblast cells were pre-treated with 5 μM polyphenols (resveratrol, quercetin, 
catechin, cyanidin, cyanidin-3-glucoside (C3G), and berberine) for 2h for most experiments 
followed by treatment with 4 μM B[a]P for 12h, 24h and 72h. Different experiments including 
measuring intracellular reactive oxygen species (ROS), mitochondrial superoxide, gene 
expression, mitochondrial content, and neoplastic transformation were conducted. 
B[a]P induced oxidative stress by increasing intracellular ROS and mitochondrial superoxide 
generation, as well as induced UCP2 expression compared to untreated cells. Most of the 
polyphenols prevented these effects; however, only anthocyanins (cyanidin and C3G) and 
berberine decreased B[a]P-induced mitochondrial superoxide generation. B[a]P induced 
neoplastic transformation almost 5-fold while resveratrol and quercetin inhibited this effect and 
resveratrol had the strongest effect, inhibiting by 75%. B[a]P also decreased mitochondrial content, 
as well as decreased SIRT1 activity, ERRα expression, and expression of some mitochondrial 
respiratory subunits (NDUFS8, ATP5A1, and CYB). All polyphenols increased at least one of 
these factors with different effectiveness. B[a]P exposure also produced mitochondrial 
dysfunction, decreased mitochondrial membrane potential (MMP) and ATP content by 25% and 
28%, respectively, while some polyphenols such as resveratrol and quercetin completely prevented 
B[a]P-induced mitochondrial dysfunction. The increased mitochondrial biogenesis by resveratrol 
corresponded with decreased ROS generation and can be suggested as a plausible mechanism by 
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which resveratrol inhibited B[a]P-induced neoplastic transformation more strongly than other 
studied polyphenols.  
The study showed that B[a]P impaired mitochondrial biogenesis and induced mitochondrial 
dysfunction, oxidative stress, and neoplastic transformation, whereas different polyphenols 
protected against these effects, with resveratrol showing the most robust effects. The results shed 
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CHAPTER 1: LITERATURE REVIEW 
1.1. Background  
Cancer is one of the most common chronic diseases worldwide. Although current therapies such 
as chemotherapy, radiation, surgery, and immune therapy contribute to decreased cancer mortality, 
still cancer is still considered as the second fatal disease after heart disease in people less than 85 
years (Yao et al., 2011). Canadian cancer statistics reported that 206,200 Canadians would be 
diagnosed with cancer in 2017 and 80,800 people would die of cancer in 2016 (Nuttall et al., 2017).  
Although current chemotherapy drugs are successful for cancer treatment, they usually are 
accompanied with adverse side effects. Moreover, due to the high expenses of cancer treatment 
for society and the mental stress of cancer disease on patients and their families, cancer prevention 
has attracted the interest of researchers for many years. Using medicines, vitamins, and other 
agents to prevent or delay the process of carcinogenesis is called chemoprevention. 
Chemopreventive agents may protect against carcinogenesis by several mechanisms including 
inhibiting carcinogen activation/mutagenesis, oxidative stress and inflammation. 
Chemotherapeutic agents may also inhibit cancer progression by inhibiting cell growth and cell 
proliferation or inducing apoptosis. Polyphenols have been suggested to be 
chemopreventive/chemotherapeutic agents in the last two decades and have shown promising 
results against carcinogenesis. In the current review, first the hallmarks of cancer and mechanisms 
involved in carcinogenesis are discussed and then it is narrowed to the involvement of 
mitochondrial dysfunction including role of oxidative stress and mitochondrial biogenesis in 
cancer development. A major question addressed in this thesis is whether a carcinogen such as 
benzo[a]pyrene (B[a]P) produces neoplastic transformation through inducing mitochondrial 
dysfunction and resultant oxidative stress. The second major question is the extent to which 
different polyphenols can inhibit neoplastic transformation through mitochondrial mechanisms.  
1.2. The hallmarks of cancer 
To dictate malignant transformations, cells need to acquire 10 essential capabilities which are 
common among all types of human tumors: self-sufficiency in growth signals, insensitivity to 
growth-inhibitory signals, evasion of apoptosis, limitless cell proliferation, sustained angiogenesis, 
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metastasis, inflammation, dysregulation of energy metabolism, genome instability and mutations, 
and evading immune destruction (Hanahan and Weinberg, 2011). These ten hallmarks make a 
comprehensible image of neoplastic transformation and tumor cell functions.  
However, there are other mechanisms including mitochondrial dysfunction that can be involved in 
transformation as well as tumor survival through ROS production and cell signaling pathways. 
Although oxidative stress due to mitochondrial dysfunction is not one of the cancer hallmarks, it 
has been identified in many cancer cells and can contribute to tumorigenesis through inducing or 
involving other hallmarks such as evasion of apoptosis, limitless cell proliferation, metastasis, 
dysregulation of energy metabolism, inflammation, and mutations (Ward and Thompson, 2012). 
Due to these major roles of mitochondria in cancer development, the focus of this review is the 
underlying mitochondrial mechanisms in carcinogenesis and neoplastic transformation. To review 
mitochondrial mechanisms involved in cancer development we first explain the three stages of 
carcinogenesis, initiation, promotion, and progression. 
1.3. Cancer initiation, promotion and progression  
Carcinogenesis is a multi-stage process divided into three stages, initiation, promotion, and 
progression (Pitot, 1993; Weston and Harris, 2003). The first stage of carcinogenesis is triggered 
with one or two mutations leading to irreversible genetic damage. Formation of DNA adducts by 
carcinogens, which may cause oncogene activation or tumor-suppressor gene inactivation, can be 
a cancer initiator. The promotion stage is a reversible step with additional adaptive changes and 
clonal expansion. This stage involves proliferation of the cells with mutations from the initiation 
stage that increases risk of further gene mutations and malignant conversion. The progression stage 
comprises transformation of preneoplastic cells to the neoplastic and malignant phenotype. This 
irreversible stage requires further genetic mutations and cell proliferation. In this stage, malignant 
cells acquire characteristics over time to become aggressive and metastatic. The main 
characteristic of the progression stage is uncontrolled cell growth and proliferation as well as 
inclination to the genome instability. To convert premalignant cells to malignant cells, the frequent 
exposure to the carcinogen is more significant than dose of exposure (Weston and Harris, 2003). 
Mitochondrial dysfunction has been shown in a variety of cancers and can be involved in all three 
stages of carcinogenesis (Higuchi, 2012; Vyas et al., 2016). In the next sections, we discuss roles 
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of mitochondria in cancer development through different mechanisms such as oxidative stress and 
energy metabolism. 
1.4. Mitochondrial dysfunction and carcinogenesis  
Mitochondria are considered as the powerhouse of cells and are responsible for the synthesis of 
most a cell’s required ATP. Mitochondria are involved in several metabolic functions including 
ATP production by oxidative phosphorylation and metabolism of carbohydrates, amino acids, and 
lipids (Modica-Napolitano and Singh, 2004). On average, cells contain several hundred 
mitochondria; however, some cells that have a larger demand for ATP such as nerve cells and 
muscle cells may contain thousands of mitochondria (Cole, 2016). 
Mitochondria play important roles in cancer cells through multiple mechanisms such as ROS 
generation, resistance to apoptosis, altered energy metabolism, and mtDNA mutations 
(Księżakowska-Łakoma et al., 2014). Mitochondrial changes can occur at any of the stages of 
carcinogenesis and neoplastic transformation (Vyas et al., 2016). As previously hypothesized, 
mitochondrial genome mutations by carcinogens may increase ROS generation and tumorigenesis 
(Bandy and Davison, 1990). ROS generation causes more mutations and can activate cell 
signalling pathways that contribute to inflammation and cell proliferation. Mechanisms by which 
mitochondria may develop carcinogenesis such as mutations in the mitochondrial genome, 
impaired energy metabolism, and oxidative stress are reviewed in the following sections. 
1.4.1 Mitochondrial mutations 
Several types of cancers express mutations in mtDNA genes (Chattopadhyay et al., 2016; Cruz-
Bermúdez et al., 2015; de Araujo et al., 2015). mtDNA is more susceptible to mutations than 
nuclear DNA due to its proximity to the ETC, which is the main source of ROS, poor DNA repair 
systems, and lack of histones which protect DNA from impairment (Gogvadze et al., 2008). 
mtDNA mutations lead to oxidative phosphorylation (OXPHOS) dysfunction and play a crucial 
role in carcinogenesis. In cancer cells, mtDNA mutations were shown to occur in mitochondrial-
encoded respiratory subunits of complexes including complex I (7 mitochondrial-encoded 
subunits), complex III (1 mitochondrial-encoded subunit), complex IV (3 mitochondrial-encoded 
subunits), and complex V (2 mitochondrial-encoded subunits) (Tan et al., 2014). Moreover, 
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mutations in mitochondrial genes encoding 2 rRNA and 22 tRNA also have effects on the 
functioning of the respiratory chain. The displacement (D)-loop is a non-encoding nucleotide 
sequence of the mitochondrial genome that controls mtDNA replication and transcription. 
Mutations in this part of mtDNA also lead to ETC dysfunction by influencing mRNA generation 
and mtDNA duplication (Fliss et al., 2000).  
An analysis of mtDNA genes of 921 tumors showed that 56% of tumors had at least one mutation 
in mtDNA with 28% belonging to complex I and 35% belonging to the D-loop (Tan et al., 2014). 
For other mutations, 5.8%, 12.7%, and 3.8 % involved complexes III, IV, and V, respectively. 
Mutations in complex I were correlated with ROS generation, DNA damage and tumor 
progression. However, extensive mutations in complex I seem to have negative effects on 
carcinogenesis. Mutated mtDNA that causes mild oxidative phosphorylation dysfunction may 
stimulate tumorigenesis more than normal mtDNA or markedly mutated mtDNA that causes cell 
death (Cruz-Bermúdez et al. (2015). Therefore, it appears that a threshold level of mitochondrial 
function is required to support tumorigenesis.  
1.4.2. Energy metabolism in cancer cells 
The idea that cancer is principally a metabolic disease was developed in the 1920s by Otto 
Warburg. Warburg showed that tumor cells choose the glycolytic pathway under normal oxygen 
conditions rather than oxidative phosphorylation to generate ATP. He hypothesized that this 
switching in energy metabolism is as a result of mitochondrial dysfunction (Warburg, 1956). 
However, several studies have demonstrated that mitochondrial dysfunction is not the main 
contributor of this shifting energy. Despite functional mitochondria, cancer cells prefer to provide 
their energy from aerobic glycolysis. The rate of ATP production in glycolysis is higher due to 
higher speed and less enzymatic steps (Guppy et al., 1993), which is an advantage in the cancer 
phenotype. Other advantages for enhanced glucose uptake to support aerobic glycolysis include 
(Cairns et al., 2011; Gatenby and Gillies, 2004) (Figure 1.1): 1) Due to rapid cell proliferation and 
inconsistent distance from blood vessels, fluctuation in oxygen levels could be fatal for tumor cells 
if energy is provided through oxidative phosphorylation; 2) ATP production by oxidative 
phosphorylation may limit the speed of glycolytic flux. Entrance of pyruvate to mitochondria and 
its oxidation by the highly regulated enzyme, pyruvate dehydrogenase, is regulated by free levels 
of acetyl-CoA and the NAD+/NADH ratio. However, proliferating cells express high levels of 
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lactate dehydrogenase A, which rapidly converts pyruvate to lactate that is easily secreted (and 
regenerates NAD+ for glycolysis); 3) Lactic acid, an end product of glycolysis, provides a 
favorable condition for tumor invasion and represses anticancer immune system effectors. 
Moreover, the excess of lactic acid produced by hypoxic cells undergoes monocarboxylate 
transporter (MTC1 and MTC2) uptake into the cell with subsequent conversion to pyruvate and 
used as fuel for mitochondrial metabolism. This cooperation between hypoxic and normoxic cells 
avoids glucose limitation and supports cell survival for cancer cells; 4) Glucose-6-phosphate in 
glycolysis can enter the pentose phosphate pathway and produce NADPH. NADPH is consumed 
to regenerate glutathione and synthesize lipids and amino acids, major building blocks needed for 
cell proliferation; and 5) The major role of glycolysis in tumor cells is to provide substrates for 
anabolic reactions. For instance, ribose-5-phosphate from the pentose phosphate pathway is used 
to synthesize nucleic acids. Besides, pyruvate can enter to a truncated tricarboxylic acid (TCA) 
cycle where citrate is exported to cytosol and cleaved to oxaloacetate and acetyl-CoA. Acetyl-CoA 
in the cytosol is used to synthesize fatty acids and cholesterol. Oxaloacetate is reduced to malate 
which then enters the matrix and converts into oxaloacetate while generating NADH (Kroemer 
and Pouyssegur, 2008). Furthermore, other TCA cycle intermediates are used to synthesize 
biomolecules. For instance, oxaloacetate and α-ketoglutarate are used to synthesize nonessential 
amino acids. Taken together, elevated glycolysis in cancer cells contributes to intermediates which 
sustain cell proliferation, the pivotal and ultimate role of glycolysis. Moreover, the TCA cycle also 




Adapted from Vander Heiden et al., 2009. 
Figure 1.1. Energy metabolic pathways in cancer cells 
This schematic illustrates cellular ATP production in cancer cells. Glucose enters into the 
glycolytic pathway and provides pyruvate. Pyruvate either enters into the mitochondrial Krebs 
cycle and produces ATP or is transformed to lactate and leaves the cell. The Krebs cycle also 
provides intermediate substances for lipid and nucleotide synthesis required for cell proliferation 
in cancer cells. HKII: hexokinase II; LDH: lactate dehydrogenase; PDK1: pyruvate dehydrogenase 
kinase 1; PDH: pyruvate dehydrogenase. 
1.4.2.1. Molecular basis of aerobic glycolysis 
In neoplastic transformation, a major change in energy metabolism is a switch to aerobic 
glycolysis. Aerobic glycolysis is a short and fast pathway of transforming glucose to lactate in the 
state of oxygen deprivation (Jones and Bianchi, 2015) or mitochondrial dysfunction. In cancer 
cells, mitochondrial dysfunction or rapid cell proliferation and insufficient angiogenesis, which 
causes lack of oxygen in cells, drive them to provide their ATP from aerobic glycolysis pathway 
instead of the mitochondrial oxidative phosphorylation pathway (Gatenby and Gillies, 2004). In 
this section we discuss mitochondrial basis of aerobic glycolysis in cancer cells. 
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Activation of phosphoinositide 3-kinase (PI3K), is one of the main changes in cancer cells. The 
PI3K/Akt pathway is highly activated in tumor cells and is a major regulator of glycolysis.  In 
normal cells, PI3K is negatively controlled by the phosphatase and tensin homolog (PTEN) which 
loses its activation in cancer cells. PI3K is activated by growth factors after binding to their 
receptors on the surface of cells. Activation of PI3K leads to activation of Akt and mTOR. mTOR 
increases expression of amino acid transporters and genes related to protein synthesis 
(DeBerardinis et al., 2008). Akt increases expression of glucose transporters and glycolytic 
pathway enzymes such as hexokinase and phosphofructokinase, through regulation of genes and 
activation of enzymes (DeBerardinis et al., 2008; Wallace, 2012). Activation of the PI3K/Akt 
pathway increases glucose consumption by tumor cells and results in 90% conversion of pyruvate 
to lactate.  
Activation of the PI3K/Akt pathway also stimulates hexokinase II (HK2) binding to the 
mitochondrial surface by its phosphorylation (Wallace, 2012). HK2 is the predominant isoform of 
four different HK enzymes and is over-expressed isoform in tumor cells. In cancer cells, HK2 
binds to the outer mitochondrial membrane protein, voltage dependent anion channel (VDAC) 
(Wallace, 2012). The bound VDAC-HK2 provides three favorable conditions for tumor cells to 
sustain cell proliferation and survival. First, glucose-6-phosphate (G-6-P), the product of HK2, 
inhibits the activity of this enzyme. However, binding to mitochondria protects HK2 from 
inhibition by G-6-P and increases the glycolysis rate. Second, the adenine nucleotide translocator 
(ANT) exchanges ATP synthesized in the matrix with ADP in the cytosol through VDAC. By 
binding to VDAC, HK2 gains this ability to access ATP that is transferred by ANT (Mathupala et 
al., 2009; Shoshan-Barmatz et al., 2010). Third, VDAC plays a role in apoptosis by interacting 
with pro-apoptotic and anti-apoptotic proteins, such as BCL-2 family proteins. HK2 association 
with VDAC leads to interaction of BCL-XL (an anti-apoptotic protein) with VDAC and inhibition 
of outer mitochondrial membrane permeability, cytochrome c release, and apoptosis (Chiara et al., 
2008). Therefore, over-expressed HK2 in cancer cells is a strong anti-apoptotic effector and results 
in cell survival. 
1.4.2.2. Role of HIF-1α in aerobic glycolysis 
Hypoxia-inducible factor 1 (HIF1) is a transcription factor that is over-expressed in fast growing 
cancer cells under hypoxia and regulates cell proliferation, glycolysis and energy metabolism, as 
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well as apoptosis, angiogenesis, and metastasis (Masoud and Li, 2015). HIF1 consists of 2 
subunits, HIF-1α and HIF-1β. HIF-1β is constitutively expressed in normoxic conditions, thus the 
activity of HIF1 is determined by expression of HIF-1α. While HIF-1α expression in normoxic 
conditions is negligible and its half-life is 5 minutes, its half-life under hypoxic conditions becomes 
30 minutes (Salceda and Caro, 1997). In addition to hypoxia, the level of HIF-1α is increased by 
activation of some oncogenes such as H-RAS and inactivation of tumor suppressors such as p53 
and PTEN (Zundel et al., 2000).  Mutation or down-regulation of TCA cycle enzymes such as 
succinate dehydrogenase and fumarate dehydrogenase cause a condition called pseudo-hypoxia in 
which tumor cells behave as if they are under a hypoxic condition. Moreover, ROS is one of the 
activators of HIF-1α by diminishing enzymes that hydroxylate and inactivate HIF-1α (Movafagh 
et al., 2015). 
HIF-1α mediates the glycolytic pathway in cancer cells by regulating enzymes and transporters. 
HIF-1α up-regulates glucose transporters including GLUT1 and GLUT3 and glycolytic enzymes 
such as HK2, phosphofructokinase, aldolase, enolase, pyruvate kinase and lactate dehydrogenase 
(Semenza, 2010). HIF-1α regulates the mitochondrial enzyme, pyruvate dehydrogenase kinase 
(PDK). PDK phosphorylates and inhibits activity of pyruvate dehydrogenase, the rate-limiting 
enzyme that transfers pyruvate to acetyl-CoA in the Krebs cycle (Papandreou et al., 2006). Up-
regulation of PDK by HIF-1α therefore decreases pyruvate oxidation and oxidative 
phosphorylation. Given its key role in regulation of the glycolytic pathway, HIF-1α over-
expression in tumor cells is correlated with poor survival in patients with many kinds of cancers 
such as lung, breast, stomach, and esophagus (Marin-Hernandez et al., 2009).   
1.4.3. Mitochondrial biogenesis  
Mitochondrial biogenesis is a biological condition where biomolecules such as proteins, lipids, 
and nucleotides are synthesized and imported to the existing mitochondria which is accompanied 
by mitochondrial DNA replication (Jornayvaz and Shulman, 2010; Lee and Wei, 2005; Ventura-
Clapier et al., 2008). These events result in mitochondrial division and increased number of healthy 
and functional mitochondria. In addition to increased mitochondrial number, mitochondrial 
biogenesis can sometimes involve increases in mitochondrial mass through increased expression 
of mitochondrial proteins and membrane lipid biosynthesis (Carelli et al., 2015; del Mar Blanquer-
Rosselló et al., 2017). In this condition, the size of mitochondria is increased and mitochondrial 
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respiratory subunits become more functional with elevated mitochondrial oxygen consumption. 
The majority of mitochondrial proteins are encoded by nuclear DNA (~ 1500) and only 13 proteins 
are encoded by the mitochondrial genome; however, these mtDNA-encoded proteins play 
important roles in oxidative phosphorylation and are considered as essential proteins. Cells and 
mitochondria contain multiple copies of mtDNA, which through mutations to different copies can 
produce a heteroplasmy of more or less functional copies (Carelli et al., 2015; Van Gisbergen et 
al., 2015). Through clonal expansion, mutated forms can predominate and contribute to 
development of mitochondria-related disease. 
To increase mitochondrial biogenesis and mitochondrial function, expression of a wide range of 
genes regulated by a group of coactivators and transcription factors are required (Figure 1.2). 
Nuclear respiratory factor-1 (NRF-1) is a transcription factor which increases expression of 
mitochondrial target genes such as oxidative phosphorylation and mitochondrial transporter genes 
(Jornayvaz and Shulman, 2010). It also regulates expression of TFAM, which induces mtDNA 
replication. The transcriptional activity of NRF-1 is determined by PPARγ coactivator-1α (PGC-
1α), PPARγ coactivator-1β (PGC-1β), and PRC (PGC-related coactivator). Phosphorylation 
mainly by PGC-1α increases translocation of NRF-1, DNA binding and transcriptional activity 
(Fernandez-Marcos and Auwerx, 2011). Nuclear respiratory factor-2 (NRF-2), is another 
transcription factor that induces mitochondrial biogenesis genes by increasing expression of 
mitochondrial genes (Dinkova-Kostova and Abramov, 2015). 
Estrogen-related receptors (ERRs) are a group of nuclear transcription factors that regulate 
mitochondrial genes including components of oxidative phosphorylation and the TCA cycle 
(Eichner and Giguère, 2011). Among three ERRs, ERRα particularly has an important role in 
mitochondrial biogenesis and is regulated by PGC-1α. In addition to increasing expression of 
ERRα, PGC-1α physically binds to this receptor and activates it. The major role of ERRα in 
mitochondrial biogenesis is induction of NRF-2. As discussed above, NRF-2 is a transcription 
factor that regulates nuclear-encoded genes that are responsible for mitochondrial proteins such as 
those in oxidative phosphorylation and mitochondrial importers (Schreiber et al., 2004) 
PGC-1α, a well-known transcriptional coactivator, binds to transcription factors and enhances 
transcriptional activity. Animal studies have demonstrated that transgenic expression of PGC-1α 
leads to induction of mitochondrial mass, mitochondrial genes, mitochondrial respiratory function 
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and exercise performance (Lin et al., 2002; Viscomi et al., 2011). In contrast, lack of PGC-1α leads 
to mitochondrial dysfunction. PGC-1α activity is regulated at the posttranslational level via 
phosphorylation and deacetylation by AMP-activated protein kinase (AMPK) and SIRT1, 
respectively (Fernandez-Marcos and Auwerx, 2011). AMPK is a sensor of energy deficiency that 
is regulated by the AMP:ATP ratio, which is increased under caloric restriction conditions. Briefly, 
animal studies have shown that treating with AMPK activators increases PGC-1α and NRF-1 
activity as well as mitochondrial biogenesis (Bergeron et al., 2001; Terada et al., 2002). Recently, 
targeting AMPK activation as a possible tumor suppressor in cancer prevention and treatment has 
emerged as a promising and novel cancer therapy (Li et al., 2015; Luo et al., 2010). AMPK 
activation inhibits tumorigenesis through several mechanisms such as regulating energy 
metabolism (e.g. mTOR), inhibiting inflammation, and activating tumor suppressor genes (e.g. 
p53) (Faubert et al., 2015; Li et al., 2015). 
In addition to AMPK, PGC-1α is also activated by SIRT1. SIRT1 is a NAD+-dependant 
deacetylase and is another sensor of caloric restriction that deacetylates and activates PGC-1α and 
thereby induces expression of mitochondrial genes (Ventura-Clapier et al., 2008). While the role 
of SIRT1 in cancer has been greatly studied for more than a decade, its role as a tumor suppressor 
or tumor promotor is still controversial. Tumorigenic or anti-tumorigenic roles of SIRT1 depend 
on the type and stage of cancers as well as signaling pathways that SIRT1 is involved in (Deng, 
2009; Lin and Fang, 2013). Analysis of a cancer patient gene expression database shows decreased 
SIRT1 gene expression in different types of tumors including breast cancer, prostate cancer, and 
hepatic carcinoma suggesting that SIRT1 acts as a tumor suppressor (Wang et al., 2008). However, 





Figure 1.2. Regulation of mitochondrial biogenesis by different signaling factors 
SIRT1 and AMPK activate PGC-1α by de-acetylation and phosphorylation, respectively. PGC-1α 
increases transcriptional activity of NRF1 and ERRα and their downstream effectors, TFAM and 
NRF2 and consequently induce mitochondrial biogenesis. 
A few studies have shown a role of mitochondrial biogenesis in cancer development; however, the 
results are conflicting. Some studies implicate impaired mitochondrial biogenesis or function in 
tumorigenesis through abolished oxidative phosphorylation and elevated aerobic glycolysis 
(Formentini et al., 2010; Roberts and Thomas, 2013; Wang and Moraes, 2011; Yadava et al., 
2013). Some other studies report increased mitochondrial biogenesis in some tumors particularly 
in invasive and metastatic tumors (LeBleu et al., 2014; Toki et al., 2010). In these studies, the 
mitochondria could be abnormal due to mutations and increased oxidative damage (Lee et al., 
2013). Moreover, increased mitochondrial biogenesis in the last stages of cancer can be an adaptive 
response for detoxification of excessive ROS.  
1.5. Role of oxidative stress in carcinogenesis 
1.5.1. Overview on oxidative Stress 
Oxidative stress is defined as an imbalance between oxidants and antioxidants resulting in an 
increase in intracellular ROS (Barber and Harris, 1994; Betteridge, 2000; Klaunig and 
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Kamendulis, 2004). There are two sources of ROS production, endogenous and exogenous. 
Mitochondrial oxidative phosphorylation, cytochrome P450 metabolism, peroxisomes, and 
leukocytes are endogenous sources of ROS, whereas pollution, radiation, and redox cycling 
compounds are exogenous sources of ROS (Phaniendra et al., 2015).  
While most oxygen molecules are reduced to water during oxidative phosphorylation, 
approximately 1-5% of electrons leak from the ETC by reacting with oxygen at sites other than 
cytochrome oxidase and form ROS, primarily superoxide anion (O2
•-). Superoxide anion can be 
converted to hydrogen peroxide (H2O2) by the enzyme superoxide dismutase (SOD). In the 
presence of reduced metal ions such as iron, hydrogen peroxide reacts with the reduced ion through 
Fenton and Haber-Weiss reactions to yield hydroxyl radicals (OH•). Hydroxyl radicals have a short 
half-life because they are highly reactive and react rapidly with lipids, proteins, carbohydrates and 
nucleic acids (Turrens, 2003). 
In normal cells, antioxidant defences are capable of counterbalancing generated ROS. Endogenous 
antioxidant defences are principally enzymatic antioxidants including superoxide dismutases (Mn-
SOD and CuZn-SOD), glutathione peroxidase (GPX), glutathione reductase (GR), and catalase. 
CuZn-SOD (SOD1) and Mn-SOD (SOD2) are located in the cytosol and mitochondrial matrix, 
respectively, and oxidize/reduce superoxide anions to oxygen and hydrogen peroxide (reactions 
[1] and [2]) (Birben et al., 2012; Ighodaro and Akinloye, 2017). 
O2




 + 2H+ + SOD (M
n+)                                                                             SOD (M(n+1) +)   +    H2O2 [2] 
Glutathione peroxidase (GPx) is localized in the cytosol and mitochondria and breaks down 
hydrogen peroxide to water while oxidizing GSH to GSSG. The GSSG is then reconverted to GSH 
by glutathione reductase (GR) using NADPH as a source of reducing equivalents (reactions [3] 
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Catalase, which is located in peroxisomes and to a lesser extent in other cell compartments, 
removes hydrogen peroxide by converting it to water and oxygen (reaction [5]) (Heck et al., 2010). 
2H2O2                  Catalase               2H2O + O2 [5] 
Glutathione is the most abundant thiol in mammalian cells and exists in two chemical forms, 
reduced (GSH) and oxidized (GSSG). In normal cells, the level of GSH is 10-100-fold higher than 
GSSG (Zitka et al., 2012). However, in a state of oxidative stress the level of the oxidized form 
increases and the level of GSH as a cofactor of glutathione peroxidase decreases. The increased 
level of GSSG is due to the activity of glutathione peroxidase to remove hydrogen peroxide. 
Glutathione reductase is a NADPH-dependant enzyme responsible for converting GSSG to GSH 
(Forman et al., 2009).  
1.5.2. Oxidative damage to biomolecules and influence of ROS on cell signalling 
Oxidative stress is one of the main triggers of cancer initiation and promotion which mediates 
carcinogenesis through direct and indirect pathways. It has been estimated that in every single cell, 
approximately 1 × 105 oxidative lesions are formed per day (Klaunig and Kamendulis, 2004). 
Endogenous and exogenous ROS can cause permanent modifications and genome instability in 
nuclear and mitochondrial DNA. ROS-mediated DNA damage induces single or double strand 
DNA breaks, as well as purine, pyrimidine, and deoxyribose modifications. DNA damage leads to 
mutations, induction or inhibition of transcripts, and replication arrest. 
8-Hydroxyguanine (8-OH-G), an oxidized product of guanosine in DNA, is considered one of the 
important biomarkers of oxidative stress and carcinogenesis found in urine and leukocytes (Irie et 
al., 2005). Smoking, tobacco, radiation, and other exogenous sources of ROS induce both urinary 
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and (Irie et al., 2005) leukocyte 8-OH-G. Reaction [6] illustrates guanine oxidation forming 8-OH-
G. 
+    OH.                                   Oxidation                                           [6] 
       Guanine (G)                                                                                                 8-Hydroxyguanine (8-OH-G) 
In addition to DNA, free radicals have the ability to react with fatty acids and produce mutagenic 
products. In the lipid peroxidation process, free radicals react with polyunsaturated fatty acids and 
produce malondialdehyde (MDA) and 4-hydroxy-2-nonenal (HNE). MDA can react with DNA 
bases guanine, cytosine, and adenine and form DNA adducts, which are mutagenic (Valko et al., 
2006). 
In addition to the ability of ROS to affect key cellular biomolecules or produce intermediates such 
as MDA that impairs both nuclear and mitochondrial DNA to cause irreversible changes and 
mutations, ROS contributes to neoplastic transformation through cell signalling pathways. ROS 
contributes to a series of cell signals which ultimately accelerate the process of cancer initiation 
and promotion. ROS has effects on cell growth and proliferation, angiogenesis, metastasis, and 
apoptosis via activating mitogen activated protein kinase (MAPK), NF-κB, and activator protein-
1 (AP-1), among other signaling proteins (Waris and Ahsan, 2006). 
NF-κB is a transcription factor that is overexpressed in cancer cells and regulates cell proliferation 
and survival. Translocation of NF-κB to the nucleus up-regulates the expression of many anti-
apoptotic gene products including of the Bcl-2 family. Bcl-2 family proteins bind to mitochondria 
to inhibit apoptosis and are associated with the survival of cancer cells. Other NF-κB-induced gene 
products (eg. cyclin D1, c-myc and COX-2) are associated with tumor proliferation (Aggarwal and 
Gehlot, 2009). Also, elevated NF-κB in tumors is correlated with drug resistance (Baldwin, 2001). 
The NF-κB system is a redox-mediated sensor for ROS which is dose-dependently up-regulated 
by exposure of cells to hydrogen peroxide (Li and Karin, 1999). In its inactive form, NF-κB binds 
to its inhibitor protein IκB located in the cytosol. Once IκB becomes phosphorylated, it liberates 
NF-κB to translocate to the nucleus. The IκB kinase (IκK) that phosphorylates IκB is activated by 
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upstream kinases such as protein kinase D1 (PKD1). The mechanism of how ROS activates NF-
κB-inducing kinases is through inhibition of phosphatase activity through oxidation of critical 
thiols in phosphatases (Morgan and Liu, 2011). Activation of IκK by upstream kinases leads to 
proteosomal degradation of IκB and translocation of NF-κB from cytosol to nucleus. Thus, in an 
indirect pathway, ROS activates NF-κB via inducing IκB degradation away from NF-κB. NF-κB 
activation also induces production of pro-inflammatory cytokines such as TNF-α and IL-1. 
Therefore, induction of pro-inflammatory cytokines by ROS is another oxidative NF-κB-inducing 
signaling pathway (Gloire et al., 2006).   
Another important signaling pathway involved in tumor progression is the MAPK pathway, which 
consists of three kinases ERK, JNK, and p38. Studies show that ROS regulate activity of MAPKs 
resulting in progression of tumors (Liou and Storz, 2010). For example, it has been shown in cancer 
cells that ROS activate ERK, a cell growth and proliferation regulating kinase (Liou and Storz, 
2010). ROS also activate AP-1 either directly or through the MAPK pathway (Wu, 2006). The 
AP-1 heterodimer is a transcription factor downstream of MAPK related to cell proliferation and 
cell survival (Thannickal and Fanburg, 2000). AP-1 proteins including c-Jun, stimulate cell 
proliferation by up-regulation of Cyclin D proteins and regulators of G1 to S phase transition that 
are often overexpressed in cancers (Shaulian and Karin, 2001).   
1.5.3. Uncoupling proteins and oxidative stress in cancer cells 
Uncoupling protein 2 (UCP2) is a key protein involved in oxidative stress in cancer cells. UCP2 
belongs to the family of uncoupling proteins acting as a mitochondrial anion transporter. 
Uncoupling proteins increase the permeability of the inner membrane to protons, which accelerates 
electron flow to cytochrome oxidase (which reduces oxygen without producing ROS) in the ETC 
and thereby lowers ROS production. During electron flux within the ETC, H+ ions are pumped 
into the inter membrane space and produce the mitochondrial membrane potential (MMP), which 
ultimately leads to formation of ATP. During transfer, some of the electrons escape from the ETC 
by reducing oxygen to generate superoxide. Formation of ROS by mitochondria induces 
expression of UCP2, a sensor and suppressor of mitochondrial ROS generation (Baffy, 2010; 
Casteilla et al., 2001). 
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ROS is a vital component for cancer progression due to ability to induce further genomic instability 
and ROS signaling pathways. On the other hand, an excessive amount of ROS could be toxic and 
leads to cell death. In cancer cells, overexpression of UCP2 acts as an adaptive response to protect 
cancer cells from excessive ROS (Derdak et al., 2008). Moreover, UCP2 is involved in 
carcinogenesis through several other mechanisms including inhibiting OXPHOS and inducing 
glycolysis, increasing cell proliferation, cell invasion, cell transformation, and cachexia resulting 
in chemoresistance and poor prognosis of cancer (Derdak et al., 2008; Pons et al., 2015).   
1.6. Inflammation and carcinogenesis 
Experimental and epidemiological studies show a strong association between cancer and chronic 
inflammation (Grivennikov et al., 2010; Mantovani et al., 2008; Shacter and Weitzman, 2002). On 
the other hand, anti-inflammatory therapies show effectiveness in cancer prevention and treatment 
(Gonda et al., 2009). The pioneering idea of inflammation-associated cancer was established by 
Virchow in the 19th century. He observed that tumors often progressed in the inflammation settings 
and inflammatory biomarkers were found in tumor biopsy samples (Balkwill and Mantovani, 
2001). Since then, clear associations between inflammatory chronic disease and cancer have been 
shown such as Crohn and ulcerative colitis with colon cancer and chronic pancreatitis with 
pancreatic cancer have been confirmed (Ekbom et al., 1990). The main component in 
inflammation-associated cancer is ROS and there is a cross-talk between ROS and inflammation. 
In inflammation, leukocytes and mast cells are recruited to the damage site and lead to a 
“respiration burst” as a result of increased consumption of oxygen for ROS generation. Moreover, 
inflammatory cells secrete mediators such as chemokines and cytokines that recruit more 
inflammatory cells contributing to more ROS generation (Reuter et al., 2010).  
Inflammation can be triggered by extrinsic factors (e.g. tobacco, infection) or intrinsic factors such 
as ROS and mutations in oncogenes and tumor suppressor genes (e.g. Ras, Myc, p53). Mutated 
oncogenes and tumor suppressor genes can induce inflammation by targeting nuclear and 
mitochondrial genes, for example p53, and increasing mitochondrial ROS production (Vafa et al., 
2002) (Kamp and Weitzman, 2011). ROS produce a cascade of signal transductions (Figure 1.3) 
by inducing a group of transcription factors involved in inflammation including NF-kB, a signal 
transducer and activator of transcription 3 (STAT3), HIF-1α, and activator protein 1 (AP-1), as 
well as enzymes such as cyclooxygenase-2 (COX2) and inducible nitric oxide synthase (iNOS) 
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(Reuter et al., 2010). COX2 and iNOS stimulate expression of inflammatory cytokines (TNF-α 
and IL-6) and chemokines (IL-8). Therefore, a vicious circle (interplay between ROS and 
inflammation) leads to enhanced DNA damage, gene instability, and cell proliferation that 
promotes cancer development (Coussens and Werb, 2002; Perwez Hussain and Harris, 2007).   
In addition to DNA damage, inflammation increases cell survival and cell proliferation in cancer 
cells via ROS cell signaling. One of the important ways that ROS induce cell survival is through 
activation of Akt and inhibition of PTEN, the phosphatase inhibiting PI3K-dependant Akt 
activation (Azad et al., 2009). Akt induces cell survival through several routes such as inducing 
cyclin D1 and degradation of cyclin dependant-kinase (Cdk) inhibitor, activating NF-ҡB, 
inhibiting apoptosis, and elevating the glycolytic pathway (Manning and Cantley, 2007; Plas and 
Thompson, 2005). In addition to Akt,  ROS regulates NF-ҡB, MAPK, and AP-1 and induce genes 
associated with cell survival, cell proliferation, angiogenesis, and cell invasion (Reuter et al., 
2010).  
 
Adapted from Kamp & Weitzman, 2011.  
Figure 1.3. Association between ROS and inflammation-related cancer 
In cancer cells, mitochondrial ROS leads to the expression of inflammatory mediators such as 
cytokines and chemokines and activates a variety of transcription factors and enzymes including 
NF-ĸB, AP-1, and MAPK. In turn, increased inflammation in tissues induces cell mitochondrial 
ROS production. The interplay between ROS and inflammation contributes to tumorigenesis 
through several mechanisms including increased cell survival, cell proliferation, mutations, 
angiogenesis, and metastasis. 
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1.7. Apoptosis  
Programmed cell death, known as apoptosis, is a critical event to maintain normal development 
and it is a balance between cell proliferation and cell death that leads to normal physiological 
process. Any imbalance between the rates of cell proliferation and apoptosis results in cancer 
progression (Indran et al., 2011). Imbalance can result from dysfunction in the two major pathways 
of apoptosis, extrinsic (receptor-mediated pathway) and intrinsic (mitochondria-mediated 
pathway) (Danial and Korsmeyer, 2004). 
The receptor-mediated pathway is an engagement between death receptors, located on the surface 
of the plasma membrane, and their ligands (Scaffidi et al., 1998). Death receptors that are involved 
in this pathway are the tumor necrosis factor (TNF) superfamily such as CD95 (fas), and TNF-
related apoptosis inducing ligands (TRAIL). Upon ligand binding, death signals are transferred 
from the surface to intracellular signaling pathways via a cytoplasmic death domain (Ashkenazi 
and Dixit, 1998). Activation of death receptors by their ligands leads to formation of a group of 
proteins known as death-inducing signaling complex (DISC). Activation of pro-caspase 8 by DISC 
activates the apoptosis execution phase by triggering caspase 3, a downstream effector of caspase 
8 (Elmore, 2007). 
In the intrinsic pathway, stimuli such as ROS, radiation, viral infections, toxins, hypoxia, and 
hyperthermia cause changes in the mitochondrial inner membrane that leads to opening of the 
mitochondrial permeability transition (MPT) pores, loss of the mitochondrial membrane potential 
and release of two major groups of pro-apoptotic proteins from the intermembrane space into the 
cytosol (Saelens et al., 2004). The first group consisting of cytochrome c and Smac/DIABO 
(second mitochondria-derived activator of caspases) activates a caspase-dependant pathway. 
Cytochrome c activates Apaf-1 leading to activation of procaspase 9 and formation of a 
cytochrome c/Apaf-1/caspase 9 complex referred to as the apoptosome. The apoptosome complex 
subsequently activates caspase 3 (execution phase) (Chinnaiyan, 1999; Hill et al., 2004). 
Smac/DIABLO deactivates IAP (inhibitors of apoptosis proteins), and thus induces apoptosis by 
arresting activity of IAP (Schimmer, 2004; van Loo et al., 2002). The second group of pro-
apoptotic proteins, apoptosis inducing factor (AIF) and endonuclease G function in a caspase-
independent pathway. Following opening of the MPT pore and collapse of the mitochondrial 
membrane potential, this group of proteins are released to the cytosol, translocated to the nucleus 
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and results in DNA fragmentation without caspase involvement. However, this is a late event and 
it occurs only when the cell is committed to die (Joza et al., 2001).  
1.7.1. The Bcl-2 family of proteins 
Apoptosis is highly regulated by the Bcl-2 family, a group of proteins divided into pro-apoptotic 
(eg, Bax, Bak, and Bad) and anti-apoptotic (eg, Bcl-2 and Bcl-XL) proteins. The Bcl-2 family 
proteins function through effects on the mitochondrial outer membrane. The pro-apoptotic proteins 
such as Bax and Bak lead to formation of a transmembrane channel across the mitochondrial inner 
and outer membrane and release of cytochrome c and AIF, while Bcl-2 and Bcl-XL prevent 
formation of pores and apoptosis and promotes cell survival (Kluck et al., 1997; Yang et al., 1997) 
(Adams and Cory, 2007; Yang et al., 1997). In the normal situation, Bax is localized in cytosol in 
an inactive form, but, in response to death stimuli, it is translocated to mitochondria and causes 
mitochondrial membrane permeabilization and release of pro-apoptotic proteins to the cytosol 
(Westphal et al., 2011). In contrast, Bak is localized in the mitochondrial membrane in an inactive 
form and it becomes activated in response to death stimuli (Gustafsson and Gottlieb, 2007). The 
fate of the cell is greatly depending on a balance between function of these two groups of proteins.   
Many cancer cells overexpress anti-apoptotic Bcl-2 proteins or have mutations in pro-apoptotic 
Bcl-2 proteins, which increase resistance to apoptosis and may cause drug resistance (Adams and 
Cory, 2007; Murphy et al., 2000; Yip and Reed, 2008). Some chemotherapy drugs (drug-induced 
apoptosis) act through the BCL-2 family. Such drugs might change conformation of Bax or induce 
expression of Bax, Bak, and Bad through up-regulation of the p53 gene (Bellosillo et al., 2002; 
Zhang et al., 2000).  
In the previous sections we discussed several aspects of carcinogenesis such as hallmarks of 
cancer, mitochondrial dysfunction, energy metabolism in cancer cells, inflammation, and 
apoptosis. In the next section we discuss the group of chemicals called polycyclic aromatic 
hydrocarbons (PAH) which include potent carcinogens such as B[a]P.  
1.8. Polycyclic aromatic hydrocarbons  
Humans are exposed to mixtures of chemicals through several routes such as cigarette smoke, 
pollution produced by vehicle exhaust and factories, pharmaceuticals and foodstuffs. Although 
exposures usually happen at low concentrations, they may occur over a prolonged period of time 
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(Jarvis et al., 2014). A major family of chemicals to which humans are exposed are polycyclic 
aromatic hydrocarbons (PAH), which consists of more than 1500 chemicals (Kim et al., 2013). 
PAHs encompass two or more bonded aromatic rings which can be found in native form or 
substituted forms (e.g. oxygenated, methylated, or nitrated). PAHs are ubiquitous pollutants that 
are yielded in an incomplete pyrolytic process. Pyrolysis occurs as a result of decomposition of 
organic chemicals at the high temperatures and in the absence of oxygen (Jarvis et al., 2014).  
Humans are exposed to PAHs via inhalation, dermal absorption and ingestion. Studies have shown 
association between PAHs exposure and chronic diseases including cancer, cardiovascular disease 
and respiratory diseases (Boffetta et al., 1997; cancer, 2010; Mumtaz et al., 1996; Peters et al., 
2001; Pope III et al., 2002). The correlation between sources of PAHs and cancer has been known 
since 1775 when British surgeon Sir Percival Pott demonstrated that there is an association 
between scrotal cancer and exposure of chimney sweepers to soot (Poirier, 2004). Although the 
carcinogenic potency of PAHs varies, the International Agency for Research on Cancer (IARC) 
categorizes these chemicals as possible carcinogens in both individual and mixture forms (Orasche 
et al., 2012). One of the most potent carcinogens in the PAH family is benzo[a]pyrene (B[a]P), 
which is assigned as a standard to assess potency of other PAHs (Boström et al., 2002; Pufulete et 
al., 2004).  
1.8.1. Benzo [a] pyrene 
Benzo[a]pyrene is classified a as a group 1 carcinogen by the International Agency for Research 
on Cancer (IARC). B[a]P is yielded from fusion of benzene with pyrene as the by-products of 
incomplete combustion of organic compounds at high temperatures between 300ºC to 600ºC. 
Burning wood, diesel exhaust, cigarette smoke, and grilled foods are the main sources of B[a]P. 
B[a]P exposure occurs through three major routes: skin exposure, dietary intake, and inhalation 
and compromises numerous organs including lung, liver, stomach, esophagus, spleen, and skin 
(Melchini et al., 2011). Cigarettes and air pollution are 2 major sources of B[a]P inhalation which 
are associated with lung and skin cancers. By analysis of smoke of cigarette samples conducted in 
the USA cigarette market between 1995 and 2000, inhalation of B[a]P by cigarettes is estimated 
to be ~ 9 ng per cigarette (Swauger et al., 2002). Moreover, studies show that B[a]P pollution in a 
developing country is higher than a developed country, 0.38 ng/m3 in La Plata (Argentina) versus 
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0.1 ng/m3 in Berlin; however, pollution and exposure to PAHs in developed countries still remains 
as a great issue (Fromme et al., 2004; Rehwagen et al., 2005).  
Exposure to dietary sources of B[a]P is one of the major routes of B[a]P uptake (~ 97% for non-
smokers) and is highly correlated with gastrointestinal cancers such as colorectal and gastric 
cancers (Lee and Shim, 2007; Vasiluk et al., 2008). Studies have demonstrated that B[a]P content 
in food is affected by the type of cooking process (grilling, frying, boiling, and broiling) and the 
time of cooking (Lee and Shim, 2007). In an epidemiological study, Kazerouni et al. (2001), found 
that grilled/barbequed steak (4.86 ng/g), grilled/barbequed chicken with skin (4.57 ng/g), and 
burger (1.52 ng/g) had highest concentrations of B[a]P. Grilled/barbequed meat and 
bread/grain/cereal contributed 21% and 29% of the total B[a]P intake respectively, while single 
items of bread/grain/cereal group had lower concentrations of B[a]P (0.5 ng/g). Several studies 
have shown association between grilled/barbequed meat consumption which contain high level of 
B[a]P and risk of colon, pancreatic, esophagus, and gastric cancers (Anderson et al., 2005; Cross 
et al., 2011; Sinha et al., 2005). 
1.8.1.1. Carcinogenic effects of B[a]P 
Binding of B[a]P metabolites to DNA and formation of bulky adducts in DNA is the major 
mechanism of B[a]P-induced mutagenesis and carcinogenesis (Conney, 1982). To be converted to 
a carcinogen, B[a]P first needs to be metabolized to its activated metabolites by cytochrome P450 
enzymes including CYP1A1, CYP1A2, and CYP1B1, that are principally involved in B[a]P 
activation (Shimada and Fujii‐Kuriyama, 2004; Shimada et al., 1996). B[a]P is a ligand for the aryl 
hydrocarbon receptor (AhR), a transcription factor regulated by aromatic hydrocarbons and 
involved in expression of P450 enzymes (Baird et al., 2005; Nebert et al., 2004). B[a]P activation 
consists of a three-step enzymatic mechanism that is initiated with conversion of B[a]P to B[a]P-
7,8-epoxides by P450 enzymes, followed by conversion to B[a]P-7,8-diols by epoxide hydrolase. 
Ultimately, B[a]P-7,8-diols are catabolized to the B[a]P-7,8-diol-9,10-epoxide metabolites by 
P450 enzymes (Figure 1.4) (Conney, 1982). An additional metabolic pathway identified in lung 
but not liver microsomes, is auto-oxidation of B[a]P radical cation metabolites resulting in 
formation of quinones (Briede et al., 2004). As well as being electrophiles that form DNA adducts, 
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the B[a]P quinones may undergo redox-cycling which ultimately results in production of 
superoxide and other ROS. 
Formation of bulky DNA adducts by B[a]P metabolites results in mutagenesis, ROS generation, 
and carcinogenesis. Following reaction with DNA, B[a]P causes mutations in oncogenes and 
tumor suppressor genes (Baird et al., 2005). Mutations in tumor suppressor genes such as p53 that 
occurs in a variety of cancer cells and contribute to DNA damage, uncontrolled cell cycle 
regulation, and ultimately carcinogenesis, have been observed after exposure to PAHs (Hainaut et 
al., 1998). Mutated pro-oncogene Ras is associated with many types of cancers (Prior et al., 2012), 
and has also been observed after exposure with PAHs (Gray et al., 2001). In addition to impairing 
nDNA, B[a]P also has effects on mtDNA and causes permanent DNA damage and mutations  
(Backer and Weinstein, 1980; Backer and Weinstein, 1982; Jung et al., 2009). Studies have 
demonstrated that mitochondria are the major target of B[a]P due to lack of histones that compact 
and protect nDNA from damage (Suliman et al., 2004). Furthermore, base excision repair (BER) 
has been detected in mtDNA but nucleotide excision repair (NER), which is responsible to repair 
bulky DNA damage, has not been observed in mtDNA (Berneburg et al., 2006). Therefore, 
mitochondria are more susceptible to bulky DNA damage by B[a]P and could be affected 40- to 
90-fold more than nDNA (Pavanello et al., 2013). Some evidence shows that B[a]P causes loss of 
mitochondrial membrane potential, decrease in ATP generation, changes in mitochondrial 
morphology, and induction of mitochondrial-dependant apoptosis (Huc et al., 2006; Ko et al., 





Figure 1.4. B[a]P metabolism via cytochrome P450 enzyme to a reactive epoxide and reaction 
with DNA to produce DNA adducts 
Adapted from Bui et al., 2009. 
1.8.1.2. Benzo [a] pyrene and mitochondrial dysfunction 
Evidence shows inhibitory effects of B[a]P on mitochondrial biogenesis and mitochondrial 
function. In human bronchial epithelial cells (16HBE), administration of 16 μM B[a]P for 48h 
decreased mRNA expression and protein levels of NRF-1 and TFAM, two important transcription 
factors regulating mitochondrial biogenesis (Zhang et al., 2014). In a later study, in the F258 rat 
liver epithelial cell line, treatment of 1 μM and 50 nM B[a]P for 24h, 48h, and 72h shifted energy 
metabolism from OXPHOS to glycolysis (Hardonnière et al., 2016). In an animal study, oral 
administration of B[a]P in different doses (2.5, 5 and 10 mg/kg body weight) significantly depleted 
antioxidant enzymes (e.g. SOD, CAT, GPx, GR) and Krebs cycle’s enzymes such as isocitrate 
dehydrogenase, succinate dehydrogenase, malate dehydrogenase and alpha-ketoglutarate 
dehydrogenase  in liver, lung, brain, stomach and kidney of ICR mice (Ji et al., 2016). Taken 
together, these studies suggest that B[a]P induces mitochondrial dysfunction and inhibits 
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mitochondrial biogenesis by stimulating oxidative stress, altering mitochondrial enzymes, 
switching energy to glycolysis, and decreasing mitochondrial biogenesis regulatory biomarkers.   
1.9. Polyphenols 
Polyphenols are a large group of phytochemicals naturally occurring in plants and are found in a 
wide range of plant foods and beverages including fruit, vegetables, cocoa, cereal, tea, wine, beer, 
and coffee, and are characterized by their hydroxylated phenyl groups (Cardona et al., 2013). Over 
8,000 polyphenols have been identified and of these more than 4,000 are flavonoids. It has been 
estimated that total dietary intake of flavonoids in the US population is 210 mg per day (98% from 
diet and 2% from supplements) (Yao et al., 2011).  
Polyphenols range from simple molecules such as phenolic acids to highly polymerized molecules 
such as tannins (Dai and Mumper, 2010). Polyphenols are responsible to protect plants from 
ultraviolet radiation damage, to deter aggression by pathogens and parasites, and to contribute to 
a plant’s color. Based on their chemical structures including the number and site of hydroxyl 
groups, the numbers of phenolic rings, and substituting groups, polyphenols are classified to 
several groups and subgroups (Figure 1.5). 
 
Figure 1.5. Chemical structure of some major polyphenols 
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1.9.1. Classification of polyphenols   
Polyphenols can be classified into two large groups: flavonoids and non-flavonoids (phenolic 
acids, tannins, stilbenes, and lignans) (Dai and Mumper, 2010). Flavonoids are a major group of 
polyphenols with a C6-C3-C6 general structure backbone and consist of six classes: flavan-3-ols 
(monomeric and proanthocyanidins), flavonols, anthocyanins, isoflavones, flavanones, and 
flavones. Most of the flavonoids except flavan-3-ols exist in the glycoside form in plants 
(Thilakarathna and Rupasinghe, 2013).  
Flavan-3-ols of the flavonoid class are found as monomers such as catechin, epicatechin, 
gallocatechin, epigallocatechin, and epigallocatechin gallate. Monomeric flavan-3-ols are mostly 
found in tea (Camellia sinensis) and fruits (except citrus). Green tea, cocoa, apples (particularly 
apple peel), berries, grapes, cherries, plums, and red wine are the best sources of catechin and 
epicatechin. Catechin and epicatechin can be polymerized to form proanthocyanidins that possess 
high anti-oxidative ability and readily bind to metal ions (Thilakarathna and Rupasinghe, 2013). 
The flavonols are ubiquitous in the human diet and foods such as apples, grapes, berries, onions, 
red wine, tea, broccoli, and kale are main sources. Quercetin, kaempferol, and myricetin are 
examples of flavonols (Thilakarathna and Rupasinghe, 2013).   
Anthocyanins are the major constituents of natural pigments, blue, purple, and red in fruits, 
vegetables, grains, and flowers. They are abundant in cherries, berries, purple and red grapes, 
pomegranates, apples, red wine, cabbages, red onion, and radishes. The colors of anthocyanins are 
influenced by different factors including pH (blue in basic and red in acidic conditions), degree of 
hydroxylation or methylation of the aromatic rings, and glycosylation pattern (Tsao, 2010). The 
anthocyanins are principally found in the glyosidic form in plants and commonly referred to as 
anthocyanins, while the aglycones are termed anthocyanidins. Cyanidin, delphinidin, malvidin, 
and pelargonidin are the major anthocyanidins out of a total of 31 monomeric anthocyanidins 
(Andersen and Markham, 2005). However, there are over 500 anthocyanins depending on the 
substitute groups can be find as hydroxylated, methylated, and glycosylated with different units of 
sugar (McCallum et al., 2007).  
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The leguminous plant family particularly soybean are the best sources of isoflavones. Genistein, 
daidzein, and biochanin A are major isoflavones found in soybean. Isoflavones have 
phytostrogenic effects and can bind to estrogen receptors (D Archivio et al., 2007); therefore, they 
may have an impact on hormone-dependent cancer prevention (Sarkar and Li, 2003). As for the 
flavanones, hesperetin and naringenin are examples and are mainly found in citrus fruits. Flavones 
are a less common class of flavonoids and can be found in vegetables such as parsley and celery. 
Apigenin and luteolin are two compounds belonging to flavones (Thilakarathna and Rupasinghe, 
2013).  
The non-flavonoids consist of the phenolic acids, stilbenes, and others. Phenolic acids are a group 
of dietary non-flavonoids divided into derivatives of benzoic acid such as gallic aid and derivatives 
of cinnamic acid such as caffeic and ferulic acid. Caffeic acid is the most abundant phenolic acid 
in fruits and vegetables and a major polyphenol in coffee. Ferulic acid is an abundant phenolic 
compound found in cereals (D Archivio et al., 2007). 
Stilbenes are a less common group of polyphenols presented in low quantities in the human diet. 
Resveratrol is the best representative of stilbenes produced by plants in response to stress 
conditions such as infection by pathogens (Delmas et al., 2006). Resveratrol is found in over 70 
species of plants particularly in grapes. Grape skin is a rich source of resveratrol (50-100 g/kg) 
which contributes to the high amount of resveratrol in wine and grape juice (up to 7 mg aglycones 
/L and 15 mg glycosides/L)(D Archivio et al., 2007). Extensive data show an effective inhibitory 
role of resveratrol in three stages of cancer, initiation, promotion and progression (Athar et al., 
2007).   
There are other non-flavonoid polyphenols found in the human diet considered as important 
compounds to human health. Among them, ellagic acid, a dimer of gallic acid, and derivatives 
found in berries, eg., raspberry and strawberry; lignans found in flax seeds, sesame, and grains; 
and curcumin found in turmeric (Tsao, 2010). 
1.9.2. Bioavailability and metabolism of polyphenols 
A definition of bioavailability is the proportion of the food or nutrient that is digested, absorbed, 
enters the circulation and has an active effect (D Archivio et al., 2007). As xenobiotics that undergo 
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extensive presystemic metabolism, polyphenols have low bioavailability which varies among 
different classes of polyphenols (Cardona et al., 2013). Furthermore, the absorption of polyphenols 
varies and depends on molecular weight and degree of structural complexity (polyphenols with 
low molecular weight such as monomeric or dimeric are readily absorbed in small intestine while 
polyphenols with higher molecular weight such as polymeric or oligomeric reach the colon almost 
unchanged)(Appeldoorn et al., 2009). Approximately 5-10% of total polyphenol intake is absorbed 
in the small intestine and 90-95% of total intake reaches the colon. The colonic microbiota 
extensively break down the polyphenolic parent structures into smaller and absorbable phenolic 
molecules (Cardona et al., 2013). The major focus of the previous studies had been on the 
bioavailability and activities of the polyphenolic parent compounds while today a growing number 
of studies investigate the biological activities of their metabolites (Forester and Waterhouse, 2010; 
Tsuda, 2018). For example, the bioavailability of anthocyanins can be as low as 0.1%; however, 
the bioavailability of its colonic degradation products and metabolites (eg., protocatechuic acid, 
syringic acid, vanillic acid) can reach as high as 10% and more in the blood (Czank et al., 2013).     
In the small intestine, flavonoids are hydrolyzed to aglycones as a result of the action of lactase 
phloridzin hydrolase and β-glucosidases (located on the brush border of small intestine). An 
alternative enzyme to hydrolyze flavonoids exists in epithelial cells known as cytosolic β-
glucosidase (Day et al., 2000; Gee et al., 2000). For the CBG-catalyzed hydrolysis route, 
flavonoids in the glycoside form need to enter epithelial cells through the activity of sodium-
dependant glucose transporter 1 (SGLT1) (Del Rio et al., 2013). At the next step, hydrolysed 
flavonoids are conjugated to O-glucuronides, sulfate esters, and O-methyl esters by intestinal 
enzymes. Almost all polyphenols are present as conjugated forms, while aglycone forms are hardly 
seen in the plasma (Landete, 2012). Therefore, the form of polyphenols in plasma and tissue is 
different than those of present in the foods. Molecules not conjugated by the intestine can be 
subsequently conjugated by the liver to facilitate their excretion through urine and bile 
(Thilakarathna and Rupasinghe, 2013). Polyphenols that are not absorbed in the small intestine 
and reach the colon, are hydrolyzed to aglycones and metabolized to derivatives of benzoic acid 
by microflora (D Archivio et al., 2007).  
There are some exceptions regarding absorption of polyphenols (D Archivio et al., 2007). For 
example, anthocyanins are mostly found as glycosides in the plasma due to the stability of 
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glycosides in comparison to aglycone forms. Moreover, glycosylation of resveratrol protects it 
from oxidation, and resveratrol glycoside is more soluble and more readily absorbed in the 
gastrointestinal tract. Glycosylation also facilitates absorption of quercetin; thus, absorption 
efficiency of quercetin glycoside is higher than that of the aglycone form.  All polyphenols except 
flavanols (catechins) exist in the glycosylated forms and resist acid hydrolysis in the stomach (Gee 
et al., 1998). Some experimental studies carried out in rats show that some flavonoids such as 
quercetin are absorbed in the stomach but only in the aglycone form (Crespy et al., 2002; Piskula 
et al., 1999). Moreover, recent studies show that other than quercetin, anthocyanins could be 
absorbed in the stomach (Matuschek et al., 2006; Passamonti et al., 2005; Talavera et al., 2003).   
1.9.3. Polyphenols and cancer prevention 
Both in vitro and in vivo studies suggest that polyphenols have anti-cancer properties. Polyphenols 
are known to cause apoptosis of cancer cells in vitro (D’Archivio et al., 2008). With regard to 
cancer prevention, epidemiological studies strongly implicate protection by dietary polyphenols 
(Athar et al., 2007; Bishayee, 2009; Yang et al., 2009). A variety of experimental studies also show 
cancer preventive effects of polyphenols at early stages of carcinogenesis and neoplastic 
transformation (for reviews see Lin et al., 2008; Shukla and Singh, 2011; Farraz da Costa et al., 
2017; Clementino et al., 2017). Polyphenols may prevent carcinogenesis and neoplastic 
transformation via multiple mechanisms including modulation of carcinogen metabolism, 
inhibition of oxidative stress and mitochondrial dysfunction, modulation of inflammation, 
induction of mitochondrial biogenesis, regulation of apoptosis, regulation of the cell cycle, and 
inhibition of angiogenesis and metastasis (del Mar Blanquer-Rosselló et al., 2017; Lin et al., 2008; 
Shukla and Singh, 2011). 
1.9.3.1. Polyphenols and preventing cancer initiation and promotion 
Polyphenols can prevent cancer initiation and promotion through various mechanisms including 
inhibition of the activation of oncogenes and genes involved in oxidative stress and inflammation 
(Lin, 2004; Villegas et al., 2008). Recent studies have shown that tea polyphenols, specifically 
epigallocatechin-3-gallate (EGCG), can protect against carcinogenesis by modulating epigenetic 
aberrations such as histone modifications, DNA methylations, and microRNAs. ECGC inhibits 
DNA methylation by altering activity of DNA methyltransferase enzymes, which may contribute 
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to its chemopreventive and chemotherapeutic effects (Bag and Bag, 2018; Henning et al., 2013). 
In addition to tea polyphenols, other polyphenols such as resveratrol, curcumin, and genistein have 
shown cancer preventive effects by altering DNA methylation levels in tumor suppressor genes 
(Dammann et al., 2017). Furthermore, polyphenols also prevent cancer initiation and promotion 
through modulation of phase I and phase II cytochrome P450 enzymes, inhibition of oxidative 
stress and inflammation, and reduction in DNA damage (Clementino et al., 2017; Ferraz da Costa 
et al., 2017). 
1.9.3.2. Polyphenols and preventing cancer progression 
In the last decade, anthocyanins have emerged as intriguing anti-cancer agents. For instance, 
delphinidin (10-50 µM) sensitized LNCaP and Du145 prostate cancer cells to TRAIL-mediated 
apoptosis through increasing protein expression of death receptor 5 (DR5), cleavage of histone 
deacetylase 3 (HDAC3), and modulation of BCL-2 family proteins (Ko et al., 2015). A bilberry 
extract containing 50% anthocyanins administered to patients with B cell chronic lymphocytic 
leukemia (B CLL) induced apoptotic pathways via activation of caspase 3 and down-regulation of 
BCL-2 family and UHRF1, an oncogene over-expressed in many cancer cells (Alhosin et al., 
2015). Delphinidin-3-O-glucoside and delphinidin-3-O-rutinoside were identified as exerting 
apoptotic effects of the bilberry extract.  
Investigations have shown the impact of several polyphenols on regulation of the cell cycle in 
cancer. Epidemiological and experimental studies have demonstrated that curcumin prevents 
growth of cancer cells through cell-cycle arrest. An inhibition of G1 to S transition is triggered by 
curcumin (10 µM) in human colorectal carcinoma cells (HCT116) (Basile et al., 2009). Quercetin 
(10-75 µM) was reported to have anti-proliferative effects through cell cycle arrest in S phase in 
Human Papillary Thyroid Cancer (B-CPAP) Cells (Mutlu Altundağ et al., 2016). Moreover, 
EGCG blocked the progression of the cell cycle at the G1 phase in HepG2 cells (Huang et al., 
2009). EGCG (3.125-50 µM) inhibited cell proliferation in oral squamous cell carcinoma (OSCC) 
cells by overexpression of B-cell translocation gene 2 (BTG2), whereas BTG2 knockdown 
revealed the opposite effect in xenograft animals injected with SAS cells (Lee et al., 2015). BTG2 
is an important regulator of cell proliferation by inhibiting expression of cell cycle proteins such 
as cyclin D1 and cyclin E (Hu et al., 2012). BTG2 expression is regulated by mitogen activated 
protein kinase (MAPKs) superfamily including extracellular signal regulated kinases (ERKs), c-
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Jun N-terminal kinases (JNKs), and p38. Polyphenols can modulate MAPKs superfamily and 
EGCG was shown to arrest the cell cycle at G1 phase and increase BTG2 expression through 
phosphorylation of p38 MAPK signaling pathway, and decrease cell proliferation via 
phosphorylation of ERK, JNK, and p38 pathways (Shih et al., 2016; Wang et al., 2014). As well, 
resveratrol and its analogs inhibited cell proliferation via modulating cyclins and cyclin-dependent 
kinases (CDK) in oral squamous cell carcinoma cell (Yu et al., 2016), glioblastoma (Chelsky et 
al., 2015), human epidermoid carcinoma (Ahmad et al., 2001), and liver carcinoma (Kuo et al., 
2002). 
1.9.4. Mechanisms of cancer prevention by polyphenols 
1.9.4.1. Anti-oxidative effects of polyphenols 
The human body contains an elaborate antioxidant defence that protects cellular components from 
oxidative damage. An antioxidant is defined as “any substance that, when present in low 
concentrations compared to that of an oxidizable substrate, significantly delays or inhibits the 
oxidation of that substrate” (Halliwell, 1995; Sies, 1993). The antioxidants that directly react with 
oxidants to protect cellular compounds from oxidation are classified as enzymatic (e.g. superoxide 
dismutase, glutathione peroxidase, and catalase) and non-enzymatic (e.g. ascorbic acid, GSH, and 
tocopherol) (Boots et al., 2008). In contrast to enzymatic antioxidants that catalyse oxidant 
removal, non-enzymatic antioxidants directly react with oxidants, donate an electron or hydrogen 
atom, scavenge the oxidant and are converted to a free radical in turn. Therefore, other antioxidants 
are needed to reduce free radicals produced from oxidation of antioxidants. 
Accumulating data have shown antioxidant effects of polyphenols in vitro and in vivo. Among all 
polyphenols, flavonoids have been known as strong antioxidants, where the antioxidant capacity 
of some flavonoids is higher than vitamin E and vitamin C (Prior and Cao, 2000). The 
configuration and number of hydroxyl groups on the B ring is the most significant factor 
determining the ROS scavenging strength of flavonoids (Kumar and Pandey, 2013). However, the 
role of hydroxyl groups on the A and C ring also has some effects on the ROS scavenging ability 
of flavonoids. The ortho-dihydroxy (catechol) on the B ring (Figure 1.6) is the most efficient 
configuration to scavenge ROS, which is common in the structure of flavonoids and contributes to 




Figure 1.6. An ortho-dihydroxy structure on the B ring of flavonoids 
Flavonoids protect cellular compounds from oxidative damage through multiple mechanisms. 
These include scavenging of ROS, chelating of metal ions, up-regulation and activation of 
antioxidant enzymes, direct effects on ROS generation, reduction of vitamin E radicals (α-
tocopheryl), and inhibition of oxidases (Leopoldini et al., 2011; Procházková et al., 2011; Sun et 
al., 2009).  Flavonoids work as antioxidants at two levels, either ROS removing or inhibiting ROS 
formation. In the first level, flavonoids remove ROS by direct scavenging or modulation of 
antioxidant enzyme activity, while in the second level they prevent ROS formation via metal 
chelating and inhibition of ROS producing enzymes (Sandoval-Acuña et al., 2014). 
The ability of flavonoids to remove ROS is determined by their free radical scavenging ability as 
well as their ability to modulate expression of antioxidant enzymes. Polyphenols can react with 
free radicals such as superoxide and hydroxyl radical to scavenge ROS. This antioxidant property 
of polyphenols belongs to the benzene ring-bound hydroxyl groups, which can either donate a 
hydrogen atom or single electron to ROS. Alternatively, polyphenols are sometimes observed to 
up-regulate antioxidant enzymes (ROS-removing enzymes) such as superoxide dismutase, catalase 
and glutathione peroxidase (Na and Surh, 2008). Flavonoids up-regulate phase II enzymes through 
activation of nuclear factor (erythroid-derived 2)-like 2 (Nrf2), resulting in up-regulation of genes 
controlled by the antioxidant response element (ARE) (Chiva-Blanch and Visioli, 2012; Na and 
Surh, 2008). Nrf2 translocation from the cytosol to the nucleus is inhibited by Kelch-like-ECH-
associated protein 1 (Keap1), a cytosolic binder of Nrf2. Polyphenols directly, or as a conjugated 
form with GSH, can stimulate Nrf2 dissociation and translocation to nucleus. In the nucleus, Nrf2 
binds to ARE to induce phase II enzymes expression (Kansanen et al., 2013). 
The ability of flavonoids to inhibit ROS formation can occur through inhibition of the generation 
of ROS by redox-active transition metals such as iron and copper, influence of polyphenol redox 
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activities in mitochondrial membranes to reduce production of superoxide by complex I, II and III, 
(or by effects on mitochondrial biogenesis, as will be discussed later), and by inhibition of ROS-
producing enzymes, such as xanthine oxidase (OX) and mitochondrial bound monoamine oxidase 
(MAO)(Lagoa et al., 2011; Sandoval-Acuña et al., 2014). 
Several studies have investigated the effect of polyphenols on B[a]P-induced ROS and cancer. For 
example, quercetin (10 µM) significantly decreased ROS generation produced by co-exposure of 
B[a]P and UVA radiation in A539 epithelial cells (Woo et al., 2008). Catechins (epicatechin (EC), 
epicatechin-3-gallate (ECG), epigallocatechin (EGC) or epigallocatechin-3-gallate (EGCG)) 
significantly decreased ROS in human breast epithelial cell line MCF10A exposed to combined 
B[a]P and nicotine-derived nitrosamine ketone (NNK) (each 100 pmol/L) (Rathore et al., 2012). 
Silymarin showed protective effects against B[a]P-induced oxidative stress in peripheral blood 
mononuclear cells (PBMC) by modulating glutathione metabolizing enzymes and decreasing the 
formation of protein oxidation products and other ROS mediated damage (Kiruthiga et al. (2010)). 
As well, in vivo quercetin (25 mg/kg b/w twice a week starting one week prior to, or at the end of 
B[a]P administration) decreased lung and serum TBARS and reversed decreases in the levels of 
antioxidants (GSH, vitamin E and vitamin C) and activity of antioxidant enzymes (SOD, CAT, 
GPx, GST, GR) in B[a]P-induced lung cancer (Kamaraj et al., 2007). Fisetin significantly 
decreased lung and plasma lipid peroxidation, and restored levels of enzymatic and non-enzymatic 
antioxidants in B[a]P exposed animals. (Ravichandran et al., 2011).  
1.9.3.4. Polyphenols and inflammation  
There are extensive data showing anti-inflammatory effects of polyphenols. Polyphenols exert 
their anti-inflammatory roles through multiple mechanisms including (a) antioxidant and radical 
scavenging activities, (b) modulation of arachidonic acid metabolism (by regulating 
cyclooxygenase, phospholipase A2, and lipoxygenase) and nitric oxide synthase activity, and (c) 
modulation of gene expression and production of pro-inflammatory molecules (García-Lafuente 
et al., 2009). 
Phagocytosis, a crucial event in inflammation performed by neutrophils and macrophages, is 
accompanied by superoxide anion production. In addition to ROS production, a high concentration 
of nitric oxide is synthesized by inducible nitric oxide synthase (iNOS) in macrophages. Nitric 
oxide reacts with superoxide and produces highly detrimental peroxynitrite, which has the ability 
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to oxidize LDL and cause irreversible damage to cell membranes and other components (Groot 
and Rauen, 1998; Haenen et al., 1997). Many studies have shown flavonoids to inhibit 
inflammation by protecting against ROS and nitric oxide generation (Cijo George et al., 2016; Pan 
et al., 2010).  
Furthermore, many studies have shown that flavonoids have inhibitory effects on the activity of 
arachidonic acid metabolizing enzymes including phospholipase A2, cyclooxygenase (COX) and 
lipoxygenase which are involved in inflammation (García-Lafuente et al., 2009). In a cell-free 
assay, the impact of wines and wine constituents on COX-1, COX-2, and 5-lipoxygenase catalytic 
activity showed that red wine was a strong inhibitor of the activity of all three enzymes (20-94%), 
while white wine was identified as a strong inhibitor of 5-lipoxygenase (41-68%) but had no 
inhibitory effect on COX-1 and COX-2. trans-Resveratrol was identified as the strongest inhibitor 
of COX-1 and COX-2 (Kutil et al., 2014). 
Gene expression regulation is one of the mechanisms by which flavonoids modulate inflammation. 
Flavonoids regulate cellular inflammation through several protein kinases, including protein 
kinase C (PKC) and MAPK, as well as transcriptional factors such as NF-κB and AP-1 that are 
involved in signal transduction (García-Lafuente et al., 2009). MAPKs link extracellular 
inflammatory signals to intracellular responses such as NF-κB. NF-κB regulates expression of 
multiple inflammatory mediators such as TNF-α, IL-6, IL-8, COX-2, and iNOS (Barnes and Karin, 
1997). Several studies have shown an inhibitory impact of different polyphenols on the 
MAPK/NF-κB pathway (Gutiérrez-Venegas et al., 2014; Min et al., 2007; Nafees et al., 2015).  
1.9.3.5. Anti-genotoxicity effect of polyphenols 
DNA damage is a fundamental contributor to cancer by carcinogens. Carcinogens are a major 
cause of 4 leading cancers worldwide including lung, breast, colon and stomach cancers (Bernstein 
et al., 2008; Bernstein et al., 2013). Carcinogens including chemical carcinogens, ionizing 
radiation, ultraviolet (UV) radiation, and many pharmaceuticals attack both nuclear and 
mitochondrial DNA and cause several kinds of DNA lesions. The lesions may result in DNA 
mutations and genome instability which consequently induce tumorigenesis (Langie et al., 2015; 
Roos et al., 2015). 
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Many studies have shown anti-genotoxicity effects of different polyphenols (Azqueta and Collins, 
2016; Eghbaliferiz and Iranshahi, 2016; Mazzoni et al., 2016). One of the well-studied carcinogens 
that polyphenols are able to protect against is B[a]P. Oral treatment with catechin for example was 
able to protect against B[a]P genotoxicity in mice (Shahid et al., 2016). Similarly, black soybean 
seed coat (4.85 µg/mL) and its main polyphenols, procyanidins and cyanidin-3-glucoside (10 µM), 
significantly decreased B[a]P-induced genotoxic effects in human hepatoma HepG2 cells and ICR 
mice. These polyphenols prevented DNA damage by decreasing micronucleus (DNA damage) and 
cytochrome P4501A1 (CYPA1A1) expression, as well as by enhancing glutathione S-transferases 
(GSTs) expression and DNA-binding activity of nuclear factor-erythroid-2-related factor 2 (Nrf2) 
(Zhang et al., 2013). Treatment with the polyphenol resveratrol (10-50 µM) also protected 
bronchial epithelial cells and animal lung (50 mg/kg/week) against bulky DNA formation and 
DNA damage induced by B[a]P (Berge et al., 2004; Revel et al., 2003). In addition to B[a]P, 
polyphenols also protect against DNA damage induced by other carcinogens such as triclocarban 
(TCC) (Sood et al., 2013) and arsenic (Rahman et al., 2009). In a chemoprevention study against 
arsenic carcinogenesis, treatment with green tea extract (10 mg/ml/100 g body weight/day for 28 
days) decreased DNA fragmentation and reversed arsenic-induced DNA damage in the liver tissue 
of animals fed with sodium arsenite (0.6 ppm/100 g body weight/day)(Acharyya et al., 2015). Due 
to the increasing levels of environmental carcinogens in the last decades and their association with 
high prevalence of several types of cancer, the anti-genotoxicity role of polyphenols has become 
an intriguing area of chemoprevention. Different polyphenols show promising protective effects 
against several kinds of carcinogen-induced DNA damage.  
 1.9.3.6. Polyphenols and energy metabolisms 
Several studies have shown the effects of different polyphenols on energy metabolism in cancer 
cells. Due to a high rate of glycolysis, cancer cells have a higher demand for glucose; thus, glucose 
uptake is significantly increased in cancer cells (Epstein et al., 2017). Polyphenols can inhibit 
glucose uptake through interfering with glucose transporters with subsequent effects on glycolysis 
(Moreira et al., 2013; Tan et al., 2016). This interference may involve down regulation of key 
glucose transporters such as glucose transporter 1 (GLUT1)(Azevedo et al., 2015). GLUT1 has 
been suggested as an oncogene due to its over-expression in most cancer cells (Furuta et al., 2010), 
and an association between over-expression of GLUT1 in cancer cells and proliferative index, 
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invasiveness, and poor prognosis. In addition to a direct effect on glucose transporters, polyphenols 
modulate energy metabolism in cancer cells through regulation of transcription factors and 
enzymes as well as molecular pathways involved in glycolysis (Keating and Martel, 2018). For 
example, HIF-1α has become an important target in cancer drug discovery, and polyphenols can 
down-regulate HIF-1α, and consequently suppress glycolysis (Jung et al., 2013; Wang et al., 2015; 
Wilson and Poellinger, 2002). Moreover, polyphenols inhibit glycolysis by regulating glycolytic 
enzymes such as hexokinase II (HKII) (Wang et al., 2015). For instance, EGCG, one of the most 
common catechins found in green tea, down-regulated protein expression of HKII in the Tca8113 
and TSCCa human tongue squamous cell carcinoma cell lines and decreased glucose consumption 
and lactate production (Gao et al., 2015). Polyphenols can inhibit glycolysis by decreasing other 
glycolytic enzymes as well (Gomez et al., 2013; Takasawa et al., 2010).  
Polyphenols can inhibit glycolysis also by regulating cell signaling pathways. Quercetin for 
example was shown to inhibit the PI3K/Akt pathway in lymphoma cells, and suppress growth 
(Maurya and Vinayak, 2015). The PI3K/Akt pathway is highly activated in tumor cells and is a 
major regulator of glycolysis.  In normal cells PI3K is negatively controlled by the PTEN which 
loses its activation in cancer cells. Activation of the PI3K/Akt pathway increases glucose 
consumption by tumor cells and results in 90% conversion of pyruvate to lactate. Activation of 
this pathway also stimulates hexokinase II binding to the mitochondrial surface by its 
phosphorylation (Wallace, 2012). 
Finally, in addition to glycolysis inhibition, induction of mitochondrial oxidative phosphorylation 
is considered a key mechanism involved in cancer prevention (Chattopadhyay et al., 2016; Keijer 
et al., 2011). Studies in cancer and non-cancer cells have shown that some polyphenols induce 
mitochondrial proteins, therefore, increase mitochondrial respiratory capacity (del Mar Blanquer-
Rosselló et al., 2017; Gomes et al., 2012; Nichols et al., 2015).   
1.9.3.7. Polyphenols and mitochondrial biogenesis  
PGC-1α is a master regulator of mitochondrial biogenesis that regulates expression of NRF1 and 
EERα and subsequently TFAM and NRF2 (Jornayvaz and Shulman, 2010). Consequently, PGC-
1α regulates transcription and replication of mtDNA and other genes involved in mitochondrial 
function. PGC-1α is deacetylated and phosphorylated by SIRT1 and AMPK, respectively 
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(Sandoval-Acuña et al., 2014). Accumulating evidence shows positive effects of different 
polyphenols on mitochondrial biogenesis (Csiszar et al., 2009; Davis et al., 2009; Grabacka et al., 
2014; Lagouge et al., 2006). However, the role of polyphenols in mitochondrial biogenesis and 
cancer prevention is not well-studied.  
Resveratrol is a well-studied polyphenol in this area and several studies have demonstrated roles 
of this stilbene in elevating mitochondrial biogenesis via activating the SIRT1/PGC-1α pathway. 
For instance, Lagouge et al., (2006) showed that dietary resveratrol (4 g/kg of food) in mice fed a 
high-fat diet, decreased muscle acetylated PGC-1α and increased expression and activity of PGC-
1α through the SIRT1 pathway. In another study carried out by Csiszar et al., (2009), treatment of 
coronary arterial endothelial cells with 10 µM resveratrol significantly increased protein and 
activity of SIRT1, which resulted in increased mitochondrial mass as well as expression of PGC-
1α, NRF-1, TFAM, and mitochondrial complexes, in a SIRT1-dependent manner. They also 
demonstrated their results in the aorta of type 2 diabetic mice given a 20 mg/kg dose of resveratrol 
for 4 weeks. Although one study in SW620 colon cancer cells showed increased mitochondrial 
mass and function without an increase in mtDNA (Blanquer-Rosselló et al., 2017), resveratrol has 
been observed to produce an increase in mtDNA copy number in other cells such as oocytes and 
neuroblastic PC12 cells (Peng et al., 2016; Sugiyama et al., 2015). 
Quercetin and some other polyphenols also induce mitochondrial biogenesis. In mice quercetin 
induced expression and activity of SIRT1 and PGC-1α as well as mtDNA content and cytochrome 
c concentration in both skeletal muscle and brain (Davis et al., 2009). This was associated with 
improved maximal physical endurance capacity and prolonged exercise activity. Supplementation 
with quercetin has also been shown to increase exercise performance in humans (MacRae and 
Mefferd, 2006; Nieman et al., 2010), although increases in muscle markers of mitochondrial 
biogenesis (mtDNA, SIRT1, PGC-1α, citrate synthase, and cytochrome c oxidase) were not 
significant (Nieman et al., 2010). Resveratrol, quercetin, epigallocatechin gallate, genistein, 
daidzein, and apigenin increased mitochondrial biogenesis biomarkers such as TFAM, COX1 
(complex IV subunit), CYB (complex III subunit), and mitochondrial content in a C2C12 muscle 
cell line (Yoshino et al., 2015).   
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Anthocyanins have shown different effects on mitochondrial biogenesis. Early in vitro studies 
showed that anthocyanins did not activate SIRT1 (even partially inhibiting) (Howitz et al., 2003). 
However, in a later in vivo study, purified anthocyanins from bilberry and black currant (1g 
purified anthocyanins per kg food) in mice with non-alcoholic fatty liver disease caused elevated 
mtDNA and expression of mitochondrial respiratory chain complexes, and increased activation of 
AMPK and expression of PGC-1α (Tang et al., 2015). In human umbilical vein endothelial cells 
(HUVECs), delphinidin increased expression of parameters involved in mitochondrial biogenesis 
(NRF1, ERRα, TFAM, and TFB2M), but did not increase mitochondrial respiration, enzyme 
activities or content of mtDNA (Duluc et al., 2014). The reason for the different effects of 
anthocyanins in different in vitro or in vivo studies is unclear. One possible explanation may be 
effects of anthocyanins themselves versus their breakdown products. 
In summary, preventive/therapeutics roles of polyphenols have been shown in several diseases 
including cancer. However, preventive effects of polyphenols on mitochondrial changes such as 
decreasing mitochondrial biogenesis in early stages of carcinogenesis are not well studied. In the 
current study, we investigated the roles of different classes of polyphenols in B[a]P-induced 













CHAPTER 2: RATIONALE, HYPOTHESES AND OBJECTIVES 
2.1. Rationale 
Cancer is one of the major leading cause of mortality in Canada and is responsible for 
approximately 30% of annual deaths (Nuttall et al., 2016). Annually, cancer treatment imposes 
high expenses on society and mental stress on patients and their families. Therefore, cancer 
prevention has attracted the interest of researchers for many years and is considered as a possible 
approach to reduce risk of cancer development. Among tactics used for cancer prevention, 
chemoprevention is considered as a promising approach using natural or synthetic compounds to 
inhibit cancer initiation and promotion. The fundamental goal of prevention is to decrease cancer 
incidence by blocking or delaying the process of cancer development (Yao et al., 2011).  
While much research has focused on mitochondria in cancer cells and in progression of 
transformed cells, less is known about mitochondrial changes in the early initiation and promotion 
stages of carcinogenesis and neoplastic transformation. Mitochondrial dysfunction is known as 
one of the main triggers of cancer development by initiating or exacerbating cancer hallmarks 
including evasion of apoptosis, abnormal metabolic pathways, genome instability, inflammation, 
and modulating the cell cycle and cell survival (Boland et al., 2013). Mitochondrial dysfunction 
also causes a shift in energy from oxidative phosphorylation to aerobic glycolysis (Warburg effect) 
which exacerbates cancer development (Warburg, 1956). 
Accumulation of mutations in both mtDNA and nDNA-encoded mitochondrial genes as well as 
decreased number of mitochondria have been identified in different types of cancer (Brandon et 
al., 2006; Chattopadhyay et al., 2016; García-Ruiz et al., 2013; Taylor and Turnbull, 2005). 
Mutations in mitochondrial genes can perturb the electron transfer chain and increase reactive 
oxygen species (ROS) production (Bandy and Davison, 1990). The resulting mitochondrial 
dysfunction and cellular oxidative stress may contribute to nuclear DNA mutations and a shift in 
energy metabolism from oxidative phosphorylation to glycolysis. Due to the importance of 
mitochondrial dysfunction in carcinogenesis, targeting mitochondrial biogenesis may be important 
for cancer prevention.  
A role for mitochondrial biogenesis in improvement of several diseases such as metabolic 
syndrome and cardiovascular disease has been previously reported (Ren et al., 2010). However, 
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not much is known regarding the role of mitochondrial biogenesis in cancer prevention. In non-
cancer models, increased mitochondrial biogenesis results in induction of ROS-detoxifying 
enzymes and a reduced level of ROS production (Guarente, 2008; Kong et al., 2010). Decreased 
ROS can protect cells from further DNA damage and signal transduction that can lead to cancer 
development. 
There are a few studies which have investigated the role of increased mitochondrial biogenesis in 
decreasing cancer progression (Bellance et al., 2009; Wang and Moraes, 2011), but none on its 
role in cancer prevention in the initiation and promotion phases of carcinogenesis. Since 
carcinogens that produce mitochondrial mutations may decrease the efficiency of oxidative 
phosphorylation and increase ROS production, elevated mitochondrial biogenesis could 
theoretically produce more functional mitochondria with efficient electron transfer chains (ETC) 
and low ROS generation, and thereby help prevent oxidative stress-mediated carcinogenesis. 
However, data showing the association between mitochondrial biogenesis and ROS generation in 
cancer prevention is lacking and needs to be elucidated.  
Unrepaired DNA damage from carcinogens is a major cause of cancers worldwide including lung, 
breast, colon, and stomach cancers (Bernstein et al., 2013; Bernstein et al., 2008). Carcinogenic 
stresses including from chemicals, pharmaceuticals, ionizing radiation, ultraviolet (UV) radiation, 
inflammation and ROS cause damage to both nuclear and mitochondrial DNA and produce several 
kinds of DNA lesions. The lesions may result in DNA mutations and genome instability, which 
consequently result in cancer initiation and progression (Langie et al., 2015; Roos et al., 2015). 
Benzo[a]pyrene (B[a]P) is recognized as a group 1 carcinogen by the International Agency for 
Research on Cancer (IARC). Binding of B[a]P diol epoxide metabolites to DNA and formation of 
bulky adducts in DNA is the major mechanism of B[a]P-induced mutagenesis and carcinogenesis 
(Conney, 1982). In addition to nDNA, B[a]P also forms adducts in mtDNA and causes mtDNA 
damage and mutations (Backer and Weinstein, 1980; Backer and Weinstein, 1982; Jung et al., 
2009). Studies have revealed that mitochondria are a major target of B[a]P, in part due to weak 
error excision repair systems (Lewis et al., 2001). Damage to mtDNA by a mutagen such as B[a]P 
may cause mitochondrial dysfunction which leads to aberrant ROS generation and increased 
aerobic glycolysis.  
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Experimental and epidemiological studies have demonstrated a direct association between 
consumption of fruits and vegetables and lowered risk of several cancers (Key, 2011; Van 
Duijnhoven et al., 2009). It has been estimated that approximately one-third of all cancer mortality 
in the US is preventable by appropriate modification of dietary habits (Liu, 2003). Therefore, using 
natural compounds has been suggested as an effective approach to cancer prevention. In this study, 
we focus on dietary polyphenols that have been of interest for their chemopreventive potential (He 
et al., 2008; Lall et al., 2015; Yang et al., 2008). 
Polyphenols are a large group of phytochemicals naturally occurring in a wide range of plant foods 
and beverages including fruits, vegetables, cocoa, cereal, tea, wine, beer, and coffee, and are 
characterized by their hydroxylated phenyl groups (Cardona et al., 2013). Polyphenols from 
different groups and food sources may prevent carcinogenesis through multiple mechanisms 
including effects on signal transduction pathways leading to enhanced apoptosis, as well as 
inhibition of cell proliferation, cell invasion, angiogenesis, and metastasis (Yang et al., 2009; Zhou 
et al., 2016). Moreover, a great portion of anti-carcinogenesis effects of polyphenols is thought to 
be due to their anti-oxidant and anti-inflammatory properties (Hu, 2011).  
Although antioxidant and anti-inflammatory effects of polyphenols have been widely investigated, 
their specific effects on mitochondria are less well known. One mitochondrial mechanism that has 
been investigated for anti-cancer (prevention or treatment) effects of polyphenols is induction of 
apoptosis (D’Archivio et al., 2008), although often this requires high concentrations. However, 
some other mitochondrial mechanisms by which polyphenols may prevent cancer initiation and 
promotion, such as effects on mitochondrial biogenesis or mitochondrial ROS generation are not 
well-understood. By increasing mitochondrial biogenesis and non-mutated copies of mtDNA, a 
polyphenol such as resveratrol may help minimize the effect of a mutagen such as B[a]P on 
mitochondria. 
Although some polyphenols have been shown to prevent carcinogenesis in rodents and humans 
(Athar et al., 2007; Yang et al., 2009), it is not known which polyphenols are the most potent and 
through what molecular mechanisms they act to inhibit carcinogenesis. Flavonoids of interest in 
the current research are quercetin, found in many fruits and vegetables, catechin found in green 
tea and cacao, and anthocyanins (such as cyanidin, delphinidin and malvidin), found in red-purple 
berries. Other polyphenols of interest in the current study are the stilbene, resveratrol, notable in 
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grapes and red wine, and the isoquinoline alkaloid, berberine (metabolized to a polyphenol), found 
in the plants and berries of berberis species such as Oregon grape and barberry. According to 
previous studies, berberine and anthocyanins can be taken up by mitochondria to a greater extent 
than other polyphenols (Peng, 2012; Serafim et al., 2008). Anthocyanins also have ROS 
scavenging properties due to their phenolic structure (Wang and Stoner, 2008). Therefore, we 
hypothesize that anthocyanins and berberine may protect against carcinogenesis by decreasing 
mitochondria-derived oxidative stress. Other polyphenols such as resveratrol and quercetin are 
known as inducers of mitochondrial biogenesis (Baur, 2010; Howitz et al., 2003), and as explained 
above we hypothesize that the increased mitochondrial biogenesis may help decrease the 
mutagenic impact of B[a]P and resulting mitochondrial dysfunction and ROS generation.  
Since cyanidin is a potent antioxidant and resveratrol is known as an inducer of mitochondrial 
biogenesis, the combination of these two polyphenols may have a combination effect on ROS 
generation. Therefore, we hypothesized that cyanidin and resveratrol will together decrease ROS 
generation more than either one alone through a direct effect on ROS generation and elevating 
mitochondrial biogenesis, respectively.  
To investigate our hypotheses, we used Bhas 42 cells which are v-Ha-ras-transfected mouse 
embryo fibroblast (BALB/c 3T3 A31-1-1) cells. Bhas 42 cells are used to identify potential 
genotoxic and non-genotoxic carcinogenic chemicals and carcinogenesis mechanisms. Bhas 42 
cells represent a multistage carcinogenesis model of tumor initiation and tumor promotion. Tumor 
initiator and promotor chemicals such as B[a]P and ROS induce transformation of the cells to a 
neoplastic phenotype (Asada et al., 2005; Sasaki et al., 2015). In the studies in this thesis therefore, 
I investigated in Bhas 42 cells the underlying mitochondrial mechanisms in B[a]P-induced 
carcinogenesis and prevention by different classes of polyphenols. 
2.2. Hypotheses 
The main hypothesis of this research is that different polyphenols such as resveratrol, quercetin, 
catechin, cyanidin, and cyanidin-3-glycoside (C3G), and the methoxyphenyl compound, 
berberine, will protect against B[a]P-induced cancer initiation and promotion in Bhas 42 cells with 
different effectiveness and mechanisms (in part through mitochondrial mechanisms). The detailed 
hypotheses of the study are: 
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1-  B[a]P will cause increased mitochondrial and intracellular ROS in its process of 
carcinogenesis in Bhas 42 cells. 
2- Berberine and anthocyanins will most effectively decrease mitochondrial ROS in B[a]P-
induced neoplastic transformation. 
3- Resveratrol and quercetin will prevent cancer initiation and promotion in part by inducing 
mitochondrial biogenesis. 
4- Resveratrol and anthocyanins will cooperatively decrease oxidative stress by increasing 
mitochondrial biogenesis and decreasing oxidative stress. 
2.3. Objectives  
Using the Bhas 42 cell in vitro model of carcinogenesis, the three main goals are: 
1- To determine the effect of B[a]P on intracellular and mitochondrial ROS generation during 
transformation of Bhas 42 cells. 
2- To determine the relative effectiveness of the selected polyphenols and their mechanisms in 
protecting against B[a]P-induced changes including, oxidative stress, inflammatory mediator 
production, mitochondrial dysfunction, and neoplastic transformation  
3- To determine the possible synergistic or cooperative antioxidant effect of resveratrol and 
anthocyanins on intracellular and mitochondrial ROS generation. 
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research questions in my PhD project, including effects on generation of intracellular ROS and 
mitochondrial superoxide as well as induction of neoplastic transformation by B[a]P and 













AP-1, activating protein 1; ARE, antioxidant response element; B[a]P, benzo [a]pyrene; ETC, 
electron transfer chain; MAPK, mitogen-activated protein kinases; NFκB, nuclear factor kappa b; 
NQO1, NAD(P)H quinone dehydrogenase 1; Nrf2, nuclear factor (erythroid-derived 2)-like 2; 
PAH, polycyclic aromatic hydrocarbons; PBS, phosphate-buffered saline; ROS, reactive oxygen 
species; SOD2, superoxide dismutase 2; SRB, sulforhodamine B; TCA, trichloroacetic acid; 
TNF-α, tumor necrosis factor-α1; UCP2, uncoupling protein 2. 
Abstract 
While dietary polyphenols are widely recognized for cancer-preventing characteristics, the relative 
effectiveness and mechanisms of action of different polyphenols is not clear. In the present study, 
we investigated the protective effects of six different polyphenols against benzo[a]pyrene (B[a]P)-
induced oxidative stress and neoplastic transformation in the Bhas 42 cell carcinogenesis assay. 
All of the polyphenols completely prevented the increased intracellular ROS generation by B[a]P 
at 12h, and most inhibited after 3 days. B[a]P increased mitochondrial superoxide generation at 
12h, which was inhibited by the anthocyanins and berberine. B[a]P increased expression of genes 
related to oxidative stress and inflammation (Nrf2, UCP2, and TNF-α) after 24h. Polyphenols 
strongly inhibited the increase in TNF-α and also several polyphenols inhibited the increase in 
UCP2. At 21 days after 72h treatment, B[a]P produced a large increase in the number of neoplastic 
colonies. This transformation was inhibited by resveratrol and quercetin, and strongly by 
resveratrol. In summary, all tested polyphenols were able to inhibit B[a]P-induced increases in 
markers of oxidative stress and inflammation, and to inhibit cellular transformation, with 
resveratrol being notable for the strongest preventive effect on cell transformation. The results 
support a role for dietary polyphenols in protecting against B[a]P-induced carcinogenesis. 
Keywords: oxidative stress, mitochondrial reactive oxygen species, polyphenols, neoplastic 




Epidemiological and experimental studies indicate a role of diet in development of many cancers 
such as colon, breast, stomach, and prostate cancers (Boada et al., 2016; Di Sebastiano and 
Mourtzakis, 2014), while consumption of polyphenol-rich fruits, vegetables and beverages has 
been widely implicated in cancer prevention (Yang et al., 2009; Zanini et al., 2015). Two critical 
ways by which polyphenols may prevent cancer initiation and progression are by acting as anti-
oxidant and anti-inflammatory agents (Lee and Lee, 2006).  
Oxidative stress and inflammation are major contributors to cancer initiation and progression 
(Candido and Hagemann, 2013; Valko et al., 2006). Damage from reactive oxygen species (ROS) 
to biomolecules, particularly DNA, is one of the principal consequences of oxidative stress causing 
DNA mutations and genome instability (Kryston et al., 2011). Moreover, oxidative stress can 
initiate a cascade of cell signaling pathways that induce cell survival, cell proliferation, 
angiogenesis, and metastasis (Halliwell, 2007). One source of reactive oxygen species (ROS) in 
cells that has been linked to tumorigenesis is the mitochondrial electron transfer chain (Sabharwal 
and Schumacker, 2014). In addition, there is cross-talk between oxidative stress and inflammation, 
which can further accelerate the process of tumorigenesis (Candido and Hagemann, 2013).  
B[a]P is a carcinogenic polycyclic aromatic hydrocarbon (PAH) found in wood and cigarette 
smoke and grilled foods (Kazerouni et al., 2001; Smith et al., 2000). In part of its carcinogenic 
mechanism, B[a]P is activated to metabolites which can form bulky DNA adducts and cause 
mutations. In addition, B[a]P has been observed to increase oxidative stress in cultured cells (Zhu 
et al., 2014) and in vivo (Briede et al., 2004). Mechanisms by which B[a]P may induce ROS are 
through formation of B[a]P quinone metabolites, which undergo redox-cycling and result in 
production of superoxide and other ROS (Briede et al., 2004) or through mutations or other 
changes to mitochondria which increase ROS generation and may persist to promote the process 
of neoplastic transformation (Bandy and Davison, 1990; Sabharwal and Schumacker, 2014). 
B[a]P has been shown to induce neoplastic transformation in several in vitro systems , including 
in two-stage carcinogenesis transformation assays using BALB\c 3T3 cells (Li et al., 2015; Rowe 
et al., 2004; Sakai et al., 2003) and Bhas 42 cells  (Sakai et al., 2010). The Bhas 42 assay has been 
developed to detect both tumor initiating and promoting activities (Asada et al., 2005). Because 
ROS have both initiating and promoting activities (Storz, 2005), this assay was chosen for testing 
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the effects of B[a]P and polyphenols on ROS generation and cellular transformation. While B[a]P 
has been observed to increase oxidative stress in some cell lines (Sigounas et al., 2010; 
Vijayaraman et al., 2012), a role for oxidative stress in B[a]P-induced transformation needs further 
investigation.  
Several studies have reported preventive effects of different polyphenols on neoplastic 
transformation and carcinogenesis induced by B[a]P in vivo or in vitro. In animal studies, oral 
delivery of polyphenols including quercetin, catechin, naringenin, curcumin, resveratrol, and a 
green tea extract have shown protection against B[a]P-induced changes in lung or other tissues 
(Banerjee et al., 2016a; Cao et al., 2011; Kasala et al., 2015; Liu et al., 2015; Shahid et al., 2016). 
In in vitro studies of cell transformation using BALB/c 3T3 cells, protection has been reported 
against B[a]P from polyphenol-rich extracts of passion fruit and mango (Percival et al., 2006; 
Rowe et al., 2004), and against other carcinogens by a resveratrol-containing extract or quercetin 
(Müller et al., 2011; Sakai et al., 1990). Although these studies showed preventive roles of different 
polyphenols on B[a]P-induced carcinogenesis, it is not known which polyphenol is the strongest 
and by which mechanisms. Moreover, prevention by different polyphenols on neoplastic 
transformation through inhibiting oxidative stress has yet to be elucidated.  
In this study, we used the Bhas 42 cell model to investigate the effects of B[a]P and different 
polyphenols on intracellular oxidative stress and neoplastic transformation. Objectives were to 
gain insight into the involvement of oxidative stress and related gene expression in neoplastic 
transformation by B[a]P, and to compare the protection by different polyphenols and the 
mechanisms involved. Therefore, we investigated the preventive effects of selected polyphenols 
of different classes that have shown promise as anticarcinogens in previous studies - resveratrol, 
berberine, and several classes of flavonoids (quercetin, catechin, and anthocyanins).  
3.2. Materials and Methods 
3.2.1. Chemicals and reagents 
Cyanidin and cyanidin-3-glucoside (C3G) were purchased from Extrasynthese (Genay, France). 
MitoSOX and 2,7-dichlorodihydrofluorescein diacetate (DCFH-DA) fluorescent dyes were 
purchased from Invitrogen (Carlsbad, CA, USA). TRIzol reagent, VILO cDNA synthesis kit, and 
SYBR green master mix were purchased from Invitrogen (Carlsbad, CA, USA). RNAeasy mini 
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kit for isolating RNA was purchased from Qiagen (Germantown, MD, USA). All primers for qPCR 
were purchased from Integrated DNA Technology (Toronto, ON, Canada). Dulbecco’s Modified 
Eagle’s Medium (DMEM) with low glucose (1 g/l) was purchased from Thermo Fisher Scientific 
(Bartlesville, OK, USA). All other reagents were purchased from Sigma-Aldrich, (St. Louis, 
MO, USA). The purity of polyphenols used in this study were as follows: resveratrol ≥ 99%, 
quercetin ≥ 95%, catechin ≥ 97%, cyanidin ≥ 96%, C3G ≥ 96%, and berberine ≥ 90%. 
3.2.2. Cell culture 
The Bhas 42 cells, which are v-Ha-ras-transfected mouse embryo fibroblast cells, were obtained 
from the JCRB cell bank (Japanese Collection of Research Bioresources Cell Bank) and were 
cultured in DMEM containing 5 mM glucose, 5% fetal bovine serum, and 1% 
penicillin/streptomycin at 5% CO2 and 37ºC.  
3.2.3. Intracellular ROS assay 
The level of intracellular ROS was determined by using 2,7-dichlorodihydrofluorescein diacetate 
(DCFH-DA). After seeding 20,000 Bhas 42 cells in a 96-well plate and growing for 24 hours, 
polyphenols at 5 µM were administrated in DMSO (final DMSO concentration 0.5 %). After 2h 
pre-treatment with polyphenols, 4 µM B[a]P was added and cells were incubated for 12-72h at 37 
ºC. After this incubation, 10 µM H2O2 was administrated to some control wells as a positive control 
and incubated for 1h. Then DCFH-DA at 25 µM final concentration dissolved in DMEM without 
FBS was loaded to each well. After incubating for 30 min all the wells were cautiously washed 
twice with phosphate-buffered saline (PBS) and read at 480/20 nm excitation and 528/20 nm 
emission using a microplate reader (BioTek, Synergy HT). Images were captured by fluorescence 
microscope (Olympus IX 71) at 473/31 nm excitation and 520/35 nm emission. We also measured 
intracellular ROS after pre-treatment with polyphenols at 5 µM for 2h and 4 µM B[a]P for 4h 
followed by replacing the medium with fresh medium and measuring ROS after 72h. 
3.2.4. Mitochondrial superoxide assay 
The level of mitochondrial superoxide was measured using MitoSOX red fluorogenic dye. After 
seeding 20,000 Bhas 42 cells for 24 hours and pre-treatment with polyphenols at 5 µM for 2 hours, 
B[a]P at 4 µM was administrated and cells were incubated for 12 hours in 5% CO2 at 37ºC. 
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Antimycin A (a cytochrome c reductase inhibitor) was added as a positive control and incubated 
for 30 minutes. Then, MitoSOX at 5 µM final concentration dissolved in DMEM without FBS was 
loaded to each well and plates were incubated for 30 minutes. Then wells were cautiously washed 
twice with PBS and read at 530±20 nm excitation and 590±20 nm emission using a microplate 
reader. Images were captured by a ZOE Cell Fluorescence Imager (Bio-Rad). 
3.2.5. Cell proliferation assay 
The sulforhodamine B (SRB) assay was conducted to observe the effect of polyphenols and B[a]P 
on proliferation of Bhas 42 cells. SRB is a bright pink dye which is used for anticancer-drug 
screening. Under a moderate acidic condition, SRB binds to protein residues and makes a sensitive 
index of cellular protein content that is linear with cell viability and cell proliferation (Vichai and 
Kirtikara, 2006). After seeding 20,000 Bhas 42 cells in 96 well-plates for 24 hours and pre-
treatment with polyphenols at 5 µM for 2 hours, B[a]P at 4 µM was administrated and cells were 
incubated for 24 and 72 hours in 5% CO2 at 37ºC. For fixation, cells were exposed to 
trichloroacetic acid (TCA) at 10% final concentration and kept at 4°C for 1 hour. After washing 
with running water, 100 μL of 0.057% (wt/vol) SRB solution was added to each well and the plate 
was kept at room temperature for 30 minutes. Then, wells were rinsed with 1% acetic acid to 
remove unbound dye. Plates were allowed to dry at room temperature, and then 10 mM Tris base 
solution (pH 10.5) was added to each well to solubilize protein-bound dye. Absorbance was 
measured at 510 nm using a microplate reader. 
3.2.6. RNA extraction, RNA quantification, and cDNA preparation  
To obtain RNA, 2x106 cells for each treatment group were seeded in 6-well plates and incubated 
for 24 hours. Polyphenols at 5 μM were administrated for 2 hours, then 4μM B[a]P was added to 
all treated groups. The untreated group was treated with 0.5% DMSO, the same concentration of 
DMSO applied to other groups. After 24h exposure, cells were lysed with Trizol, 1 ml for each 
well. Cell lysates were transferred to microtubes and 200 μL chloroform was added to each. After 
centrifuging and adding 500 μL isopropanol, RNA was extracted using the RNeasy Mini Kit. A 
NanoVue (GE Healthcare Bio-Sciences Corp, USA) spectrometer was used to measure the amount 
and quality of RNA. The quality of yielded RNA was with A260/A280 ratio ~2. cDNA was 
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synthesized in a 20 µl reaction using the SuperScript VILO cDNA Synthesis Kit and a Bio-Rad 
Thermocycler. 
3.2.7. Real-time polymerase chain reaction (PCR) 
Real-time RT-PCR was conducted to analyze mRNA expression using the Applied Biosystems 
7300 and SYBR green real-time PCR master mix, according to the manufacturer’s protocol. 
Thermal cycling for PCR was as follows: One cycle at 95oC for 5 min (for enzyme activation), 
followed by 40 cycles at 95oC for 15 s, and at 60oC for 30 s. Analysis of the results was performed 
by a comparative method (2−ΔΔCT) using beta actin as a reference gene. All results were normalized 
to the beta actin gene. Sequences of primers were used are as follows: B-actin (forward: CCT TCT 
TGG GTA TGG AAT CCT G, reverse: AGC ACT GTG TTG GCA TAG AG); UCP2 (forward: 
GGG TTC ATG CCT TCC TTT CT, reverse: GAG ATT GGT AGG CAG CCA TTA G); Nrf2 
(forward: GGC TCA GCA CCT TGT ATC TT, reverse: CAC ATT GCC ATC TCT GGT TTG); 
SOD2 (forward: GTA GAG CCT TGC CTG TCT TAT G, reverse: AAA CCC AGA GGC ACC 
ATT AC); TNF-α (forward: GAG GCA CTC CCC CAA AAG, reverse: GGG TCT GGG CCA 
TAG AAC T). 
3.2.8. Transformation assay 
The transformation assay was conducted according to the protocol of Sakai et al., (2011) with 
slight modification. After seeding 40,000 cells in a 6-well plate and incubating them in 5% CO2 at 
37ºC for 24 hours, polyphenols at 5 µM were administrated to the medium. After 2h pre-treatment 
with polyphenols, 4 µM B[a]P was added and cells were incubated for 21 days. Medium was 
replaced with the fresh medium (without polyphenols or B[a]P) at days 3, 7, 11, and 14. On day 
21 the cells were fixed with methanol and stained with 5% Giemsa’s solution. The number of 
transformed foci (colonies) were scored by counting under the microscope (at least twice for each 
well) considering the following morphological characteristics: (a) more than 100 cells, (b) spindle-
shaped cells different from the contact-inhibited monolayer cells, (c) deep basophilic staining, (d) 
random orientation of cells at the edge of foci, (e) dense multi-layering of cells and (f) invasive 
growth into the monolayer of surrounding contact-inhibited cells (Sakai et al., 2010). Colonies 
without these characteristics were recorded as normal colonies. For the transformation assay, two 
biological experiments with different batches of cells and polyphenols were conducted. In each 
experiment, one 6-well plate was assigned for each group. 
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3.2.9. Statistical analysis  
Data were analysed by one-way ANOVA and significant differences between groups was 
determined by Tukey’s post-hoc test and differences of p<0.05 were considered significant. 
Results are reported as means ± SEM of 2 - 3 independent experiments with 3 sample wells of 
cells per treatment condition per experiment; except for the transformation assay which was 6 
sample wells of cells per treatment condition per experiment. Correlation was determined by 
Pearson’s R. 
3.3. Results 
3.3.1. Effect of polyphenols and B[a]P on cell proliferation after 24h and 72h 
Treatment of Bhas 42 cells with B[a]P at 4 μM gave a significant 20% increase in cell proliferation 
after 24h (Fig. 3.1A), but no significant effect after 72h (Fig. 3.1B). In the results after 24h, 
quercetin, catechin, and cyanidin blocked the effect of B[a]P by 100%. In the results after 72h the 
same three polyphenols plus C3G decreased cell proliferation significantly by 16-22% compared 





Figure 3.1. Effect of polyphenols on B[a]P-induced cell proliferation in Bhas 42 cells after 24 
and 72 h. 
Cell proliferation was measured in Bhas 42 cells after pre-treatment with polyphenols at 5 µM for 
2h and treatment with 4 µM B[a]P after (A) 24h and (B) 72h by the SRB assay. Data are presented 
as percentage of the untreated cells. The figure represents means ± SEM of 3 independent 
experiments with 3 wells of cells per treatment condition in each experiment. The significant 
difference between groups was tested with one-way ANOVA followed by Tukey’s post-hoc test. 
* Significantly different from the UT group at p < 0.05. # Significantly different from the B[a]P 
group at p < 0.05.  UT, untreated cells; Res, resveratrol; Que, quercetin; Cat, catechin; Cyn, 
cyanidin; C3G, cyanidin-3-glucoside; Ber, berberine. 
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3.3.2. Effects of B[a]P and polyphenols on intracellular ROS and mitochondrial superoxide 
generation  
Analysis of intracellular ROS for 12h shows that treatment of Bhas 42 cells with 4 µM B[a]P 
significantly increased ROS generation by 25% compared to untreated cells (Fig. 3.2A&B). The 
additional presence of all of the polyphenols significantly decreased the ROS levels compared to 




Figure 3.2. Effect of polyphenols on B[a]P-induced intracellular ROS generation after 12 h. 
Intracellular ROS generation was measured using DCFH-DA, incubated for 30 min in Bhas 42 
cells after pre-treatment with polyphenols at 5 µM for 2h and treatment with 4 µM B[a]P for 12h. 
(A) Representative images of intracellular ROS generation captured by fluorescence microscope. 
(B) Quantification of intracellular ROS generation. Data are presented as percentage of the 
untreated cells. The figure represents means ± SEM of 3 independent experiments with 3 wells of 
cells per treatment condition in each experiment.  The significant difference between groups was 
tested with one-way ANOVA followed by Tukey’s post-hoc test. * Significantly different from 
the UT group at p < 0.05. # Significantly different from the B[a]P group at p < 0.05. 
Treatment with B[a]P for 72h induced ROS generation more than 200%, and all administrated 
polyphenols except cyanidin significantly inhibited this effect (Fig. 3.3A). C3G and berberine had 
the strongest effect, decreasing ROS by up to 76%, while resveratrol, quercetin, and catechin 
decreased ROS by ~ 60%. In the short-term exposure experiment, exposure to B[a]P for 4h 
increased ROS generation after 72h by 40% and polyphenols except resveratrol and quercetin 
significantly inhibited this effect (Fig. 3.3B). Cyanidin and berberine had the strongest effect and 




Figure 3.3. Effect of polyphenols on intracellular ROS generation with long- and short-term 
B[a]P exposure. 
Intracellular ROS generation was measured with DCFH-DA in Bhas 42 cells after pre-incubation 
with polyphenols at 5 µM for 2h and (A) adding 4 µM B[a]P for 72h and (B) adding 4 µM B[a]P 
for 4h then replacing media with fresh media and measuring after 72h. Data are presented as 
percentage of the untreated cells. The figure represents means ± SEM of 3 independent 
experiments with 3 wells of cells per treatment condition in each experiment.  The significant 
difference between groups was tested with one-way ANOVA followed by Tukey’s post-hoc test. 
* Significantly different from the UT group at p < 0.05. # Significantly different from the B[a]P 
group at p < 0.05. 
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Treatment of Bhas 42 cells with 4 µM B[a]P significantly increased mitochondrial superoxide 
generation by 52% compared to untreated cells, measured 30 min after adding MitoSox probe (Fig. 
3.4A&B). Among the polyphenols, cyanidin and C3G as well as berberine significantly decreased 










Figure 3.4. Effect of polyphenols on B[a]P-induced mitochondrial superoxide generation 
after 12 h. 
Mitochondrial superoxide was measured using MitoSOX Red, incubated for 30 min in Bhas 42 
cells after pre-treatment with polyphenols at 5 µM for 2h and treatment with 4 µM B[a]P for 12h. 
(A) Representative fluorescent and bright-field images of mitochondrial superoxide generation 
captured by ZOE Fluorescent Cell Imager. (B) Quantification of mitochondrial superoxide 
generation. Data are presented as percentage of the untreated cells. The figure represents means ± 
SEM of 3 independent experiments with 3 wells of cells per treatment condition in each 
experiment.  The significant difference between groups was tested with one-way ANOVA 
followed by Tukey’s post-hoc test. * Significantly different from the UT group at p < 0.05. # 
Significantly different from the B[a]P group at p < 0.05. 
3.3.3. Effects of B[a]P and polyphenols on gene expression 
Treatment of Bhas 42 cells with B[a]P significantly up-regulated mRNA expression of the UCP2 
gene by 70% after 24h compared to the untreated cells (Fig. 3.5A). Resveratrol, cyanidin, and 
berberine at 5 µM significantly inhibited B[a]P-induced UCP2 mRNA expression by 70, 87%, and 
90%, respectively. 
Analysis of gene expression showed that B[a]P significantly increased Nrf2 expression compared 
to untreated cells by 49% (Fig. 3.5B). None of the polyphenols significantly affected the 
expression compared to the B[a]P alone condition. 
Treatment with B[a]P had no effect on expression of SOD2 (Fig. 3.5C). Among different 
polyphenols, quercetin and catechin increased expression of SOD2 by 68% and 63%, respectively.  
Treatment of Bhas 42 cells with B[a]P increased mRNA expression of TNF-α by 269% after 24h 
(Fig. 3.5D). All administrated polyphenols strongly inhibited this pro-inflammatory effect, 




Figure 3.5. Effect of B[a]P and polyphenols on gene expression in Bhas 42 cells. 
Gene expression was measured by RT-qPCR in Bhas 42 cells after pre-treatment with polyphenols 
at 5 µM for 2h and treatment with 4 µM B[a]P for 24h. (A) UCP2, (B) NRF2, (C) SOD2, (D) 
TNF-α. Data are presented as a percentage of the untreated cells normalized to beta actin. The 
figure represents means ± SEM of 2 independent experiments with 3 wells of cells per treatment 
condition in each experiment. The significant difference between groups was tested with one-way 
ANOVA followed by Tukey’s post-hoc test. * Significantly different from the UT group at p < 
0.05. # Significantly different from the B[a]P group at p < 0.05. 
3.3.4. Effects of B[a]P and polyphenols on neoplastic transformation 
Figure 3.6A represents images of an invasive focus and different characteristics between a 
neoplastic focus and normal cells in the same image (the purpled ones are normal cells). Treatment 
of Bhas 42 cells with B[a]P for 21 days increased the number of neoplastic transformed foci 
(colonies) by 465% (Fig. 3.6B). Only resveratrol and quercetin significantly inhibited B[a]P-




Figure 3.6. Effect of B[a]P and polyphenols on neoplastic transformation in Bhas 42 cells. 
After pre-treatment with polyphenols at 5 µM for 2 h, followed by 4 µM B[a]P for 21 days. (A) 
Images of foci captured by fluorescence microscope at 100X and 400X magnifications. (B) 
Number of foci. The figure represents means ± SEM of 2 independent experiments with 6 wells 
of cells per treatment condition in each experiment. The significant difference between groups was 
tested with one-way ANOVA followed by Tukey’s post-hoc test. * Significantly different from 





3.3.5. Correlation results  
Analysis of correlations between different studied biomarkers show that intracellular ROS has 
positive correlations with TNF-α expression (Fig. 3.7A), showing elevated oxidative stress by 
B[a]P induces expression of this pro-inflammatory cytokine (r=0.46, p<0.01). TNF-α expression 
also correlated with cell proliferation (Fig. 3.7B) (r=0.62, p<0.01). Expression of UCP2 was 
correlated with expression of TNF-α (Fig. 3.7C) (r=0.47, p<0.01).  
 
Figure 3.7. Correlations between different parameters of interest. 
Correlations between (A) intracellular ROS and TNF-α mRNA expression (B) TNF-α mRNA 
expression and cell proliferation (C) UCP2 and TNF-α mRNA expression. The significant 
correlations between different parameters were tested with Pearson’s R and significance was 




3.4. Discussion   
In the current study, we used Bhas 42 cells to evaluate the effects of different polyphenols on 
B[a]P-induced changes in intracellular ROS generation, mitochondrial superoxide generation, 
gene expression (of SOD2, Nrf2, UCP2, and TNF-α), cell proliferation, and cellular transformation 
(formation of foci). These cells are transfected cells (BALB/c 3T3 cells transfected with the v-Ha-
ras gene) and the model therefore represents one of progression to a neoplastic phenotype. This 
assay can detect both initiating and promoting carcinogens (Sakai et al., 2011).  
After 12h, B[a]P increased intracellular ROS by 25% and after 72h, it increased intracellular ROS 
more than 200%. B[a]P has previously been found to produce oxidative stress in vivo , and in some 
cultured cells (Nkrumah-Elie et al., 2012). The current results show that B[a]P produces ROS 
generation in the Bhas 42 cell carcinogenesis system. Acting both in initiation and promotion 
(Valko et al., 2006), this increased ROS may have contributed to the increased neoplastic 
transformation observed after 21 days.  
An objective of this study was to compare the ability of different polyphenols to inhibit B[a]P-
induced oxidative stress and cell transformation. The polyphenols were from different classes and 
structures, and expectedly exert anti-oxidant effects to differing extents and by different 
mechanisms. However, they were all similarly effective in decreasing the B[a]P-induced 
intracellular ROS, eliminating the increase in detected ROS at 12h and all except cyanidin 
inhibiting by 57-76% at 72h. Different mechanisms by which the polyphenols might decrease the 
detected ROS include direct scavenging of ROS, induction of antioxidant enzymes, and decreasing 
the generation of ROS. Although the current study did not distinguish the mechanisms involved 
the net result was that the polyphenols were more similar than different in decreasing intracellular 
ROS. 
We also evaluated the effects of B[a]P and polyphenols on mitochondrial superoxide. The 
mitochondrial electron transfer chain (ETC) is a major source of endogenous ROS that may 
participate in carcinogenesis by inducing nuclear and mitochondrial DNA mutations as well as cell 
signaling pathways  (Sabharwal and Schumacker, 2014). Exposure of the cells to B[a]P for 12h 
increased mitochondrial superoxide generation by 52% compared to untreated cells. Although the 
mechanism behind this increased mitochondrial superoxide generation is not clear, B[a]P has 
previously been observed to increase mitochondrial superoxide generation in HaCaT keratinocytes 
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exposed in vitro to B[a]P for 48h (Das et al., 2016) and in oocytes after 7 day in vivo i.p. 
administration of B[a]P to mice (Sobinoff et al., 2012). Here certain of the polyphenols, 
anthocyanins and berberine decreased the B[a]P-induced generation of mitochondrial superoxide 
by 60-73%. The result with berberine is consistent with evidence showing that berberine is 
localised to mitochondria (Serafim et al., 2008). While not itself a polyphenol, berberine is 
demethylated to a phenolic metabolite in the intestine (Liu et al., 2009), and perhaps in the Bhas 
42 cells. These results are also in agreement with previous studies showing mitochondrial anti-
oxidative effects of berberine or its metabolites (Zhang et al., 2014; Zhang et al., 2015) and 
anthocyanins (Zhu et al., 2012). 
One question about the B[a]P-induced ROS observed after 72h is whether the increase is due to 
the continual presence of B[a]P or to changes induced by B[a]P over a shorter term. To test whether 
a short-term exposure to B[a]P produced sustained effects on intracellular ROS generation, the 
cells were exposed for 4h to B[a]P (6h to polyphenols), after which the media was replaced and 
intracellular ROS generation was measured after 72h. With this short-term exposure, B[a]P 
increased generation of ROS at 72h by 40%. These data show that B[a]P produced intracellular 
changes that resulted in sustained ROS generation. All of the polyphenols except resveratrol and 
quercetin significantly inhibited this effect. These results identified a possible difference between 
different polyphenols. Some polyphenols, particularly cyanidin and berberine completely 
prevented the increase in ROS generation at 72h after short-term B[a]P exposure, suggesting that 
they exert acute effects against the B[a]P-induced changes. Since cyanidin and berberine were also 
the most effective against mitochondrial superoxide generation after 12h exposure, perhaps they 
most effectively inhibited B[a]P-induced changes to mitochondria. Other polyphenols such as 
resveratrol and quercetin were more effective when continually present for 72h. 
Effects of B[a]P and polyphenols on expression of genes related to oxidative stress (Nrf2, UCP2, 
SOD2) and inflammation (TNF-α) were measured to gain more insights into the mechanisms 
involved. Nrf2 is a transcription factor that is activated and translocated to the nucleus under the 
presence of oxidative stress and induces expression of antioxidant enzymes (Ma, 2013). We found 
that B[a]P significantly increased Nrf2 gene expression by 49% compared to untreated cells. Nrf2 
expression is regulated by aryl hydrocarbon receptor (AHR) activation (Miao et al., 2005). Since 
B[a]P is known as an activator of the AHR, it may explain the up-regulation of Nrf2 by B[a]P. 
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This result is consistent with a previous study that reported increased Nrf2 mRNA expression after 
treatment of Caco-2 cells with B[a]P (Niestroy et al., 2011). Unlike in this previous study however, 
where quercetin inhibited the effect of B[a]P (Niestroy et al., 2011), polyphenols had no effect on 
Nrf2 gene expression induced by B[a]P in the current study.  
In expression of SOD2, 4µM B[a]P had no significant effect after 24 hours, while two of the 
polyphenols, quercetin and catechin induced it by 41-45%. SOD2 is a manganese-containing 
superoxide dismutase located in the mitochondrial matrix that has been strongly implicated in 
carcinogenesis and tumor development (Clair et al., 2005). SOD2 is regulated by different 
mechanisms, including mitochondrial biogenesis regulatory factors such as SIRT3 and PGC-1α. 
Down-regulation of SOD2 gene expression, along with mitochondrial dysfunction and increased 
ROS generation, by B[a]P has been previously described in human airway epithelial A549 cells 
(Min et al., 2011). In the current study, however, the induction of SOD2 by quercetin and catechin 
was not reflected in a significant decrease in the measured mitochondrial superoxide generation. 
Another protein involved in modulating oxidative stress is UCP2, which is often overexpressed in 
cancer cells (Baffy, 2010). Formation of ROS by mitochondria induces expression of UCP2, a 
sensor and suppressor of mitochondrial ROS generation (Brand et al., 2004). In Bhas 42 cells, we 
found that B[a]P increased UCP2 expression by 70%, and some polyphenols inhibited this effect. 
ROS is a vital component for cancer cell progression due to inducing further genomic instability 
and ROS signaling pathways. On the other hand, excessive ROS could be toxic and leads to cell 
death. In cancer cells, overexpression of UCP2 acts as an adaptive response to protect cancer cells 
from excessive ROS and apoptosis (Derdak et al., 2008). Besides involvement in oxidative stress, 
UCP2 is involved in carcinogenesis through several other mechanisms including inhibiting 
oxidative phosphorylation and inducing glycolysis, increasing cell proliferation, cell invasion, cell 
transformation, and cachexia, and producing chemoresistance and poor prognosis of cancer 
(Derdak et al., 2008; Pons et al., 2015). Protecting against UCP2 expression shows that the 
administrated polyphenols have anti-carcinogen influences by abrogating this pathway of 
carcinogenesis. As a novel therapeutic target, inhibition of UCP2 has been recently suggested to 
be effective against cancer initiation and progression (Derdak et al., 2008). However, the role of 
UCP2 in cancer initiation and progression has not been well understood and more in vitro and in 
vivo studies are needed to elucidate other possible roles of UCP2 in cancer progression.  
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In the current study in Bhas 42 cells, B[a]P increased expression of TNF-α more than 200%, and 
all of the polyphenols, especially the flavonoids quercetin, catechin, and cyanidin, almost 
completely inhibited this effect. Up-regulation of TNF-α by B[a]P was shown previously in animal 
models (Huang et al., 2015). TNF-α plays an important role in carcinogenesis by producing 
inflammatory signals that induce cell survival, cell proliferation, angiogenesis, and metastasis (Wu 
and Zhou, 2010). The current result is consistent with previous studies in human lung fibroblasts 
(Chen et al., 2016) and A549 alveolar cells  showing that quercetin inhibited production of pro-
inflammatory cytokines such as IL-6 and TNF-α induced by B[a]P or B[a]P diol epoxide (Günay 
et al., 2016).  
The protective effects of the polyphenols on TNF- α expression may reflect the decreases in 
intracellular ROS. Flavonoids exert anti-inflammatory effects by inhibiting ROS-induced 
activation of transcription factors such as NF-kB and activating protein 1 (AP-1) that induce 
expression of inflammatory cytokines such as TNF-α and interleukins (Leyva-López et al., 2016). 
TNF-α and ROS act in carcinogenesis in a coordinated manner (Blaser et al., 2016). Therefore, 
inhibiting either one abrogates the vicious cycle and its involvement in carcinogenesis. 
In the current study, treatment with B[a]P mildly but significantly increased cell proliferation in 
Bhas 42 cells compared to untreated cells. This increased proliferation coincided with increased 
ROS, which at sub-lethal levels is known to stimulate cell proliferation (Reuter et al., 2010). This 
result is consistent with a previous observation (Burdick et al., 2003) of increased ROS generation 
and proliferation of breast epithelial cells exposed to B[a]P. Therefore, this process may be part of 
the promotion of neoplastic transformation. Among administrated polyphenols, resveratrol, 
quercetin, catechin, and cyanidin significantly inhibited this effect.  
Ultimately, we investigated the preventive effects of polyphenols on carcinogenesis induced by 
B[a]P in a 21-day transformation assay. Similar to previous studies in Bhas 42 cells (Sakai et al., 
2010) and other cell lines (Bersaas et al., 2016), B[a]P stimulated neoplastic transformation in 
Bhas 42 cells and strongly increased the number of foci (colonies) compared to untreated cells. 
Carcinogenicity of B[a]P involves complex mechanisms, including formation of bulky DNA 
adducts and gene mutations (Liu et al., 2015), induction of oxidative stress (Vijayaraman et al., 
2012), inflammation (Shahid et al., 2016), cell proliferation (Burdick et al., 2003), and cell 
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signaling pathways (Jiao et al., 2008). A few previous studies have reported protective effects of 
individual polyphenols or polyphenol-rich extracts against neoplastic transformation induced by 
B[a]P or other carcinogens in cultured cells (Kao et al., 2007; Xue et al., 2001). Comparing 
different polyphenols in the current study, resveratrol and quercetin significantly decreased the 
number of formed foci. Resveratrol was revealed as the notably strongest polyphenol in protecting 
against neoplastic transformation in this assay. Since there was no difference between resveratrol 
and other administrated polyphenols in measurements of ROS or gene expression at earlier time 
points, it may have been a delayed effect of resveratrol or an effect on other non-measured 
parameters that produced such a strong effect in the transformation assay.  
Other possible mechanisms by which resveratrol may inhibit formation of neoplastic colonies in 
vitro and tumors in vivo have been previously reported. These include effects on drug metabolising 
enzymes, such as inhibiting expression of CYP1B1and inducing NQO1expression (Lu et al., 2008)  
which may influence carcinogen metabolism, or effects on cell signaling such as decreasing 
expression of the MAPK family and increasing expression of P53 (George et al., 2011). Therefore, 
influences on other pathways involved in carcinogenesis is a possible reason that resveratrol 
showed the strongest effect in inhibiting formation of neoplastic transformation in the current 
study. Further investigations are needed to understand the special effect of resveratrol in 
preventing neoplastic transformation in the current study. 
Several correlations were identified in the current study. Consistent with other studies (Reuter et 
al., 2010), we found a correlation between intracellular ROS and TNF-α gene expression. ROS 
can induce inflammation by activating NF-kB and up-regulating cytokine expression (Gloire et 
al., 2006). In turn, leukocytes and mast cells are recruited to the damage site and generate further 
ROS. Moreover, in non-inflammatory cells pro-inflammatory cytokines including TNF-α and IL-
1β have been observed to increase intracellular NO and mitochondrial superoxide generation, 
induce damage to mitochondrial DNA, and disturb mitochondrial function (Kim et al., 2010). 
Therefore, ROS and inflammatory cytokines such as TNF-α are intricately involved in tumor 
promotion. 
Furthermore, we found positive correlations between TNF-α and cell proliferation and between 
UCP2 and TNF-α. These correlations may reflect a common influence of increased intracellular 
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ROS, which can stimulate cell proliferation as well as increase cytokine expression (Reuter et al., 
2010). A correlation between UCP2 and TNF-α expression was described in previous studies 
(Wang et al., 2016).  
In conclusion, the present study revealed that polyphenols protected against oxidative stress and 
neoplastic transformation induced by B[a]P in Bhas 42 cells. The results suggest that dietary 
polyphenols may inhibit B[a]P induced oxidative stress and inflammation by protecting against 
increased mitochondrial superoxide generation, intracellular ROS generation, TNF-α expression, 
and UCP2 over-expression. Figure 3.8 illustrates a summary of the results. Together these effects 
help decrease cell proliferation, and neoplastic transformation induced by B[a]P. Additional 
studies are needed to further elucidate mechanisms by which dietary polyphenols, especially 
resveratrol, act as anti-carcinogens to protect against cancer initiation and progression.  
 
Figure 3.8. Schematic representation of molecular mechanisms by which polyphenols 
prevent neoplastic transformation induced by B[a]P in Bhas 42 cells. 
B[a]P induces neoplastic transformation by stimulating mitochondrial and intracellular ROS 
production, up-regulating TNF-α and UCP2, and increasing cell proliferation. Polyphenols 
protected against these effects of B[a]P, up-regulated SOD2 expression, and decreased cellular 
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3.5. Transition to CHAPTER 4 
In CHAPTER 3 we investigated oxidative stress and cellular transformation induced by B[a]P and 
preventive effects of different polyphenols on B[a]P-induced oxidative stress and neoplastic 
transformation. The results showed that B[a]P increased intracellular ROS generation and 
polyphenols prevented B[a]P-induced intracellular ROS to a similar extent. B[a]P also increased 
mitochondrial superoxide generation, and only polyphenols with more positive charges 
(anthocyanins and berberine) decreased mitochondrial superoxide. B[a]P also strongly induced 
TNF-α expression and all polyphenols inhibited this effect. We also observed that B[a]P 
significantly induced neoplastic transformation in Bhas 42 cells while only resveratrol and 
quercetin protected against this effect of B[a]P, and resveratrol protected most strongly. One 
question from CHAPTER 3 is whether the observed inhibitory effects of the polyphenols may 
have occurred through decreased expression of cytochrome P450 drug metabolizing enzymes that 
activate B[a]P to mutagenic metabolites. In CHAPTER 4 I report the effects of B[a]P and 
polyphenols on expression of mRNA for the cytochrome P450 drug metabolizing enzymes 









CHAPTER 4: EVIDENCE AGAINST AN INVOLVEMENT OF ARYL 
HYDROCARBON RECEPTOR (AHR) IN POLYPHENOL INHIBITION OF 
BENZO[A]PYRENE-INDUCED OXIDATIVE STRESS AND NEOPLASTIC 
TRANSFORMATION 
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In a letter to editor, published in the Journal of Food and Chemical Toxicology, in response to a 
letter regarding a possible down-regulation of P450 enzymes by polyphenols in preventing 
effects of B[a]P, we showed that the effects of our studied polyphenols were not through an 












Some cytochrome P450 drug metabolizing enzymes (CYP450) have been identified which in 
metabolizing carcinogens also bioactivate them to reactive metabolites leading to DNA damage 
and mutations (Nebert and Dalton, 2006). CYP450 enzymes can metabolize polycyclic aromatic 
hydrocarbons such as B[a]P to their mutagenic metabolites which can form bulky DNA adducts 
and provoke neoplastic transformation. CYP1A1 and CYPB1 are two primary enzymes that are 
known to participate in metabolizing B[a]P to mutagenic metabolites (Harrigan et al., 2006). B[a]P 
exposure increases expression of these enzymes by binding to and activating the aryl hydrocarbon 
receptor (AhR), which induces expression of CYP1A1 and CYP1B1 (Shiizaki et al., 2017). 
Extensive experimental studies have revealed the role of different polyphenols in modulating CYP 
enzymes. Polyphenols show positive or negative effects on CYP450 enzymes depending on their 
structure and the model of study. Polyphenols exert their effects through either direct interaction 
with CYP450 enzymes or by regulating gene expression. For instance, polyphenols can modulate 
gene expression through the pregnane X receptor (PXR) or AhR, two receptors that induce 
expression of detoxifying enzymes (Korobkova, 2015; Krizkova et al., 2008). 
We previously showed that polyphenols prevent B[a]P-induced oxidative stress and neoplastic 
transformation in Bhas 42 cells, which could occur by different mechanisms. One plausible 
mechanism by which polyphenols could exert these effects is by inhibiting expression of CYP450 
enzymes that activate B[a]P. There is no study which measured levels of the CYP450 enzymes in 
Bhas 42 cells, and data regarding effects of polyphenols on changes in these enzymes after B[a]P 
treatment are limited. Therefore, we measured the effects of B[a]P and polyphenols on mRNA 
expression of CYP1A1 and CYP1B1 in Bhas 42 cells. 
4.2. Materials and Methods 
4.2.1. Chemicals and reagents 
See section 3.2.1 
4.2.2. Cell culture 
See section 3.2.2 
4.2.3. RNA extraction, RNA quantification, and cDNA preparation for qPCR 
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See section 3.2.6 
4.2.4. Real-time polymerase chain reaction (PCR) 
See section 3.2.7 
4.2.5. Statistical analysis  
See section 3.2.9 
4.3. Results 
Treatment of the Bhas 42 cells with 4 µM B[a]P significantly increased mRNA expression of 
CYP1A1 and CYP1B1 by 393-fold and 5-fold, respectively compared to untreated cells (Fig. 4.1. 
A&B). None of the polyphenols decreased expression of CYP1A1, and resveratrol, quercetin, 
catechin, and berberine further increased expression of CYP1A1 mRNA over that induced by 




Figure 4.1. Effect of B[a]P and polyphenols on CYP1A1 and CYP1B1 gene expression in 
Bhas 42 cells. 
CYP1A1 (A) and CYP1B1 (B) gene expression were measured by qPCR in Bhas 42 cells after 
pre-treatment with polyphenols at 5 µM for 2h and treatment with 4 µM B[a]P for 24h. Data are 
presented as a percentage of the untreated cells normalized to beta actin. The figure represents 
means ± SEM of 2 independent experiments with 3 wells of cells per treatment condition in each 
experiment. The significant difference between groups was tested with one-way ANOVA followed 
by Tukey’s post-hoc test. * Significantly different from the UT group at p < 0.05. # Significantly 





In the current study we measured mRNA expression of CYP1A1 and CYP1B1 to understand 
mechanisms behind the preventive effects of polyphenols against B[a]P-induced oxidative stress 
and neoplastic transformation. Under the conditions of these experiments therefore, the results do 
not support a mechanism involving antagonism by the polyphenols of AhR activation for the 
observed findings. Polyphenols have been found as both agonists and antagonists of the AhR. 
Multiple studies have demonstrated different polyphenols to inhibit induction of CYP450 enzymes 
by other AhR ligands. For example, Andrieux et al. (2004) showed that resveratrol at 100 μM 
acted as an AhR antagonist against a novel AhR agonist and inhibited induction of CYP1A1 
expression in rat primary hepatocytes. Other studies have shown resveratrol to antagonise AhR 
mediated CYP450 induction by dioxins (Casper et al., 1999) or B[a]P (Revel et al., 2003). 
However, there are some studies showing AhR-agonist activity of polyphenols. In immortalized 
human keratinocytes (HaCaT) and HepG2 hepatocytes, quercetin, resveratrol, and curcumin at 1, 
5, and 10 μM induced AhR-mediated CYP1A1 activity (Mohammadi-Bardbori et al., 2012). 
Resveratrol has been shown to be an AhR agonist alone, but to antagonise CYP450 protein 
expression by a dioxin AhR agonist (Lee and Safe, 2001; Pastorková et al., 2017). The expression 
of CYP450 enzymes is regulated through several pathways including translocation of the AhR to 
the nucleus and binding to the response elements in the gene, and polyphenols have been suggested 
to affect all of these pathways. AhR-agonist or antagonist activity of polyphenols can be 
determined by showing the ability of direct interactions with the CYP450 enzyme, or by regulating 
any step of CYP450 expression process (Korobkova, 2015). In summary, we showed that some of 
the polyphenols of our study such as resveratrol, quercetin, catechin, and berberine augmented 
induction of CYP1A1 mRNA by B[a]P and all the polyphenols had no effect on the B[a]P-induced 
expression of CYP1B1 mRNA.  
In conclusion, the results of our previous study showing preventive effect of polyphenols against 
B[a]P-induced oxidative stress and neoplastic transformation are not due to inhibiting induction of 
mRNA for enzymes involved in B[a]P metabolism and activation.  
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4.5. Transition to CHAPTER 5 
In CHAPTER 4 we investigated a possible inhibitory effect of polyphenols on B[a]P metabolism 
by measuring mRNA for CYP1A1 and CYP1B1, two enzymes which primarily metabolize B[a]P 
to its mutagenic metabolites. We observed that not only did polyphenols not inhibit induction of 
these enzymes, but some of the polyphenols significantly increased the expression of CYP1A1 
over that of B[a]P alone. In CHAPTER 5, to further explore mechanisms behind protective effects 
of polyphenols on B[a]P-induced neoplastic transformation, we investigated effects of 























CHAPTER 5: INCREASED MITOCHONDRIAL BIOGENESIS BY POLYPHENOLS 
PROTECTS AGAINST MITOCHONDRIAL DYSFUNCTION IN BHAS 42 
FIBROBLASTS EXPOSED TO BENZO[A]PYRENE 
Abbreviations 
B[a]P, Benzo[a]pyrene; C3G, cyanidin-3-glucoside; ERRα, estrogen-related receptor α; ETC, 
electron transfer chain; IARC, International Agency for Research on Cancer; MMP, 
mitochondrial membrane potential; mtDNA, mitochondrial DNA; MTG, MitoTracker Green; 
nDNA, nuclear DNA; NRF1, nuclear respiratory factor 1; PAH, polycyclic aromatic 
hydrocarbon; PGC-1α, peroxisome proliferator-activated receptor gamma coactivator 1-alpha; 
ROS, reactive oxygen species; TFAM, mitochondrial transcription factor A; TMRE, 
tetramethylrhodamine ethyl ester  
Abstract 
Background: Polyphenols naturally occurring in fruits and vegetables have been shown to act in 
cancer prevention and may inhibit carcinogenesis. Changes to mitochondria have been implicated 
in carcinogenesis and neoplastic transformation; however, a possible mitochondrial mechanism by 
which polyphenols inhibit cancer initiation and promotion is largely unexplored. In this study, we 
investigated the effects of benzo[a]pyrene and different polyphenols on mitochondrial biogenesis 
and dysfunction in the Bhas 42 cell model of carcinogen-induced neoplastic transformation. 
Methods: Bhas 42 cells were treated with 5 μM polyphenol (resveratrol, quercetin, catechin, 
cyanidin, C3G) or berberine starting 2h before exposure to 4 μM B[a]P. The effects on parameters 
of mitochondrial biogenesis (mitochondrial content, citrate synthase, nDNA and mtDNA-encoded 
respiratory subunits, transcription factors, SIRT1 expression and activity, and deacetylated PGC-
1α) and function (mitochondrial membrane potential and galactose-dependent cellular ATP) were 
measured after 24 and 72h. 
Results: Exposure to B[a]P decreased mitochondrial content by 46% after 24h and 30% after 72 
h. Except for cyanidin and berberine after 72h, the polyphenols protected against these decreases, 
with resveratrol being the most effective (increasing the content after 72h to significantly more 
than cells without B[a]P exposure). In the presence of B[a]P, different polyphenols significantly 
increased expression of mRNA for transcription factors or enzymes involved in mitochondrial 
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biogenesis, for citrate synthase, and for nDNA- and mtDNA-encoded mitochondrial respiratory 
subunits. Resveratrol most notably increased SIRT1 activity, leading to deacetylation of PGC1α 
protein. Exposure to B[a]P also induced mitochondrial dysfunction as evidenced by decreased 
mitochondrial membrane potential (MMP) and galactose-dependent ATP level in cells after 24h 
by 25% and 22%, respectively. Some polyphenols, most notably resveratrol (and less so quercetin 
and catechin), prevented these effects on mitochondrial dysfunction. 
Conclusion: The results support involvement of a mitochondrial mechanism in carcinogenesis by 
B[a]P, and in chemoprevention by polyphenols. 
5.1. Introduction  
While much research has focused on mitochondria in cancer cells and in progression of 
transformed cells (Boland et al., 2013; Yadava et al., 2013), less is known about mitochondrial 
changes in the early initiation and promotion stages of carcinogenesis and neoplastic 
transformation. Carcinogen-induced mutations in mtDNA and in nDNA encoding mitochondrial 
respiratory proteins might trigger transformation through different mechanisms such as increasing 
ROS generation and shifting energy from oxidative phosphorylation to aerobic glycolysis. 
Benzo[a]pyrene (B[a]P) is a carcinogen present in wood and cigarette smoke and in charbroiled 
foods, which was previously shown to damage mtDNA and cause mitochondrial dysfunction 
(Backer and Weinstein, 1980; Gao et al., 2010). The role of mitochondrial pathways in 
carcinogenesis by B[a]P however is not well-understood. In a recent study using the Bhas 42 cell 
in vitro carcinogenesis model, we found that exposure of the cells to benzo[a]pyrene caused an 
increase in mitochondrial and intracellular ROS generation, which was inhibited by several dietary 
polyphenols (Omidian et al., 2017). In addition, exposure of the Bhas 42 cells to B[a]P led to 
increases in transformed foci. The neoplastic transformation was inhibited by treatment with 
polyphenols, most effectively by resveratrol.  
Mechanisms by which B[a]P and polyphenols might influence mitochondrial ROS generation and 
neoplastic transformation include effects on mitochondrial content and function. Some studies 
have shown that increased mitochondrial biogenesis helps prevent cancer cell progression to a 
more tumorigenic phenotype (Bellance et al., 2009; del Mar Blanquer-Rosselló et al., 2017; Wang 
and Moraes, 2011). Few, if any, studies have investigated mitochondrial biogenesis induction as a 
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possible mechanism to prevent the initiation and promotion phases of carcinogenesis. We 
hypothesized that by stimulating mitochondrial biogenesis and function, the number of healthy 
and functional mitochondria would be increased to reduce the impact of a mitochondrial mutagen. 
Increased mitochondrial electron transport efficiency and capacity may decrease ROS generation 
and help prevent a shift from oxidative phosphorylation to aerobic glycolysis.  
Polyphenol-rich fruits, vegetables and beverages are of interest for possible roles in cancer 
chemoprevention (Gullett et al., 2010; Lambert and Elias, 2010; Ramos, 2008). While 
chemopreventive effects of polyphenols are often attributed to their antioxidant characteristics, 
other mechanisms and influences on molecular pathways, including mitochondrial biogenesis  
(Kim et al., 2014; Sandoval-Acuña et al., 2014) may play important roles in chemoprevention. 
Polyphenols such as resveratrol and quercetin have been widely reported to induce mitochondrial 
biogenesis and provide beneficial roles in several diseases and conditions (Csiszar et al., 2009; de 
Oliveira et al., 2016; Kulkarni and Cantó, 2015). In cancer treatment, targeting mitochondrial 
pathways with polyphenols, particularly mitochondria-mediated apoptotic pathways has been 
reported in many studies (Gorlach et al., 2015). However, studies investigating preventive roles of 
polyphenols on cancer initiation through mitochondrial mechanisms are limited.  
In our previous study on in vitro cell transformation by B[a]P (Omidian et al., 2017) we found that 
several polyphenols, at a physiologically relevant dose of 5 μM (Howells et al., 2007), strongly 
decreased mitochondrial and intracellular ROS. While the different polyphenols were similarly 
effective at decreasing ROS, resveratrol was notable for giving the strongest decrease in cell 
transformation. However, the mechanisms by which polyphenols decreased B[a]P-induced ROS 
generation and neoplastic transformation needed further investigation. Regarding a potentially 
pivotal role of mitochondria in carcinogenesis, in the current study we further investigated the role 
of mitochondrial biogenesis in preventive effects of different polyphenols on B[a]P-induced 




5.2. Materials and Methods 
5.2.1. Chemicals and Reagents 
Cyanidin and C3G were obtained from Extrasynthese (Genay, France). Primers for qPCR were 
obtained from Integrated DNA Technologies (Toronto, ON, Canada). MitoTracker Green, TRIzol 
reagent, VILO cDNA synthesis kit, and SYBR green master mix were obtained from Invitrogen 
(Carlsbad, CA, USA). RNAeasy mini kit for isolating RNA was obtained from Qiagen 
(Germantown, MD, USA). Tetramethylrhodamine ethyl ester perchlorate (TMRE) and Dulbecco’s 
Modified Eagle’s Medium (DMEM) with low glucose (1g/l) were obtained from Thermo Fisher 
Scientific (Bartlesville, OK, USA). SIRT1 Direct Peptide, SIRT1 Direct NAD+, and SIRT1 Direct 
Developer were purchased from Cayman Chemical (Ann Arbor, Michigan, USA). CellTiter-
Glo kit was purchased from Promega, USA. All other reagents were obtained from Sigma-Aldrich 
(St. Louis, MO, USA). 
5.2.2. Cell culture 
See section 3.2.2 
5.2.3. RNA extraction, RNA quantification, and cDNA preparation RT-qPCR 














Table 1. The sequences of primers used to measure the expression of genes involved in 
mitochondrial biogenesis and mitochondrial function 
Gene Species  Primer sequence (5'-3') 
SIRT1 Mouse FWD: GGA ACC TTT GCC TCA TCT ACA 
REV: CAC CTA GCC TAT GAC ACA ACT C 
PGC-1α Mouse FWD: CGA CAG CTA TGA AGC CTA TGA G 
REV: CTT CTG CCT CTC TCT CTG TTT G 
Citrate 
synthase 
Mouse FWD: TCC TGG TCG TTT GGC TTT ATC 
REV: GTT CCG TGC CAG AGC ATA TT 
ERRα Mouse FWD: CTG CTT AAT CCG ATC TCC TCT C 
REV: GGA GCC TGC TTG GAG TTA TT 
NRF1 Mouse FWD: ACC CTC AGT CTC ACG ACT AT 
REV: GAA CAC TCC TCA GAC CCT TAA C 
TFAM Mouse FWD: GTT GGA TGG CAT GGG TTT AAG 
REV: CTC ACG TCT CTC CTG GAT TTG 
NDUFS8 Mouse FWD: GAG TCT GAG GTG GAC ATG AAG 
REV: GGC TCT CGA AAG AGG TAA CTT AG 
SDHb Mouse FWD: GCG ATT GCG GAA ATC AAG AAG 
REV: TTT GAC ACC AGA GTT GAC AGG 
UQRCB Mouse FWD: GAG GCA TCA GAT CTT GCC TAA G 
REV: CCC ACT CTT CTC TCT CCT TTC T 
COX5A Mouse FWD: GCT AGT GCT GTT CGC ATC TT 
REV: GTT GGT CTA AGT TCC TGG ATG AC 
ATP5A1 Mouse FWD: CCA AGG TAG CGT TGG TAT ATG G 
REV: CCC TCC TGG TCT CTG AAG TAT 
MTND1 Mouse FWD: TGC ACC TAC CCT ATC ACT C 
REV: ATT GTT TGG GCT ACG GCT C 
MTCYB Mouse FWD: CTT TGG GTC CCT TCT AGG AGT CTG 
REV: GCT GTG GCT ATG ACT GCG AAC AG 
MTCOX1 Mouse FWD: GCT GAA GGA GAA GGA GAA G 
REV: ATA CAC ATA GCT CTT CTC CC 
MTATP6 Mouse FWD: CCA CAC ACC AAA AGG ACG AAC ATG A 
REV: CGG ACT GCT AAT GCC ATT GGT TG 
b-actin Mouse FWD: CCT TCT TGG GTA TGG AAT CCT G 
REV: AGC ACT GTG TTG GCA TAG AG 
5.2.4. Protein extraction, protein quantification, and Western blot 
Bhas 42 cells were seeded in T25 flasks for 24h and exposed to polyphenols at 5 μM for 2h 
followed by treatment with 4 μM B[a]P for 24h. For protein extraction, cells were lysed in ice-
cold RIPA buffer 1X (Millipore, USA) supplemented with Halt Protease Inhibitor, EDTA, and 
Phosphatase Inhibitor (Thermo Fisher Scientific, USA) and centrifuged for 15 minutes at 1400 
79 
 
rpm and 4°C. The supernatant containing protein was gently removed and used for protein 
quantification, SIRT1 activity measurement, and Western blots. Protein content was determined 
using a BCA assay kit (Thermo Fisher Scientific, USA). Results of protein quantification are 
shown in Appendix 1. For Western blots, protein samples were normalized and denatured by 
boiling at 70°C with loading buffer (2X Laemmli buffer supplemented with 10% β-
mercaptoethanol) for 10 minutes. Equal amounts of protein samples (30-35 μg) were loaded per 
well using 8% NuPAGE Bis-Tris Pre-Caset gels (Invitrogen, USA) and then transferred to a 
nitrocellulose membrane using Mini Gel Tank (Life Technologies, USA). After transfer, the 
membrane was blocked with 5% bovine albumin serum (BSA) and Tris-buffered saline containing 
0.1% Tween-20 (TBST, pH 7.6) for 1 hour at room temperature. The membrane was incubated at 
4°C overnight with rabbit polyclonal primary anti-de-acetylated PGC-1α (1:1000; Abcam, USA) 
and anti-b-actin (1:1000; Cell Signaling Technologies, USA) antibodies. The membrane was 
washed with TBST three times each 5 minutes and then incubated with secondary anti-rabbit 
(Horseradish Peroxidase 1:2000, Santa Cruz Biotech) antibody. After several washings with 
TBST, the membrane was incubated with Pierce ECL Western Blotting Chemiluminescent 
Substrate (Thermo Fisher Scientific, USA) for 3 minutes. Protein bands were observed and 
quantified using an Alpha Imager Gel Imaging System (Alpha Innotech). Results were normalized 
to b-actin.  
5.2.5. Measurement of mitochondrial membrane potential (MMP) 
TMRE fluorescent dye was used to measure the MMP in Bhas 42 cells. TMRE is a positively 
charged dye that accumulates in active mitochondria due to the negative charge in the matrix. 
Therefore, higher polarized mitochondria have greater TMRE fluorescence intensity (Perry et al., 
2011). After seeding 20,000 Bhas 42 cells in a 96 well optical bottom plate for 24h and pre-
treatment with 5 μM polyphenols for 2h followed by treatment with 4 μM B[a]P for 24h, cells 
were incubated with TMRE dye for 20 minutes. Cells were gently washed twice with PBS and 
then the average fluorescence intensity was quantified at 540±20 nm excitation and 590±20 nm 
emission using a microplate reader. Carbonyl cyanide m-chlorophenylhydrazone (CCCP) at 100 
nM administered to control cells for 10 minutes was used as a positive control. 
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5.2.6. Measurement of mitochondrial content 
MitoTracker Green (MTG) fluorescent dye was used to measure mitochondrial content in Bhas 42 
cells. MTG stains mitochondria independently from mitochondrial membrane potential changes 
(Métivier et al., 1998). MTG is taken up into mitochondria where it binds to protein thiols and 
interacts with mitochondrial lipids to produce a fluorescent green color (Cottet‐Rousselle et al., 
2011). After seeding 20,000 Bhas 42 cells in a 96 well optical bottom plate for 24 hours and pre-
treatment with polyphenols at 5 µM for 2 hours, B[a]P at 4 µM was administrated and cells were 
incubated for 24h and 48h in 5% CO2 at 37ºC. Medium was then removed and MTG probe at 250 
nM final concentration was loaded in medium without FBS. After 30 minutes incubation, cells 
were carefully washed twice with PBS. The average fluorescence intensity was quantified at 
485±20/528±20 nm using a microplate reader. 
5.2.7. Measurement of SIRT1 activity 
To measure SIRT1 activity in cell extracts, 25 μL assay buffer and 5 μL samples (described in 
section 5.2.4 for protein extraction and quantification) of each T25 flask experiment in triplicate 
were added to a 96 well optical bottom plate. This measurement is based on deacetylation of SIRT1 
Direct Peptide, a fluorogenic p53 protein sequence (Arg-His-Lys-Lys(ε-acetyl)-AMC) with an 
acetyl group, in the presence of SIRT1 co-substrate, NAD+ (Cayman Chemical, USA). The 
reaction was initiated by adding 15 μL of substrate solution containing SIRT1 Direct Peptide and 
NAD+, and 25 μL assay buffer (50 mM Tris buffer (pH 8.0), 137 mM NaCl, 2.7 mM KCl, and 
1mM MgCl2). The plate was covered and incubated for 45 minutes on a shaker at room 
temperature. In the second step, 50 μL of developer dissolved in assay buffer was added to each 
well to release AMC from deacetylated peptide, and the plate was incubated for 30 minutes at 
room temperature. The fluorescence intensity from free AMC was read at 360±40/465±40 nm 
using a microplate reader. Protein concentration was determined using a BCA assay kit and results 
of SIRT1 activity assay were normalized to protein concentration.  
5.2.8. Measurement of ATP 
Intracellular ATP content was measured using a Cell Titer-Glo Luminescent Cell Viability Assay 
kit (Promega, USA) based on the manufacturer’s protocol. This kit is based on cell lysis and 
generation of a luminescence signal proportional to the amount of ATP present. Briefly, 20,000 
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Bhas 42 cells were seeded in a 96 well optical bottom plate in the presence of 5 mM glucose or 25 
mM galactose and then incubated for 24h. Cells were treated with 5 μM polyphenols for 2h 
followed by treatment with 4 μM B[a]P for 24h. Antimycin A (inhibitor of complex III) at 10 μM 
added to control cells for 30 minutes was used as a positive control. Cells were lysed using reagent 
included in the kit with 3 minutes vigorous shaking and then 10 minutes standing at room 
temperature to stabilize luminescence signal. The luminescence was recorded using a microplate 
reader under standard luminescence settings. 
5.3. Results   
5.3.1. Effects of polyphenols and B[a]P on mitochondrial content 
Figure 5.1A shows fluorescence images from a mitochondrial content experiment after 24h 
exposure to 4 µM B[a]P and 5 µM polyphenols. Bhas 42 cells treated with 4 µM B[a]P for 24h 
had lower fluorescence compared to untreated cells, while for all polyphenols mitochondrial 
content was similar to untreated cells. Figure 5.1B shows quantification of experiments 
represented in Figure 5.1A. The treatment with B[a]P decreased mitochondrial content by 46% 
compared to untreated cells, and all polyphenols significantly protected against this effect, with 
most inhibiting by 39-54%. At this time point cyanidin had the strongest effect and inhibited the 
B[a]P effect by 78%, resulting in a level not significantly different from control untreated cells.  
To investigate the effect of the polyphenols alone on mitochondrial content, we measured their 
effect without B[a]P (Fig 5.1C). Resveratrol had the strongest effect and increased mitochondrial 
content compared to untreated cells by 62% after 24 h. Catechin and C3G also increased the 





Figure 5.1. Effect of B[a]P and polyphenols on mitochondrial content after 24h. 
Mitochondrial content was measured in Bhas 42 cells after treatment with polyphenols at 5 µM 
for 2h, adding 4 µM B[a]P and incubating for 24h, or after treatment with polyphenols alone for 
24 h. (A) Representative fluorescence images (with 20X objective lens) of mitochondrial content 
after staining with MitoTracker Green. (B) Quantification of mitochondrial content fluorescence. 
(C) Mitochondrial content after treatment with 5 µM polyphenols for 24h. Data are presented as a 
percentage of the untreated cells. The figure represents means ± SEM of 3 independent 
experiments with 3 wells of cells per treatment condition per experiment.  The significant 
difference between groups was tested with one-way ANOVA followed by Tukey’s post-hoc test. 
* Significantly different from the UT group at p < 0.05. # Significantly different at p < 0.05 from 
the B[a]P group for graph B, and from the resveratrol group for graph C. 
After 72h exposure, B[a]P decreased the mitochondrial content by 30% compared to untreated 
cells, and the polyphenols except cyanidin and berberine significantly inhibited the effect of B[a]P 
(Fig. 5.2). At this time point resveratrol had the strongest effect among administrated polyphenols 





Figure 5.2. Effect of B[a]P and polyphenols on mitochondrial content after 72h.  
Mitochondrial content was measured in Bhas 42 cells after treatment with polyphenols at 5 µM 
for 2h, adding 4 µM B[a]P and incubating for 72h. Data are presented as a percentage of the 
untreated cells. The figure represents means ± SEM of 3 independent experiments with 3 wells of 
cells per treatment condition per experiment. The significant difference between groups was tested 
with one-way ANOVA followed by Tukey’s post-hoc test. * Significantly different from the UT 
group at p < 0.05. # Significantly different from the B[a]P group at p < 0.05. 
5.3.2. Effects of B[a]P and polyphenols on expression of mRNA for nuclear and 
mitochondrial DNA-encoded mitochondrial proteins, and proteins regulating mitochondrial 
biogenesis 
5.3.2.1. Citrate synthase 
We measured the level of the nDNA-encoded mitochondrial enzyme citrate synthase as an 
additional marker of mitochondrial content (Price et al., 2012). Treatment of the Bhas 42 cells with 
4µM B[a]P for 24h had no significant effect on expression of mRNA for citrate synthase (Fig 5.3). 
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Among all of the polyphenols only resveratrol significantly increased expression, to a significant 
level 80% above untreated cells. 
 
Figure 5.3. Effect of B[a]P and polyphenols on citrate synthase mRNA expression. 
Citrate synthase gene expression was measured in Bhas 42 cells using qPCR after treatment with 
polyphenols and B[a]P for 24h. Data were normalized to beta actin and are presented as a 
percentage of the untreated cells. The figure represents means ± SEM of 2 independent 
experiments with 3 wells of cells per treatment condition per experiment. The significant 
difference between groups was tested with one-way ANOVA followed by Tukey’s post-hoc test. 
* Significantly different from the UT group at p < 0.05. # Significantly different from the B[a]P 
group at p < 0.05. 
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5.3.2.2. nDNA-encoded respiratory subunits 
The effects of B[a]P and polyphenols on expression of nuclear DNA-encoded mitochondrial 
respiratory subunits are shown in Figure 5.4. Treatment with B[a]P for 24h significantly decreased 
expression of the complex I subunit NDUFS8 and the complex V subunit ATP5A1 by 30% and 
35%, respectively, but had no significant effect on other nDNA-encoded subunits. Only berberine 
prevented the effect on NDUFS8 by 140%, and only cyanidin inhibited the effect on ATP5A1 by 
85%. Some of the polyphenols (resveratrol, quercetin, and berberine) increased expression of 
COX5A by up to 68% compared to B[a]P alone, and two polyphenols (cyanidin and berberine) 
increased expression of UQRCB by up to 43% compared to B[a]P alone. Catechin and C3G were 
without effect on nDNA-encoded subunits. 
 
Figure 5.4. Effect of B[a]P and polyphenols on nDNA-encoded mitochondrial respiratory 
subunits.  
nDNA-encoded mitochondrial respiratory subunits were measured in Bhas 42 cells using qPCR 
after treatment with polyphenols and B[a]P for 24h. Data were normalized to beta actin and are 
presented as a percentage of the untreated cells. The figure represents means ± SEM of 2 
independent experiments with 3 wells of cells per treatment condition per experiment. The 
significant difference between groups was tested with one-way ANOVA followed by Tukey’s 
post-hoc test. * Significantly different from the UT group at p < 0.05. # Significantly different 
from the B[a]P group at p < 0.05. 
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5.3.2.3. mtDNA-encoded respiratory subunits 
The effects of B[a]P and polyphenols on expression of mitochondrial DNA-encoded respiratory 
subunits are shown in Figure 5.5. Treatment with B[a]P for 24h significantly decreased expression 
of the complex III subunit CYB by 28% but did not affect expression of other subunits. Quercetin, 
catechin and berberine prevented the effect of B[a]P on CYB, and catechin significantly increased 
the level to 40% higher than control untreated cells. Quercetin, catechin and berberine also 
increased expression of mRNA for ND1 compared to B[a]P alone, and significantly by up to 95% 
above untreated cells. Catechin and berberine significantly increased ATP6 mRNA compared to 
B[a]P and untreated control cells. 
 
Figure 5.5. Effect of B[a]P and polyphenols on mtDNA-encoded respiratory subunits. 
mtDNA-encoded respiratory subunits were measured in Bhas 42 cells using q-PCR after treatment 
with polyphenols and B[a]P for 24h. Data were normalized to beta actin and are presented as a 
percentage of the untreated cells. The figure represents means ± SEM of 2 independent 
experiments with 3 wells of cells per treatment condition per experiment. The significant 
difference between groups was tested with one-way ANOVA followed by Tukey’s post-hoc test. 
* Significantly different from the UT group at p < 0.05. # Significantly different from the B[a]P 
group at p < 0.05. 
5.3.2.4. Transcription factors (ERRα, NRF1, TFAM) involved in mitochondrial biogenesis 
Exposure to B[a]P significantly decreased expression of mRNA for ERRα by 29% and had no 
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effect on expression of mRNA for NRF1 and TFAM compared to untreated cells (Fig. 5.6). 
Resveratrol, quercetin, and cyanidin completely inhibited the effect of B[a]P on ERRα and up-
regulated ERRα expression to the level of untreated cells. Although B[a]P had no effect on NRF1, 
quercetin and berberine significantly up-regulated its expression compared to B[a]P alone to levels 
50% higher than untreated cells. Among the polyphenols, only C3G significantly increased TFAM 
expression (by 45% compared to B[a]P alone). 
 
Figure 5.6. Effect of B[a]P and polyphenols on mitochondrial biogenesis transcription 
factors. 
Mitochondrial biogenesis transcription factors gene expression were measured in Bhas 42 cells 
after treatment with polyphenols and B[a]P for 24h. Data are presented as a percentage of the 
untreated cells normalized to beta actin. The figure represents means ± SEM of 2 independent 
experiments with 3 wells of cells per treatment condition per experiment. The significant 
difference between groups was tested with one-way ANOVA followed by Tukey’s post-hoc test. 
* Significantly different from the UT group at p < 0.05. # Significantly different from the B[a]P 
group at p < 0.05. 
5.3.3. Effects of polyphenols and B[a]P on mRNA expression, and enzyme activity or protein 
level of SIRT1 and PGC-1α 
Figure 5.6A shows that treatment of Bhas 42 cells with 4 µM B[a]P for 24h significantly down-
regulated SIRT1 gene expression by 37% compared to untreated cells.  Polyphenols at 5 µM except 
resveratrol and berberine significantly prevented this effect by up to 140%. In measurements of 
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SIRT1 activity however, B[a]P had no significant effect (Fig. 5.6B). Although resveratrol had no 
significant effect on SIRT1 gene expression (Fig. 5.6A), it significantly increased SIRT1 activity 
compared to B[a]P alone by 22% (Fig. 5,6B). Quercetin also significantly increased SIRT1 activity 
by 18% compared to B[a]P alone. In spite of significantly up-regulating SIRT1 gene expression, 
catechin, cyanidin, and C3G did not show any significant effect on SIRT1 activity. 
 
Figure 5.7. Effect of B[a]P and polyphenols on SIRT1 mRNA expression and activity.  
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SIRT1 gene expression and activity were measured in Bhas 42 cells after treatment with 
polyphenols and B[a]P for 24h. (A) SIRT1 mRNA expression, (B) SIRT1 activity. Data are 
presented as a percentage of the untreated cells normalized to beta actin mRNA (for gene 
expression) or protein (for SIRT1 activity). The figure represents means ± SEM of 2 independent 
experiments with 3 wells of cells per treatment condition in gene expression, and 3 independent 
experiments with SIRT1 activity measurements in triplicate.  The significant difference between 
groups was tested with one-way ANOVA followed by Tukey’s post-hoc test. * Significantly 
different from the UT group at p < 0.05. # Significantly different from the B[a]P group at p < 0.05. 
Treatment of Bhas 42 cells with 4 µM B[a]P had no significant effect on PGC-1α mRNA 
expression (Fig. 5.7A) or on de-acetylated protein level (Fig. 5.7B&C) compared to untreated 
cells. All polyphenols except resveratrol significantly increased mRNA expression of PGC-1α by 
up to 70% compared to the B[a]P alone condition (Fig. 5.7A). Resveratrol, however, increased the 
level of de-acetylated PGC-1α protein (by 135%), as did all of the polyphenols except C3G (Fig. 
5.7C). The result for berberine was excluded due to a technical problem with one of the gels. 
 
Figure 5.8. Effect of B[a]P and polyphenols on PGC-1α mRNA expression and de-acetylated 
PGC-1α protein level. 
PGC-1α mRNA expression and de-acetylated protein levels were measured in Bhas 42 cells after 
pre-treatment with polyphenols at 5 µM for 2h and treatment with 4 µM B[a]P for 24h. (A) PGC-
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1α mRNA expression, (B) Example Western blot of de-acetylated PGC-1α protein, (C) Quantified 
de-acetylated PGC-1α protein. Data were normalized to beta actin mRNA or protein and are 
presented as a percentage of the untreated cells. The figure represents means ± SEM of 2 
independent experiments with 3 wells of cells per treatment condition in gene expression 
experiments, and 2 independent experiments in deacetylated PGC-1α measurements. The 
significant difference between groups was tested with one-way ANOVA followed by Tukey’s 
post-hoc test. * Significantly different from the UT group at p < 0.05. # Significantly different 
from the B[a]P group at p < 0.05. 
5.3.4. Effect of polyphenols and B[a]P on mitochondrial function 
To further investigate mitochondrial dysfunction, we assessed the effect of B[a]P and polyphenols 
on mitochondrial membrane potential (MMP), and on ATP levels in the presence of glucose or 
galactose.  
5.3.5. Mitochondrial membrane potential 
Figure 5.9A shows fluorescence images of a representative experiment evaluating the effects of 
B[a]P and polyphenols on MMP. Treatment of Bhas 42 cells with 4 µM B[a]P showed lower 
TMRE fluorescence compared to untreated cells. All polyphenols except C3G and berberine 
appeared to decrease the B[a]P effect and increase TMRE fluorescence. Figure 5.9B shows 
quantification of TMRE fluorescence. The exposure to B[a]P significantly decreased the MMP by 
25%. Resveratrol had the strongest effect and significantly increased the MMP to levels 28% above 
untreated cells. Quercetin, catechin, and cyanidin also significantly increased the MMP compared 




Figure 5.9. Effect of B[a]P and polyphenols on MMP.  
MMP was measured using the fluorescent probe TMRE in Bhas 42 cells 24h after treatment with 
polyphenols and exposure to B[a]P. (A) Representative fluorescence images at 20X objective lens 
magnification. (B) Quantification of MMP fluorescence. Data are presented as a percentage of the 
untreated cells. The figure represents means ± SEM of 3 independent experiments with 3 wells of 
cells per treatment condition per experiment.  The significant difference between groups was tested 
with one-way ANOVA followed by Tukey’s post-hoc test. * Significantly different from the UT 
group at p < 0.05. # Significantly different from the B[a]P group at p < 0.05. 
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5.3.6. Cellular ATP content 
The effects of B[a]P and polyphenols on cellular ATP content was measured in Bhas 42 cells 
grown in glucose medium and grown in galactose medium which requires mitochondrial 
metabolism for net ATP synthesis. Exposure to B[a]P depleted cellular ATP in both the glucose 
and galactose medium by 28% and 22%, respectively (Fig. 5.10. A& B). In glucose medium, all 
of the polyphenols except cyanidin, C3G, and berberine prevented the effect of B[a]P. In galactose 
medium, only resveratrol protected the effect of B[a]P. In both media, resveratrol showed the 
strongest effect and completely protected against B[a]P-induced cellular ATP depletion. Berberine 





Figure 5.10. Effect of B[a]P and polyphenols on cellular ATP content.  
Cellular ATP content was measured in Bhas 42 cells using a Cell Titer-Glo Assay kit after 
treatment with polyphenols and B[a]P for 24h as in Figure 5.1. (A) ATP content in cells grown in 
glucose medium, (B) ATP content in cells grown in galactose medium. Data are presented as a 
percentage of the untreated cells. The figure represents means ± SEM of 3 independent 
experiments with 3 wells of cells per treatment condition per experiment. The significant 
difference between groups was tested with one-way ANOVA followed by Tukey’s post-hoc test. 
* Significantly different from the UT group at p < 0.05. # Significantly different from the B[a]P 




In the current experiments we explored the possibility that the ability of polyphenols to protect 
against carcinogenesis by B[a]P, as we observed previously (Omidian et al., 2017), might be 
through inducing mitochondrial biogenesis. By increasing the number of functional mitochondria, 
such an effect might diminish the impact of a mutagenic agent like B[a]P that produces 
mitochondrial DNA adducts and lesions / targets mitochondrial DNA to a greater extent than 
nuclear DNA (Backer and Weinstein, 1980). 
To investigate the impact of B[a]P and polyphenols on mitochondria, we measured mitochondrial 
content after 24h and 72h. Exposure of Bhas 42 cells to B[a]P for 24h and 72h decreased 
mitochondrial content by 46% and 30%, respectively. Previous studies have shown metabolites of 
B[a]P to alkylate mtDNA 40-90 times greater than nuclear DNA (Backer and Weinstein, 1980)( 
and to deplete mtDNA (Pieters et al., 2013). The exposure to B[a]P may produce adducts that 
interfere with mtDNA replication or produce mutations that increase mitochondrial oxidative 
stress and decrease mitochondrial content through mitophagy (Van Houten et al., 2016). Such a 
mechanism is consistent with our previous observation that exposure of Bhas 42 cells to B[a]P 
increased intracellular and mitochondrial ROS generation (Figs. 3.2 and 3.3; Omidian et al, 2017). 
The effects of the different polyphenols on B[a]P-induced decline in mitochondrial content at 24h 
and 72h distinguished some differences between polyphenols. The polyphenols all protected 
against the effect of B[a]P on mitochondrial content by 39-78% after 24h, with cyanidin being the 
most effective. The effect of cyanidin is consistent with its strong protection against mitochondrial 
superoxide at early time points as we observed previously (Fig. 3.4). At 72h B[a]P exposure 
however, cyanidin (and berberine) had lost protection, while resveratrol became the most effective. 
The lack of effect of cyanidin at this time point compared to C3G may be a result of its instability 
in the medium, whereas C3G has more stability due to having a glucoside group (Khoo et al., 
2017). The differences might also be explained by different abilities to induce mitochondrial 
biogenesis. 
Although resveratrol protected with similar potency to other polyphenols against the decreased 
mitochondrial content after 24h, it had the strongest effect after 72h exposure and increased 
number of mitochondria to levels higher than that of untreated cells. This robust long-term effect 
of resveratrol on inducing mitochondrial content is most likely one of the key mechanisms by 
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which resveratrol has shown the strongest preventive effect on B[a]P-induced neoplastic 
transformation (with 72h exposure) compared to other polyphenols (Fig. 3.6). Induction of 
mitochondrial content by resveratrol and its beneficial effects on health have been shown in several 
diseases and conditions such as neurodegenerative diseases, aging and exercise performance (Hart 
et al., 2013; Pallàs et al., 2009). However, data showing preventive roles of resveratrol or other 
polyphenols in carcinogenesis through mitochondrial biogenesis mechanisms are limited. In one 
report on SW620 colon cancer cells (del Mar Blanquer-Rosselló et al. (2017), treatment with 10 
μM resveratrol for 48h induced mitochondrial mass and mitochondrial respiratory capacity, which 
was associated with elevated ROS production and apoptosis. In Bhas 42 cells exposed to B[a]P we 
showed decreased ROS production (Figure 3.2 & 3.3) as a result of increased mitochondrial 
biogenesis by polyphenols. Given that our study is a prevention but not a treatment study, 
decreasing ROS production would be beneficial. 
To explore molecular mechanisms by which resveratrol and other polyphenols induced 
mitochondrial content, we measured effects of polyphenols and B[a]P on the expression of mRNA 
for citrate synthase and mitochondrial and nuclear DNA-encoded respiratory subunits. Citrate 
synthase is the first enzyme in the tricarboxylic acid cycle and is often used as a marker of 
mitochondrial content and aerobic energy metabolism (Price et al., 2012). In our study, although 
B[a]P had no significant effect on citrate synthase expression, resveratrol increased its expression 
up to a level higher than untreated cells. This result suggests a role for resveratrol in protecting 
against a shift to aerobic glycolysis by increasing oxidative energy metabolism. In human 
colorectal cancer cell lines (HCT116 and Caco2), 100 μM resveratrol increased citrate synthase 
activity and decreased glucose consumption which was concomitant with activation of apoptotic 
markers (Fouad et al., 2013). However, an effect of resveratrol on citrate synthase in anti-
carcinogenesis has not been previously shown. 
We also measured effects of B[a]P and polyphenols on expression of mtDNA- and nDNA-encoded 
respiratory subunits. Exposure to B[a]P decreased expression of nDNA-encoded complex I 
(NDUFS8) and V (ATP5A1) and mt-DNA-encoded complex III (CYB) subunits. Only a few 
studies have reported an effect of B[a]P on expression of mitochondrial complex subunits 
(Kamaraj et al., 2011; Qiao et al., 2015) and none of them investigated mtDNA-encoded subunits. 
Previous studies have shown that mutations in the nuclear and mtDNA-encoded subunits are 
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correlated with poor prognosis for cancer (Allalunis-Turner et al., 2006; Kulawiec et al., 2006; 
Moro et al., 2009). Consistent with our results, some studies reported that mutations to mtDNA 
increases the tumorigenicity of cultured cancer cells (Chattopadhyay et al., 2016; Cruz-Bermúdez 
et al., 2015; de Araujo et al., 2015; Yadava et al., 2013). In one study for example, a mutation to 
the mtDNA-encoded complex 1 subunit ND5 in C8T and C9T cell lines, increased tumorigenesis 
compared to the control 143B cells through increasing ROS production, decreasing ATP 
production from oxidative phosphorylation, and increasing resistance to apoptosis (Park et al., 
2009). Mitochondrial subunit mutations, specifically in complexes I and III are the major 
mutations and sources of ROS production observed in cancer cells (Brandon et al., 2006; Sullivan 
and Chandel, 2014). The decrease in expression of the mtDNA-encoded complex III subunit CYB 
that we observed in this study, which can impair electron flow through the respiratory chain and 
increase ROS generation (Bandy and Davison, 1990), may have contributed to the increased ROS 
generation in Bhas 42 cells exposed to B[a]P that we observed previously (Omidian et al., 2017, 
Chapter 3). Therefore, inhibiting mitochondrial subunit mutations prevents ROS production and 
cancer progression. Moreover, complex V (ATP synthase) mutation is associated with shifting 
energy from oxidative phosphorylation to aerobic glycolysis (Warburg effect) in cancer cells 
(Sánchez-Cenizo et al., 2010). In our study, most polyphenols protected against these B[a]P effects 
and up-regulated mitochondrial complex subunits some to a level higher than untreated cells.  
To further investigate an involvement of mitochondrial biogenesis in effects produced by 
polyphenols, we measured SIRT1, PGC-1α, and mitochondrial biogenesis-related transcription 
factors (NRF-1, TFAM, and ERR α). SIRT1 is a NAD+-dependent deacetylase that deacetylates 
and activates PGC-1α, and thereby increases expression of genes involved in mitochondrial 
biogenesis (Ventura-Clapier et al., 2008). Briefly, PGC-1α co-activates transcription-inducing 
activity of NRF-1 which up-regulates nDNA-encoded mitochondrial proteins as well as TFAM. 
In turn, TFAM translocates to mitochondria and stimulates mtDNA replication and mitochondrial 
gene expression (Tang, 2016). PGC-1α also co-activates ERRα, a nuclear transcription factor that 
up-regulates genes involved in aerobic energy metabolism and mitochondrial function (Schreiber 
et al., 2004).  
SIRT1 expression is regulated at multiple levels (Milner, 2009), and so we measured expression 
of both mRNA and activity. We observed that exposure of the Bhas 42 cells to B[a]P decreased 
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SIRT1 mRNA expression by 37% but did not significantly affect cellular SIRT1 activity. These 
observations conflict with those of a previous study (Lu et al., 2015) in which B[a]P exposure 
increased SIRT1 mRNA and protein levels in cultured human lung epithelial cells and in the lungs 
of mice. The reason behind these different responses to B[a]P is not clear.  
The polyphenols differently affected SIRT1 mRNA expression and SIRT1 activity. Several of the 
polyphenols (quercetin, catechin, cyanidin and C3G) prevented the B[a]P-induced decrease in 
SIRT1 mRNA expression. The regulation of SIRT1 mRNA expression is complex and not well 
understood (Milner, 2008), and so it is difficult to know the mechanism behind this effect of the 
polyphenols. With measurements of SIRT1 activity, although B[a]P had no significant effect, 
resveratrol and quercetin increased SIRT1 activity compared to cells exposed to B[a]P alone. 
Resveratrol is known as a direct or indirect activator of SIRT1 (Howitz et al., 2003; Hu et al., 
2011); and its ability to suppress tumorigenesis through activating SIRT1 has been previously 
shown (Wang et al., 2008). Quercetin also is well known as a SIRT1 activator (Baur, 2010), and 
induced both SIRT1 gene expression and activity. Catechin, cyanidin, and C3G increased SIRT1 
gene expression however had no effect on SIRT1 activity.  
To further investigate whether effects of B[a]P and polyphenols on mitochondrial content during 
carcinogenesis involve effects on mitochondrial biogenesis, we measured their effects on PGC-1α 
mRNA expression and on cellular de-acetylated PGC-1α protein levels. In addition to the anti-
Warburg effect of PGC-1α in cancer prevention, it can also prevent carcinogenesis through other 
mechanisms such as decreased ROS production, increased anti-oxidant enzymes and reduced 
inflammation (Girnun, 2012). Our data show that B[a]P had no significant effect on PGC-1α gene 
and de-acetylated protein expression. Therefore, down-regulation of PGC-1α does not seem to be 
a major mechanism in the decreased mitochondrial content produced by B[a]P. All of the 
polyphenols, however, increased expression of either PGC-1α mRNA or de-acetylated PGC-1α 
protein, or both. Resveratrol was unique in having no significant effect on PGC-1α mRNA 
expression, but it strongly increased the level of de-acetylated PGC-1α protein. This effect on de-
acetylated PGC-1α is consistent with its effect to increase SIRT1 activity, which de-acetylates 
PGC-1α. A role of increased PGC-1α by resveratrol and other polyphenols in protecting against 
other diseases has been previously reported (Krishnamoorthy and Venkatraman, 2017; Ma et al., 
2017), however this effect of polyphenols on PGC-1α has not been shown in cancer prevention.  
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To further investigate effects on mitochondrial biogenesis, we measured expression of the 
transcription factors ERRα, NRF1, and TFAM. B[a]P significantly down-regulated ERRα mRNA 
by 29% but had no effect on NRF1 and TFAM gene expression. The effect of B[a]P on ERRα may 
have contributed to the decrease in mitochondrial content. The lack of effect on NRF1 and TFAM 
suggest that these transcription factors were not involved in the decrease caused by B[a]P. Previous 
studies have shown conflicting effects of B[a]P on expression of TFAM and NRF1 (Wu et al., 
2016; Zhang et al., 2011). Zhang et al. (2011) showed that 12 µM B[a]P in human bronchial 
epithelial cells (16HBE) had no effect on mRNA expression but decreased protein expression of 
NRF1 and TFAM. In this study, NRF1 down-regulation by siRNA increased susceptibility of the 
cells to decreased mitochondrial membrane potential and ROS generation induced by B[a]P. In a 
subsequent study by this group, Wu et al. (2016) reported that transfection-induced overexpression 
of NRF1 in the 16HBE cells could attenuate the cytotoxic effect of the B[a]P metabolite benzo a 
pyrene-7,8-diol-9,10-epoxide (BPDE) . Although the results on effects of B[a]P on expression of 
mitochondrial biogenesis transcription factors are mixed, they suggest that increased expression 
of these factors can help protect against the detrimental effects of B[a]P on mitochondrial content 
and function. 
The effects of the polyphenols in the presence of B[a]P on expression of mRNA for the 
mitochondrial biogenesis transcription factors were modest. Quercetin and berberine increased 
NRF1 expression to a level above that of untreated cells. Resveratrol, quercetin, and cyanidin 
significantly increased the expression of ERRα, and only C3G increased TFAM compared to the 
level in the presence of B[a]P alone.  
To investigate effects of B[a]P and polyphenols on mitochondrial function, we measured their 
effects on MMP and ATP. Mitochondrial dysfunction as a result of gene mutations and aberrant 
ETC, increases ROS production and decreases MMP; therefore, MMP reflects mitochondrial 
status in the cells and is a biomarker of mitochondrial dysfunction (de Moura et al., 2010). Another 
consequence of mitochondrial dysfunction is decreased ATP content as a result of impaired ETC 
(Lu et al., 2009; Moiseeva et al., 2009; Wang and Moraes, 2011).  
In our study, exposure to B[a]P decreased MMP and ATP levels by 22-28%, suggesting a positive 
association between decreased MMP and ATP depletion. Loss of MMP and ATP by exposure of 
99 
 
cells to B[a]P has been shown in previous studies (Jiang et al., 2011; Zhang et al., 2011). Given 
shifting energy from oxidative phosphorylation to aerobic glycolysis in cancer cells and increasing 
the rate of glycolysis to compensate energy, we also measured ATP content in the presence of 
galactose. Because galactose cannot provide net ATP synthesis in glycolysis, galactose medium 
suppresses glycolysis and forces cells to supply their energy from oxidative phosphorylation (Dott 
et al., 2014). Therefore, results of ATP content in the presence of galactose reflect the ATP 
produced from mitochondrial oxidative phosphorylation. Complete suppression of ATP by 
antimycin A, a complex III inhibitor, in the presence of galactose but not glucose confirmed 
glycolysis repression (Fig. 3C, D). B[a]P significantly depleted ATP in the presence of both 
glucose and galactose with the same potency. This effect of B[a]P shows that aerobic glycolysis 
was not able to compensate loss of ATP caused by decreased oxidative phosphorylation.  
Treatments with several of the polyphenols prevented the B[a]P induced decreases in MMP and 
ATP. Resveratrol, quercetin, catechin, and cyanidin prevented the decrease in MMP, and 
resveratrol increased the MMP to a level significantly higher than untreated cells. Also, while 
resveratrol, quercetin and catechin alleviated the B[a]P-induced decrease in ATP in cells grown 
on glucose, resveratrol was the only polyphenol that prevented B[a]P-induced ATP depletion in 
cells grown on galactose. These effects of resveratrol are consistent with the observations that had 
the most consistent and often strongest effect on mitochondrial content, citrate synthase mRNA, 
SIRT1 activity, and de-acetylated PGC-1α. Quercetin was also notable as the next strongest 
polyphenol in protecting against many of these effects of B[a]P. Together the results support the 
hypothesis that polyphenol-induced increases in mitochondrial content and function helps to 
protect against the detrimental effects of B[a]P.  
One notable exception among the different polyphenol derivatives tested for its effects on MMP 
and ATP was berberine. Berberine significantly decreased the ATP level in cells grown on 
galactose even more than that of B[a]P alone, and berberine did not protect against the B[a]P-
induced decreases in MMP and ATP in cells grown on glucose. This effect of berberine may be 
related to the observation in a previous study (Yin et al., 2008) that 5 μM berberine inhibited 
oxygen consumption in 3T3-L1 adipocytes and L6 myotubes, which increased the AMP/ATP 
ratio, activated AMPK, and increased glycolysis. The results suggest that berberine may have an 
inhibitory effect on mitochondrial oxidative phosphorylation. Further investigations are required 
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to clarify the role of berberine in aerobic metabolism and B[a]P induced mitochondrial 
dysfunction.    
5.5. Conclusions  
In summary, B[a]P decreased mitochondrial content and induced mitochondrial dysfunction while 
different polyphenols inhibited these effects with different effectiveness. B[a]P abolished 
mitochondrial biogenesis by decreasing expression of mitochondrial and nuclear DNA-encoded 
respiratory subunits, SIRT1 activity, and expression of gene transcription factor. In addition to 
effect on mitochondrial proliferation, B[a]P induced mitochondrial dysfunction by decreasing 
MMP and ATP content. Although all pre-treated polyphenols induced mitochondrial biogenesis 
and decreased mitochondrial dysfunction, resveratrol showed the most robust effect in induction 
of mitochondrial content after 72h. However, further studies are required to investigate other 
molecular mechanisms of polyphenols in cancer prevention. 
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5.6. Transition to CHAPTER 6 
In CHAPTER 5, we investigated possible mitochondrial mechanisms that are involved in B[a]P-
induced oxidative stress and neoplastic transformation and prevention by polyphenols, particularly 
prevention by resveratrol. In some experiments including mitochondrial content after 72h, citrate 
synthase mRNA expression, and ATP content, resveratrol showed the most robust protection 
against B[a]P exposure compared to other polyphenols. 
Because resveratrol and anthocyanidins might act by different mechanisms (inducing 
mitochondrial biogenesis and scavenging mitochondrial ROS, respectively), we hypothesized that 
resveratrol and cyanidin might act synergistically to decrease B[a]P-induced mitochondrial ROS. 
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Results of experiments to test this hypothesis did not show any additive or synergistic effects and 
are shown in APPENDIX 2.  
In CHAPTER 6, we further assessed the hypothesis and results in CHAPTER 5 suggesting that 
mitochondrial biogenesis induced by the polyphenols, especially resveratrol, results in decreased 
intracellular and mitochondrial ROS generation. In this chapter we measured the effects of B[a]P 
and polyphenols on intracellular ROS and mitochondrial superoxide generation after 24h (to 
complete the measurements at this time point and allow comparisons with mitochondrial content 
and function in CHAPTER 5), effects of polyphenols on intracellular ROS when given after 
exposure to B[a]P (to help distinguish direct antioxidant effects), the effects of the different 
polyphenols alone (in absence of B[a]P) on the mitochondrial content after 24h in Bhas 42 cells, 
and effects of polyphenols when given for 24h and removed prior to exposure to B[a]P for 24 and 
72h on intracellular ROS and mitochondrial superoxide (to show pre-conditioning effects in the 
absence of continued presence of the polyphenols in the medium).  
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CHAPTER 6: PROMOTING MITOCHONDRIAL BIOGENESIS BY RESVERATROL, 
MORE STRONGLY THAN OTHER POLYPHENOLS INHIBITS ROS GENERATION 
IN B[A]P-INDUCED CARCINOGENESIS 
 
Abstract 
Background: Previous studies suggest a pivotal role of mitochondria in ROS production and 
carcinogenesis when cells are exposed to a carcinogen such as B[a]P and show potential protection 
by dietary polyphenols such as resveratrol. However, data to show a link between induction of 
mitochondrial biogenesis and cancer prevention through suppressing oxidative stress are limited. 
Therefore, in the present study we investigated the association between induction of mitochondrial 
biogenesis by natural polyphenols and B[a]P-induced ROS generation in fibroblast Bhas 42 cells. 
Materials and Methods: Bhas 42 cells were treated with polyphenols before, during or after 
exposure to B[a]P for different times. Intracellular ROS and mitochondrial superoxide were 
measured using DCFH-DA and MitoSox red fluorescent dyes, respectively, and mitochondrial 
content was measured using MitoTracker Green fluorescent dye. 
Results: In co-treatments starting 2h before B[a]P, all of the polyphenols strongly protected against 
B[a]P-induced intracellular ROS generation after 24h, but only the anthocyanins (cyanidin and 
C3G) and berberine significantly decreased B[a]P-induced mitochondrial superoxide. In post-
treatments after 12h exposure to B[a]P, 12h treatment with all of the polyphenols significantly 
decreased B[a]P-induced intracellular ROS by 58-90%, with resveratrol giving the least and 
cyanidin the strongest effect. After treatment of Bhas 42 cells for 24h with the different 
polyphenols (in absence of B[a]P), resveratrol, catechin and C3G significantly increased 
mitochondrial content and resveratrol had the strongest effect, increasing the mitochondrial 
content by 62%. With 24h polyphenol pre-treatment and subsequent 24h and 72h exposure to 
B[a]P, all of the polyphenols almost completely prevented the B[a]P-induced increase in 
intracellular ROS after 24h exposure, and inhibited by 48-96% after 72h with resveratrol and 
quercetin most strongly decreasing intracellular ROS generation. 
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Conclusion: The present study revealed a positive association between induction of mitochondrial 
content and decreased B[a]P-induced ROS generation in Bhas 42 cells that may help explain the 
anti-carcinogenesis effect of resveratrol.  
6.1. Introduction 
Mitochondrial dysfunction caused by aberrant mitochondrial electron transfer chains contributes 
to increased mitochondrial superoxide production (Park et al., 2011; Sauer et al., 2001), and 
increased intracellular ROS and oxidative stress. Oxidative stress is a major contributor to tumor 
initiation and promotion by producing DNA mutations and genome instability, and influencing 
cell signalling pathways involved in cell proliferation (Visconti and Grieco, 2009). In our previous 
study we showed that the carcinogen B[a]P increased mitochondrial superoxide and intracellular 
ROS generation in Bhas 42 cells and ultimately increased the number of transformed foci (by 
465%, 21 days after exposure to 4 µM B[a]P for 72h), while different polyphenols (at 5 µM) 
protected against these effects (Fig 3.2-3.6). Resveratrol and quercetin significantly inhibited 
neoplastic transformation by B[a]P, with resveratrol showing the strongest effect (inhibiting by 
75%) (Fig. 3.6). 
By increasing the number of healthy and functional mitochondria, we postulated that induced 
mitochondrial biogenesis results in decreased ROS generation due to improved function of the 
mitochondrial respiratory chain. There are a few studies that have shown decreased ROS 
generation along with induced mitochondrial biogenesis (Kong et al., 2010; Takanche et al., 2017). 
Kong et al. (2010), reported that overexpression of PGC-1α and its downstream SIRT3 in C2C12 
myotubes increased mitochondria and decreased ROS through induction of ROS-detoxifying 
enzymes including glutathione peroxidase-1 and SOD2. Takanache et al. (2017) showed that, 
through increases in PGC-1α and antioxidant enzymes (SOD1 and SOD2), the plant natural 
product schisandrin C inhibited an increase in intracellular ROS and decrease in mitochondria 
induced by lipopolysaccharide in cultured human dental pulp cells. Conversely with cancer cells, 
which generally have decreased mitochondrial oxidative phosphorylation (Bellance et al., 2009), 
induction of mitochondrial biogenesis by a reasonably low dose of resveratrol can increase 
oxidative stress and promote apoptosis (del Mar Blanquer-Rosselló et al., 2017). Although a few 
previous studies have reported increased mitochondrial biogenesis along with decreased oxidative 
stress, no studies have shown this in carcinogenesis. There are many studies that have reported a 
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contribution of oxidative stress in tumorigenesis and extensive data have shown that decreased 
ROS may prevent carcinogenesis (Seifried et al., 2007; Sosa et al., 2013). However, none of them 
have shown whether increased mitochondrial biogenesis can prevent carcinogenesis through 
decreased ROS production. 
The data in Chapter 5 showed protective effects of polyphenols including resveratrol, quercetin, 
catechin, cyanidin, C3G, and berberine against B[a]P-induced decreases in mitochondrial content 
and function, with resveratrol showing the strongest effect on mitochondrial content after 72h (Fig. 
5.2) and on some other measures after 24h. The data in Chapter 3 showed that the polyphenols 
also decreased B[a]P-induced intracellular ROS generation, with similar effectiveness (Figs. 3.2 
and 3.3), but that resveratrol most strongly inhibited neoplastic transformation. In the current 
study, we further investigated the hypothesis that induction of mitochondrial biogenesis by 
polyphenols prevents B[a]P-induced carcinogenesis in Bhas 42 cells partly through decreasing 
ROS production.  
6.2. Materials and Methods 
6.2.1. Chemicals and reagents 
See sections 3.2.1 and 5.2.1. 
6.2.2. Cell culture 
See section 3.2.2. 
6.2.3. Intracellular ROS measurement 
The level of intracellular ROS was determined by using 2,7-dichlorodihydrofluorescein diacetate 
(DCFH-DA). After seeding 2 × 104 Bhas 42 cells in a 96-well plate and growing for 24 hours, 
polyphenols at 5 µM were administrated in DMSO (final DMSO concentration 0.5 %) for 24h, 
medium was replaced with the fresh medium containing 4 μM B[a]P (but no polyphenol) and 
incubating for 24h and 72h. After these incubations, 10 µM H2O2 was administrated to some 
control wells as a positive control and incubated for 1 h. Then DCFH-DA at 25 µM final 
concentration dissolved in DMEM without FBS was loaded to each well. After incubating for 30 
min all of the wells were cautiously washed twice with phosphate-buffered saline (PBS) and read 
at 480/20 nm excitation and 528/20 nm emission using a microplate reader (BioTek, Synergy HT). 
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Images were captured by fluorescence microscope (Olympus IX 71) at 473±31 nm excitation and 
520±35 nm emission. Intracellular ROS also was measured after treating Bhas 42 cells with B[a]P 
first for 12 h, replacing the medium and then treating them with polyphenols for 12 h. 
6.2.4. Mitochondrial superoxide measurement 
The level of mitochondrial superoxide production was measured using MitoSOX red fluorogenic 
dye. After seeding 2 × 104 Bhas 42 cells for 24 hours followed by pre-treatment with 5µM 
polyphenols for 24h, the medium was replaced with fresh medium containing B[a]P (but no 
polyphenol) and incubating for 24h and 72h in 5% CO2 at 37ºC. Antimycin A (a cytochrome c 
reductase inhibitor) was added as a positive control and incubated for 30 minutes. Then, MitoSOX 
probe at 5 µM final concentration dissolved in DMEM without FBS was loaded to each well and 
plates were incubated for 30 minutes. Then wells were cautiously washed twice with PBS and read 
at 530±20 nm excitation and 590±20 nm emission using a microplate reader. Images were captured 
by a ZOE Fluorescent Cell Imager (Bio-Rad).  
6.2.5. Mitochondrial content measurement 
After seeding 2 × 104 Bhas 42 cells in a 96 well optical bottom plate for 24 hours and treatment 
with polyphenols at 5 µM, cells were incubated for 24h in 5% CO2 at 37ºC. Medium was then 
removed and MTG probe at 250 nM final concentration was loaded in medium without FBS. After 
30 minutes incubation, cells were carefully washed twice with PBS. The average fluorescence 
intensity was quantified at 485±20 excitation and 528±20 nm emission using a microplate reader. 
6.2.6. Statistical analysis  
Data were analysed by one-way or two-way ANOVA where appropriate. Significant differences 
between groups was determined by Tukey’s post-hoc test and differences of p<0.05 were 
considered significant. Results are reported as means ± SEM of 3 independent experiments with 3 





6.3.1. Effect on intracellular ROS generation after 2h pre-incubation with polyphenols and 
24h exposure to B[a]P 
Analysis of intracellular ROS generation after 24h shows that treatment of Bhas 42 cells with 4 
µM B[a]P significantly increased ROS generation by 80% compared to untreated cells (Fig. 6.1). 
All of the polyphenols completely prevented the increase in ROS generation with similar potency. 
 
Figure 6.1. Effect of polyphenols on B[a]P-induced intracellular ROS generation after 24 h. 
Intracellular ROS generation was measured using DCFH-DA in Bhas 42 cells after pre-incubation 
with polyphenols at 5 µM for 2h and adding 4 µM B[a]P for 24h. Data are presented as percentage 
of the untreated cells. The figure represents means ± SEM of 3 independent experiments with 3 
wells of cells per treatment condition in each experiment.  The significant difference between 
groups was tested with one-way ANOVA followed by Tukey’s post-hoc test. * Significantly 
different from the UT group at p < 0.05. # Significantly different from the B[a]P group at p < 0.05. 
6.3.2. Effect on mitochondrial superoxide generation after 2h pre-incubation with 
polyphenols and 24h exposure to B[a]P 
Treatment with 4 µM B[a]P significantly increased mitochondrial superoxide generation after 24h 
by 65% compared to untreated cells (Fig. 6.2). Among the polyphenols, cyanidin, C3G, and 




Figure 6.2. Effect of polyphenols on B[a]P-induced mitochondrial superoxide generation 
after 24 h. 
Mitochondrial superoxide was measured using MitoSOX Red in Bhas 42 cells after pre-incubation 
with polyphenols at 5 µM for 2h and adding 4 µM B[a]P for 24h. Data are presented as percentage 
of the untreated cells. The figure represents means ± SEM of 3 independent experiments with 3 
wells of cells per treatment condition in each experiment.  The significant difference between 
groups was tested with one-way ANOVA followed by Tukey’s post-hoc test. * Significantly 
different from the UT group at p < 0.05. # Significantly different from the B[a]P group at p < 0.05. 
6.3.3. Effect on intracellular ROS generation after pre-exposure to B[a]P for 12h and post-
treatment with polyphenols for 12h  
With 12h exposure to B[a]P followed by its removal and treatment with polyphenols for another 
12h, B[a]P significantly increased intracellular ROS generation by ~ 130% and all of the 
polyphenols significantly reversed this effect (Fig. 6.3). Cyanidin had the strongest inhibitory 
effect (~90%). The effect of cyanidin against B[a]P-induced intracellular ROS generation after 




Figure 6.3. Effect of polyphenol post-treatment on B[a]P-induced intracellular ROS 
generation. 
Intracellular ROS was measured with DCFH-DA in Bhas 42 cells after pre-treatment with B[a]P 
4 µM for 12h, replacement of the medium, and treatment with 5 µM polyphenols for 12h. Data are 
presented as percentage of the untreated cells. The figure represents means ± SEM of 3 
independent experiments with 3 wells of cells per treatment condition in each experiment. The 
significant difference between groups was tested with one-way ANOVA followed by Tukey’s 
post-hoc test. * Significantly different from the UT group at p < 0.05. # Significantly different 
from the B[a]P group at p < 0.05. $ Significantly different from cyanidin at p < 0.05 
6.3.4. Effect on intracellular ROS generation after 24h pre-treatment with polyphenols and 
24h and 72h exposure to B[a]P 
Treatment with B[a]P alone increased intracellular ROS generation ~ 90% and 130% after 24h and 
72h, respectively (Fig. 6.4 A&B). With 24h pre-treatment (and removal prior to B[a]P exposure) 
all of the polyphenols significantly decreased intracellular ROS generation and some of them 
completely prevented the effect of B[a]P after 24h and 72h. After 24h exposure to B[a]P, all of the 
polyphenols gave similar protection; however, after 72h exposure to B[a]P, resveratrol pre-
treatment had the strongest effect (95% inhibition) against B[a]P-induced intracellular ROS 
generation. The effect of resveratrol against B[a]P-induced intracellular ROS generation was 




Figure 6.4. Effect of 24h pre-treatment with polyphenols on subsequent B[a]P-induced 
intracellular ROS generation after 24h and 72h. 
Intracellular ROS generation was measured with DCFH-DA in Bhas 42 cells after pre-treatment 
with polyphenols at 5 µM for 24h, replacement of the medium without polyphenols and treatment 
with 4 µM B[a]P for (A) 24h and (B) 72h. Data are presented as percentage of the untreated cells. 
The figure represents means ± SEM of 3 independent experiments with 3 wells of cells per 
treatment condition in each experiment. The significant difference between groups was tested with 
one-way ANOVA followed by Tukey’s post-hoc test. * Significantly different compared to the 
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B[a]P group at p < 0.05. * Significantly different from the UT group at p < 0.05. # Significantly 
different from the B[a]P group at p < 0.05. 
6.3.5. Effect on mitochondrial superoxide generation after 24h pre-treatment with 
polyphenols and 24h and 72h exposure to B[a]P 
Treatment with B[a]P increased mitochondrial superoxide generation ~ 46% and 90% after 24h 
and 72h, respectively (Fig. 6.5 A&B). With 24h pre-treatment (and removal prior to B[a]P 
exposure) all of the polyphenol pre-treatments significantly decreased mitochondrial superoxide 
generation after 24h and 72h by up to almost 100%. None of the effects of the polyphenols were 





Figure 6.5. Effect of 24h pre-treatment with polyphenols on subsequent B[a]P-induced 
mitochondrial superoxide after 24h and 72h. 
Mitochondrial superoxide was measured using MitoSOX Red in Bhas 42 cells after pre-treatment 
with polyphenols at 5 µM for 24h, replacement of medium without polyphenols and (A) treatment 
with 4 µM B[a]P for 24h and (B) treatment with 4 µM B[a]P for 72h. Data are presented as 
percentage of the untreated cells. The figure represents means ± SEM of 3 independent 
experiments with 3 wells of cells per treatment condition in each experiment. The significant 
difference between groups was tested with one-way ANOVA followed by Tukey’s post-hoc test. 
* Significantly different from the UT group at p < 0.05. # Significantly different from the B[a]P 




In the present study we explored the role of mitochondrial biogenesis induction by polyphenols in 
decreasing B[a]P-induced ROS generation. We also aimed to show whether mitochondrial 
biogenesis induction and associated decrease in ROS may help explain the strong effect of 
resveratrol on B[a]P-induced neoplastic transformation that was reported in our previous study 
(Omidian et al., 2017). In that study, after treatment with polyphenols and B[a]P for 72h, only 
resveratrol and quercetin could protect against B[a]P-induced neoplastic transformation after 21 
days. Protective effects of resveratrol and quercetin against neoplastic transformation have been 
previously shown in different cell lines (Chen et al., 2016; Lu et al., 2008); however, studies 
comparing effect of resveratrol and quercetin against neoplastic transformation with other studied 
polyphenols are lacking. Lu et al. (2008) reported that resveratrol dose-dependently (12.5-50 µM) 
inhibited both 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)- and estradiol-induced neoplastic 
transformation in MCF-10F cells. In this study, resveratrol inhibited neoplastic transformation by 
decreasing CYP1B1 and increasing NQO1 expression. In a study conducted by Chen et al. (2016), 
quercetin at 0.5 and 2 µM inhibited IL-6 enhancement of B[a]P-induced cell transformation in 
human bronchial epithelial cells (HBEC). The experiments in CHAPTER 5 showed that after 72h 
treatment, resveratrol prevented a B[a]P-induced decrease in mitochondrial content stronger than 
other polyphenols (Fig. 5.2).  
To investigate the effect of polyphenols alone on mitochondrial biogenesis in the current studies, 
we measured mitochondrial content after 24h treatment of Bhas 42 cells without B[a]P present 
(Fig 5.1C). Resveratrol, catechin and C3G increased mitochondrial content, however the effect of 
resveratrol was significantly stronger compared to the other polyphenols. Previous experimental 
and clinical studies have demonstrated a role of resveratrol in induction of mitochondrial 
biogenesis (De Paepe and Van Coster, 2017; Howitz et al., 2003); however, data comparing this 
effect of resveratrol with other studied polyphenols is limited.  
To complete the measurements after 24h, we also measured effects of polyphenols on B[a]P-
induced intracellular ROS generation after 24h. Consistent with our previous results after 12h 
measurement (Fig. 3.2), all polyphenols prevented against this effect of B[a]P with similar 
effectiveness. Therefore, the decrease in B[a]P-induced intracellular ROS at this time point was 
not only related to the effect of the polyphenol on mitochondrial content. It may be that the 
113 
 
decrease in ROS at this time point reflects both direct antioxidant effects of the polyphenols and 
their effects on mitochondrial content and function. Preventive effects of some of our studied 
polyphenols on B[a]P-induced ROS production have been previously shown (Banerjee et al., 
2016b; Rathore and Wang, 2012; Woo et al., 2008). For example, in an animal study (Banerjee et 
al., 2016b), resveratrol (50 mg/kg of body weight) inhibited B[a]P-induced testicular dysfunction 
and decreased intracellular ROS production in testes tissue homogenates. 
To investigate 24h pre-treatment effects of polyphenols on later B[a]P-induced intracellular ROS 
generation, Bhas 42 cells were exposed to 5 µM polyphenols for 24h and then medium with 
polyphenols was removed and 4 µM B[a]P was administrated for 24h and 72h. The purpose of this 
experiment was to observe whether polyphenols which induced mitochondrial biogenesis after 24h 
(Fig. 5.1C), would have any distinguished effect on intracellular ROS generation after subsequent 
24h and 72h exposure to B[a]P. Although all polyphenols decreased ROS generation with similar 
effectiveness after 24h exposure to B[a]P, resveratrol and quercetin had the strongest effect on 
decreasing ROS generation compared to other studied polyphenols after 72h exposure to B[a]P. 
These strong protective effects of resveratrol and quercetin against B[a]P-induced ROS generation 
compared to other polyphenols therefore could be a plausible mechanism for their strongest 
protective affects against B[a]P-induced neoplastic transformation (Fig. 3.6).  
These experiments also were designed to investigate the hypothesis that increased mitochondrial 
biogenesis contributed to the decreased ROS generation, and consequently prevent carcinogenesis. 
Taking into account the results of mitochondrial content and ROS generation, we conclude that 
induced mitochondrial biogenesis can be suggested as a mechanism for decreasing intracellular 
ROS generation by resveratrol after 24h treatment with polyphenols and 72h exposure to B[a]P. 
Our data are consistent with the previous studies showing association between induced 
mitochondrial biogenesis and decreased ROS generation (Chen et al., 2017b; Kong et al., 2010). 
The association between mitochondrial biogenesis and ROS generation has not been previously 
shown in carcinogenesis. The current results support the possibility that increasing the number of 
healthy mitochondria limits the impact of B[a]P-induced adducts in mtDNA on mitochondrial 
function. 
The effects of 24h pre-treatment with polyphenols on mitochondrial superoxide generation after 
exposure of Bhas 42 cells to B[a]P for 24h and 72h was also investigated. After both time-points, 
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all polyphenols decreased mitochondrial superoxide generation with the similar potency by up to 
90%. After 72h, resveratrol, cyanidin, and berberine showed the strongest effects. In the current 
and previous studies, we have shown that cyanidin, C3G, and berberine are the only polyphenols 
that protected against B[a]P-induced mitochondrial superoxide generation after 2h pre-treatment 
with polyphenols and 24h and 12h treatment with B[a]P, respectively. This effect of anthocyanins 
and berberine may be related to their abilities to accumulate in mitochondria to a greater extent 
than other polyphenols (Omidian et al., 2017). 
To investigate treatment effects of polyphenols versus their preventive effects on B[a]P-induced 
intracellular ROS generation, Bhas 42 cells were pre-treated with B[a]P for 12h and then the 
medium containing B[a]P was removed and the cells were treated with polyphenols for another 
12h. The anthocyanins and berberine showed the strongest effect in this treatment experiment. 
These results may be related to the strong direct antioxidant ability of anthocyanins (Kong et al., 
2003), as well as the accumulation of these agents in mitochondria (Serafim et al., 2008). 
In conclusion, the present study showed that one of the plausible mechanisms by which quercetin 
and resveratrol prevented against B[a]P-induced neoplastic transformation is through decreasing 
intracellular ROS generation. Moreover, this study revealed that induction of mitochondrial 
biogenesis by resveratrol is related to decreased B[a]P-induced intracellular ROS. With the limited 
amount of data in the area of mitochondrial biogenesis and cancer prevention as well as underlying 







CHAPTER 7: GENERAL DISCUSSION AND CONCLUDING REMARKS 
 
7.1. General discussion 
In the present study, we investigated protective effects of different polyphenols against B[a]P-
induced carcinogenesis in Bhas 42 cells. Bhas 42 cells are partially transformed cells (BALB/c 
3T3 cells transfected with the v-Ha-ras gene) and are used as a model of neoplastic transformation 
for both initiating and promoting carcinogens (Sakai et al., 2011). One of our hypotheses was that 
B[a]P will cause increased mitochondrial and intracellular ROS in its process of carcinogenesis in 
Bhas 42 cells. B[a]P has been previously shown to produce oxidative stress and oxidative DNA 
damage in vivo (Briede et al., 2004), and in cultured cells (Nkrumah-Elie et al., 2012). Oxidative 
stress is considered as both a trigger and consequence of carcinogenesis which contributes to DNA 
damage and mutations, inflammation, cell growth and proliferation, angiogenesis, and metastasis 
(Sabharwal and Schumacker, 2014). We showed that B[a]P at 4 μM significantly increased 
mitochondrial superoxide generation 42% and 65% after 12h and 24h, respectively. Increased 
mitochondrial superoxide by B[a]P has been shown by a few studies. Das et al. (2016) reported 
that B[a]P (5 μM) after 48h induced mitochondrial superoxide generation in human keratinocytes 
(HaCaT). Another study conducted by Sobinoff et al. (2012) showed that i.p. administration of 
B[a]P to mice after 7 days increased mitochondrial superoxide in oocytes. That increased 
mitochondrial ROS generation is a cause and consequence of mitochondrial dysfunction 
(Kudryavtseva et al., 2016), is consistent with our observations that B[a]P induced mitochondrial 
dysfunction in Bhas 42 cells. We also showed that B[a]P increased intracellular ROS generation 
25%, 80%, and 220% after 12h, 24h, and 72h. Increased intracellular ROS by B[a]P has been 
previously shown in vitro and in vivo studies (Sang et al., 2012; Yang et al., 2017). The increased 
intracellular ROS generation can then promote the genome instability and changes to signaling 
pathways that ultimately lead to neoplastic transformation (Sabharwal and Schumacker, 2014). 
We also hypothesized that berberine and anthocyanins will most effectively decrease 
mitochondrial superoxide in B[a]P-induced mitochondrial dysfunction. Polyphenols all inhibited 
intracellular ROS generation with similar effectiveness, but only positively charged polyphenols 
(cyanidin, C3G, and berberine) inhibited mitochondrial superoxide generation with 12h and 24h 
B[a]P exposure. The possible mechanism of this effect of anthocyanins and berberine, as explained 
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in CHAPTER 3, may be the preferential accumulation of these molecules in mitochondria, which 
then allows them to scavenge superoxide.  
To support our results regarding carcinogenic effects of B[a]P in Bhas 42 cells, we conducted a 
transformation assay experiment. B[a]P stimulated neoplastic transformation in Bhas 42 cells and 
strongly increased the number of foci (colonies) compared to untreated cells. Carcinogenicity of 
B[a]P involves complex mechanisms involving formation of bulky DNA adducts and gene 
mutations (Lemieux et al., 2011), oxidative stress (Vijayaraman et al., 2012), inflammation 
(Shahid et al., 2016), cell proliferation (Burdick et al., 2003), and cell signaling pathways (Jiao et 
al., 2008). Some of these studies showed protective effects of individual polyphenols such as 
catechin (Shahid et al., 2016) and quercetin (Liu et al., 2015), and the flavonoid mixture silymarin 
(Vijayaraman et al., 2012). A few studies (Kao et al., 2007; Xue et al., 2001) have shown a 
preventive role of an individual polyphenol such as ellagic acid, or of polyphenol-rich extracts 
against neoplastic transformation induced by B[a]P . We found that among different polyphenols, 
resveratrol and quercetin significantly prevented B[a]P-induced neoplastic transformation and 
resveratrol showed the most robust effect. Although resveratrol had a strong effect on decreasing 
the number of foci induced by B[a]P, it showed similar effectiveness to the rest of the polyphenols 
in decreasing intracellular ROS in experiments in CHAPTER 3. Therefore, to elucidate plausible 
mechanisms by which resveratrol protected against B[a]P-induced neoplastic transformation, we 
conducted further experiments.   
A possible mechanism that may explain this strong effect of resveratrol on B[a]P-induced 
neoplastic transformation is through decreasing cytochrome P450 drug metabolizing enzymes 
(CYPs) that activate B[a]P to mutagenic metabolites. We measured mRNA expression of CYP1A1 
and CYP1B1, two known enzymes that metabolize B[a]P in most tissues and cells. Although some 
studies have reported an antagonist role of a polyphenol such as resveratrol on induction of CYPs 
(Andrieux et al., 2004), we showed that resveratrol, quercetin, catechin, and berberine further 
induced expression of CYP1A1. We conclude that the preventive effect of resveratrol on B[a]P-
induced neoplastic transformation was not through inhibition of expression of CYP enzymes. 




Due to important roles of changes to mitochondria in carcinogenesis, possible mitochondrial 
mechanisms by which resveratrol may have prevented B[a]P-induced neoplastic transformation 
were investigated. We showed that B[a]P impaired mitochondrial biogenesis and mitochondrial 
function whereas polyphenols protected against these effects. Although B[a]P-induced mtDNA 
adducts have been substantially reported (Allen and Coombs, 1980; Graziewicz et al., 2004), 
evidence showing effects of B[a]P on mitochondrial biogenesis are limited. In our study, exposure 
to B[a]P decreased the number of mitochondria by 46% and 30% after 24h and 72h, respectively. 
As noted in the study by Graziewicz et al., (2004), this decrease could have occurred by 
interference of B[a]P adducts with mtDNA replication. In another possible mechanism, Zhang et 
al. (2011) reported that exposure of human bronchial epithelial cells (16HBE) to B[a]P increased 
intracellular ROS generation, perhaps through DNA mutations, that produced mitochondrial 
dysfunction along with down-regulated expression of the mitochondrial biogenesis proteins NRF1 
and TFAM. A few studies have investigated effects of B[a]P on mitochondrial number. For 
example, in a clinical study conducted on 148 non-smoking women, exposure to B[a]P from indoor 
and outdoor polution had inverse association with mitochondrial DNA number in leukocytes 
(Wong et al., 2017). Although resveratrol inhibited the decrease in mitochondrial content with 
similar effectiveness as other polyphenols after 24h exposure, it had the strongest effect after 72h 
exposure and increased the number of mitochondria to a level higher than untreated cells. These 
results support our third hypothesis and also may help explain the robust preventive effect of 72h 
treatment with resveratrol against B[a]P-induced neoplastic transformation after 21 days. 
To further investigate effects of B[a]P and polyphenols on mitochondria biogenesis, other relevant 
biomarkers were measured. B[a]P had no effect on the expression of citrate synthase, the first 
enzyme in Krebs cycle and a nDNA-encoded biomarker of mitochondrial biogenesis, however 
resveratrol induced its expression by 80%, to a level higher than untreated cells. This result 
supports a role for resveratrol in induction of mitochondrial biogenesis. Lagouge et al. (2006) 
showed that mice fed with high fat diet and resveratrol had higher mitochondrial enzymatic activity 
including increased citrate synthase activity compared to the mice fed with the high fat diet alone. 
B[a]P also significantly decreased nDNA-encoded complex I and V subunits, and a mtDNA-
encoded complex III subunit. Complexes I and III are the main sites of electron leakage and ROS 
production while complex V is the site of ATP production; therefore, impaired electron transfer in 
complexes I and III induces oxidative stress and impaired complex V shifts energy from OXPHOS 
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to aerobic glycolysis (Sánchez-Cenizo et al., 2010). These alterations may help explain induction 
of ROS generation (Fig. 3.2 & 3.4) and decreased ATP content (Fig. 5.10) induced by B[a]P. All 
of the polyphenols except C3G increased expression of at least one of the nDNA or mt-DNA-
encoded mitochondrial subunits. Effects of these polyphenols on mitochondrial complexes in non-
cancer models have been previously described (Gomes et al., 2012; Nichols et al., 2015). 
Resveratrol is well known as an activator of SIRT1 (Howitz et al., 2003) and its ability to decrease 
tumorigenesis through activating SIRT1 has been previously shown (Wang et al., 2008). In our 
study, although resveratrol had no effect on SIRT1 or PGC-1α gene expression, it increased SIRT1 
activity and deacetylated PGC-1α protein. We also showed that B[a]P had no significant effect on 
SIRT1 activity or on PGC-1α gene and deacetylated PGC-1α protein expression. However, B[a]P 
downregulated expression of ERRα, a transcription factor involved in mitochondrial biogenesis, 
while different polyphenols such as resveratrol, quercetin, and cyanidin protected against this 
effect.  
To investigate the effects of B[a]P and polyphenols on mitochondrial function, we measured MMP 
and ATP content. B[a]P consistently decreased MMP and ATP while different polyphenols 
prevented these effects of B[a]P. In addition to decreased mitochondrial content, increased UCP2 
expression by B[a]P (Fig 3.5 A) could have contributed to the decreased MMP. Other studies have 
shown decreased MMP and ATP in cells exposed to B[a]P. Exposure of human trophoblast cell 
Swan 71 to benzo(a)pyren-7,8-dihydrodiol-9,10-epoxide, an ultimate carcinogenic product of 
B[a]P, decreased MMP (Wang et al., 2018). B[a]P exposure also decreased cellular ATP content 
in immortalized human keratinocyte cell line (HaCaT) (Das et al., 2017). Resveratrol was the only 
polyphenol that increased the ATP content in cells grown on galactose, showing the ability of 
resveratrol to induce mitochondrial oxidative phosphorylation.  
Resveratrol had the strongest effect on mitochondrial parameters such as mitochondrial content 
after 72h, citrate synthase expression and ATP content. However, these results are not ample 
enough to support the strong protective effect of resveratrol against B[a]P-induced neoplastic 
transformation. Therefore, we extended our investigations to explore the possible connection 




In CHAPTER 6 we showed that resveratrol, catechin and C3G increased mitochondrial content 
without B[a]P present. Resveratrol had the strongest effect and significantly increased 
mitochondrial content compared to other polyphenols. To show whether prior mitochondrial 
biogenesis decreases the impact of B[a]P on intracellular and mitochondrial ROS production, we 
pre-treated with the polyphenols for 24h, removed the polyphenol-containing media, and then 
measured intracellular ROS and mitochondrial superoxide generation after exposure to B[a]P for 
24h and 72h. We observed that 24h prior treatment with resveratrol and quercetin almost 
completely prevented the B[a]P-induced intracellular ROS generation after 72h exposure to B[a]P. 
Therefore, we can conclude that induced mitochondrial biogenesis by resveratrol is associated with 
decreased B[a]P-induced intracellular ROS generation. Since increased mitochondrial biogenesis 
increases the mtDNA copy number (Peng et al., 2016; Sugiyama et al., 2015), this likely 
diminished the impact of B[a]P adducts and mutations in the genes for mtDNA-encoded 
respiratory complexes. Therefore, the increased mitochondrial biogenesis and most strongly 
decreased ROS generation by resveratrol and quercetin may explain the strong effects of these 
polyphenols against B[a]P-induced neoplastic transformation. Pre-treatments with all of the 
polyphenols strongly suppressed B[a]P-induced mitochondrial superoxide generation, perhaps by 
direct antioxidant effects with some polyphenols (such as cyanidin) and increased mitochondrial 
biogenesis with others. This result suggests that not only decreasing mitochondrial superoxide, but 
increasing mitochondrial biogenesis is important for the strongest protective effect against 
neoplastic transformation. 
Taken together, we showed that B[a]P exposure induces neoplastic transformation in Bhas 42 cells 
subsequent to decreasing mitochondrial content and function, increasing intracellular ROS and 
mitochondrial superoxide generation, and inducing TNF-α expression (a pro-inflammatory 
cytokine). Different polyphenols protected against these effects and resveratrol had the strongest 
effect against B[a]P-induced neoplastic transformation whereas it had similar effectiveness as 
other polyphenols in other experiments. These effects of polyphenols were not associated with an 
AhR antagonism activity. Resveratrol showed the strongest effects in some experiments including 
increasing mitochondrial content after 72h. In addition, we showed that induction of mitochondrial 
biogenesis by resveratrol lead to decreased ROS production. We conclude that the strong 
preventive effect of resveratrol and quercetin on B[a]P-induced neoplastic transformation is 
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possibly through their combined effect of increasing biogenesis of functional mitochondria and 
decreasing B[a]P-induced ROS generation.  
 
Figure 7.1. Effect of B[a]P and polyphenols on mitochondrial biogenesis and mitochondrial 
function. 
B[a]P decreased mitochondrial content and expression of mitochondrial respiratory subunits I, III, 
V, and ERRα. However, different polyphenols prevented these B[a]P effects and induced 
mitochondrial biogenesis. B[a]P also induced mitochondrial dysfunction by decreasing levels of 
MMP and ATP content, while polyphenols prevented B[a]P-induced mitochondrial dysfunction. 
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7.2. Limitations of the study 
7.2.1. Model of study 
One of the limitations of this study was that we used an in vitro model of carcinogenesis. Although 
in vitro models are good models for identifying and testing molecular mechanisms, they do not 
show all the features of cancer in humans. Moreover, polyphenol bioavailability following oral 
consumption is typically low and highly variable, and they appear in the blood and tissues in 
different forms (e.g. O-glucuronides, sulfate esters, and O-methyl esters) that may impact their 
functional abilities. Therefore, lack of an in vivo model is one of our limitations.   
7.2.2. Other mechanisms involved in carcinogenesis 
Cancer is a complex and multifactorial disease developing through interactions between several 
known and unknown mechanisms. In the current study we mainly investigated mitochondrial 
mechanisms by which B[a]P and polyphenols may play a role in carcinogenesis. However, there 
are other mechanisms that need to be considered including effects on MAPK, Akt, and glycolytic 
pathways. 
7.2.3. Mitochondrial respiratory chain activity 
Although mitochondrial respiratory subunit mRNA expression can show the state of mitochondrial 
function to some extent, measuring mitochondrial respiratory complex activity is more reliable 
and accurate. Therefore, one of the limitations of our study is lack of determining respiratory chain 
activity. Moreover, to have a comprehensive understanding of mitochondrial function, 
mitochondrial oxygen consumption needs to be measured (e.g. by Seahorse XF).  
7.3. Future directions 
In the current study, the roles of B[a]P and polyphenols in cancer initiation and progression mainly 
through mitochondrial pathways was investigated. Polyphenols ameliorated decreased 
mitochondrial biogenesis and prevented mitochondrial dysfunction; however, resveratrol showed 
the strongest effect in preventing against neoplastic transformation induced by B[a]P. Although 
we showed that resveratrol had the most robust effect in some key experiments and probably exerts 
its effect by inducing mitochondrial biogenesis and decreasing ROS production, further studies are 
still required to elucidate anti-carcinogenetic mechanisms of resveratrol. In addition to studying 
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the role of mitochondrial function and biogenesis in cancer initiation and progression, other 
pathways involved in carcinogenesis including MAPK, Akt pathways, and glycolytic pathway 
(e.g. HIF-1α, glycolytic enzymes, and glucose transporters) need to be investigated. In the current 
study, mRNA expression of mitochondrial respiratory subunits and citrate synthase were 
measured. To confirm these results, activity of mitochondrial complexes and citrate synthase 
should be measured in future studies. 
Moreover, conducting an in vivo study is one of the future directions. An in vivo evaluation is 
necessary to test the in vivo validity of preventive effects of dietary polyphenols on B[a]P-induced 
carcinogenesis, considering their bioavailability and metabolism. This would require chronic 
dietary administration of polyphenols before during and after B[a]P exposure. In such an in vivo 
study, animals could be fed with resveratrol, anthocyanin-rich extract (eg, bilberry extract), and 
combination of resveratrol and bilberry extract. The dose of resveratrol could be 30 mg/kg body 
weight throughout the experiment (added to diet). This amount is equivalent to 340 mg per day for 
a 70 kg human, which is far below the dose considered safe for humans (up to 5000 mg) (Boocock 
et al., 2007; Cui et al., 2010). The dose of bilberry extract could be 50 mg/kg body weight 
throughout the experiment (in the diet or water). This amount of anthocyanin extract has ~ 12 mg 
anthocyanins (equivalent to 200 mg in humans). The average intake of anthocyanins in the U.S. 
diet is estimated to be 180-215 mg (Wang & Stoner, 2008). For dietary relevance, B[a]P could be 
orally administrated (by gavage) with daily dose of 75 mg/kg dissolved in olive oil for 28 days 
(Ajayi et al., 2016; Huderson et al., 2013; Labib et al., 2012). After 16 weeks, effects on tumour 
incidence and pre-neoplastic lesions (eg. aberrant crypt foci) would be determined histologically, 
and possible mitochondrial mechanisms including mitochondrial content would be investigated in 
the liver, lung, and intestine of the animals. Biomarkers of interest could include inflammatory 
biomarkers (such as plasma and/or tissue levels of C-reactive protein, TNF-α and IL-6), liver 
damage biomarkers (such as alanine aminotransferase), tissue markers of oxidative stress such as 
TBARS and 8-oxo-dG (in mitochondrial and nuclear DNA), and tissue markers of mitochondrial 
content such as citrate synthase and mitochondrial respiratory complex activities, and the amount 
of mtDNA.  
Another suggestion for future study is using in vitro and in vivo models of knockdown genes. 
Knockdown of mitochondrial biogenesis factors such as PGC-1α, NRF1, or TFAM can show us 
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the role of mitochondria in carcinogenesis induced by B[a]P. In our study, we found that B[a]P 
induced mitochondrial dysfunction and reduced mitochondrial biogenesis; however, contribution 
of mitochondria to B[a]P-induced neoplastic transformation is as yet unknown. Mitochondrial 
gene knockdown also can show the contribution of mitochondria to cancer prevention by different 
polyphenols. 
Another suggestion is applying antimycin A (to increase mitochondrial superoxide) and ethidium 
bromide (to deplete mtDNA) for Bhas 42 transformation, and inhibition by polyphenols (maybe 
just resveratrol and cyanidin). By applying antimycin A, we observe whether increased 
mitochondrial superoxide along with impaired mitochondrial function can induce neoplastic 
transformation. By applying ethidium bromide, we can observe whether the absence of 
mitochondrial respiratory function can induce neoplastic transformation in Bhas 42 cells.   
In the present study, we compared preventive roles of different polyphenols against cancer 
initiation and progression induced by B[a]P. Recent studies have investigated and compared roles 
of conjugated forms of polyphenols in prevention and treatment of several diseases. Several studies 
attributed beneficial effects of some polyphenols to their conjugated forms (Patel et al., 2013). 
Therefore, we recommend investigating role of polyphenols and their conjugated metabolites such 
as resveratrol-3-O-sulfate in different models of carcinogenesis. 
In order to investigate the effect of B[a]P and polyphenols on mitochondrial mass versus 
mitochondrial biogenesis/replication, we suggest measuring the amount of mtDNA. This 
experiment will clarify why some polyphenols increase mitochondrial content, however, have no 
effect on mitochondrial respiratory subunits. To further investigate effects of B[a]P on mtDNA, 
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9.1. APPENDIX 1: Protein levels quantified by BCA assay kit 
 
Figure 9.1. Effect of B[a]P and polyphenols on protein level. 
Protein level was measured with a BCA assay kit in Bhas 42 cells after pre-treatment with 
polyphenols at 5 µM for 2h followed by treatment with 4 µM B[a]P for 24h. Data are presented as 
percentage of the untreated cells. The figure represents means ± SEM of 3 independent 
experiments with one T25 flask of cells per treatment condition in each experiment. The significant 




9.2. APPENDIX 2: Investigations into a possible synergism between cyanidin and resveratrol 
in decreasing B[a]P-induced intracellular and mitochondrial ROS. 
9.2.1 Abstract 
While resveratrol is a potent mitochondrial biogenesis inducer, flavonoids are notable antioxidants 
due to their more hydroxylated structure. Among flavonoids, anthocyanins are perhaps even 
stronger mitochondrial antioxidants due to having a more positive charge. In this study, we 
hypothesized that a combination of resveratrol and cyanidin decreases B[a]P-induced intracellular 
ROS and mitochondrial superoxide significantly more than each of them alone. Treatment with 
different concentrations of resveratrol and cyanidin and their combinations for 2h followed by 
administrating B[a]P for 12-72h showed no synergistic effects on B[a]P-induced intracellular ROS 
and mitochondrial superoxide generation. 
9.2.2 Introduction 
Resveratrol is a well-known polyphenol as a mitochondrial biogenesis inducer. Resveratrol 
induces mitochondrial biogenesis through activating SIRT1 (Howitz et al., 2003). So far, a few 
studies have reported a role of increased mitochondrial biogenesis with decreased ROS generation 
(Chen et al., 2017a; Kong et al., 2010; Takanche et al., 2017). In our study also, we showed that 
pre-treatment of Bhas 42 cells with resveratrol for 72h decreases B[a]P-induced intracellular ROS 
generation stronger than that of other polyphenols. We also showed that treatment of the Bhas 42 
cells with resveratrol for 72h increases the content of mitochondria significantly more than that of 
other polyphenols. The results of our and other studies suggest that induction of mitochondrial 
biogenesis with resveratrol can decrease ROS generation. One possible mechanism could be that 
increasing number of healthy and functional mitochondria improves performance of the ETC 
resulting in lower production of ROS. 
The antioxidative role of anthocyanins has been shown by several studies. Among anthocyanins, 
cyanidin is known as a potent antioxidant. The antioxidative role of anthocyanins has been 
attributed to the number of hydroxyl groups on the B ring (Procházková et al., 2011). Moreover, 
anthocyanins possess a positive charge that make them more susceptible to readily enter to and 
accumulate in the mitochondrial inner membrane and matrix (Peng, 2012). Also, unlike other 
flavonoids, anthocyanins were unable to activate SIRT1 to induce mitochondrial biogenesis 
(Howitz et al., 2003), although their breakdown products or metabolites may.  
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Although growing evidence shows synergistic effects between different polyphenols and their 
beneficial effects on health, a possible synergism between grape polyphenols such as resveratrol 
and anthocyanins in chemoprevention is not well-understood (Singh et al., 2016). Some studies 
have reported protective effects of resveratrol and quercetin in combination against carcinogenesis 
(Del Follo-Martinez et al., 2013; Zamin et al., 2009). Quercetin is a potent antioxidant and a 
mitochondrial biogenesis inducer as well.  
Given the role of resveratrol as a mitochondrial biogenesis inducer and the potent antioxidative 
effects of cyanidin, in the current study, we investigated the possible synergistic effect between 
resveratrol and cyanidin against B[a]P-induced intracellular ROS generation and mitochondrial 
superoxide. 
9.2.3 Material and Methods  
9.2.3.1. Chemicals and reagents 
See sections 3.2.1 and 5.2.1. 
9.2.3.2. Cell culture 
See section 3.2.2. 
9.2.3.3. Intracellular ROS measurement 
The level of intracellular ROS was determined using 2,7-dichlorodihydrofluorescein diacetate 
(DCFH-DA). After seeding 2 × 104 Bhas 42 cells in a 96-well plate and growing for 24 hours, 
resveratrol, cyanidin and combination of resveratrol and cyanidin at different concentrations (0.1-
10 µM) were administrated in DMSO (final DMSO concentration 0.5 %) for 2h followed by 
administrating 4 μM B[a]P for 12-72h. After these incubations, 10 µM H2O2 was administrated to 
some control wells as a positive control and incubated for 1 h. Then, medium was removed and 
DCFH-DA at 25 µM final concentration dissolved in DMEM without FBS was loaded to each 
well. After incubating for 30 min all of the wells were cautiously washed twice with phosphate-
buffered saline (PBS) and read at 480/20 nm excitation and 528/20 nm emission using a microplate 
reader (BioTek, Synergy HT). Images were captured by fluorescence microscope (Olympus IX 




9.2.3.4. Mitochondrial superoxide measurement 
The level of mitochondrial superoxide production was measured using MitoSOX Red fluorogenic 
dye. After seeding 2 × 104 Bhas 42 cells in a 96-well plate and growing for 24 hours, resveratrol, 
cyanidin and a combination of resveratrol and cyanidin at different concentrations (0.1-10 µM) 
were administrated in DMSO (final DMSO concentration 0.5 %) for 2h followed by administering 
4 μM B[a]P for 12-72h. Antimycin A (a cytochrome c reductase inhibitor) was added as a positive 
control and incubated for 30 minutes. Then, the medium was removed and MitoSOX dye at 5 µM 
final concentration dissolved in DMEM without FBS was loaded to each well and plates were 
incubated for 30 minutes. Then, wells were cautiously washed twice with PBS and read at 
530±20/590±20 nm using a microplate reader. Images were captured by a ZOE Fluorescent Cell 
Imager (Bio-Rad).  
9.2.4 Results 
9.2.4.1. Combination effects of resveratrol and cyanidin on intracellular ROS generation 
after 12h, 24h, and 72h 
One of the hypotheses of this research is that the combination of resveratrol and cyanidin would 
give a synergistic effect in preventing initiation and promotion of B[a]P-induced carcinogenesis 
via increasing mitochondrial biogenesis and decreasing oxidative stress. To assess this hypothesis, 
Bhas 42 cells were pre-treated with combinations of equal concentrations of resveratrol and 
cyanidin to yield final concentrations each of 1, 5 and 10 µM and intracellular ROS was measured 
(Fig. 9.2). The results showed that the combination of resveratrol and cyanidin at the 
concentrations of 0.5 and 2.5 µM had a slightly greater effect on intracellular ROS generation 
compared to those of the polyphenols alone at concentrations of 1 and 5 µM. In these experiments 
however, resveratrol or cyanidin alone completely prevented the B[a]P-induced increase in 
intracellular ROS, so no significant synergistic effect was observed. 
To further investigate the possible synergistic effect of resveratrol and cyanidin, intracellular ROS 
generation was measured after 24h and 72h with Bhas 42 cells pre-treated with the combination 
of equal concentrations of resveratrol and cyanidin to yield final concentrations of 1 µM, 0.4 μM, 
and 0.2 μM (Fig. 9.3A&B; 9.4A&B). The results showed no synergistic effect on intracellular 




Figure 9.2. Combination effect of resveratrol and cyanidin on B[a]P-induced intracellular 
ROS generation after 12h. 
Intracellular ROS generation in Bhas 42 cells was measured after treatment with different 
concentrations of resveratrol and cyanidin as well as their combination for 2h and exposure to 4 
µM B[a]P for 12h, after adding the fluorogenic probe, DCFH-DA for 30 min. Data are presented 
as percentage of the untreated cells. The figure represents means ± SEM of 3 independent 
experiments with 3 wells of cells per treatment condition in each experiment. The significant 
difference between groups was tested with two-way ANOVA followed by Tukey’s post-hoc test. 
* Significantly different from the UT group at p < 0.05. # Significantly different from the B[a]P 




Figure 9.3. Combination effect of resveratrol and cyanidin on B[a]P-induced intracellular 
ROS generation after 24h and 72h.  
Intracellular ROS generation in Bhas 42 cells was measured after treatment with different 
concentrations of resveratrol and cyanidin as well as their combination for 2h and exposure to 4 
µM B[a]P for (A) 24h and (B) 72h, after adding the fluorogenic probe, DCFH-DA for 30 min. 
Data are presented as percentage of the untreated cells. The figure represents means ± SEM of 3 
independent experiments with 3 wells of cells per treatment condition in each experiment. The 
significant difference between groups was tested with two-way ANOVA followed by Tukey’s 
post-hoc test. * Significantly different from the UT group at p < 0.05. # Significantly different 




Figure 9.4. Combination effect of resveratrol and cyanidin on B[a]P-induced intracellular 
ROS generation after 24h and 72h. 
Intracellular ROS generation in Bhas 42 cells was measured after treatment with different 
concentrations of resveratrol and cyanidin as well as their combination for 2h and exposure to 4 
µM B[a]P for (A) 24h and (B) 72h, after adding the fluorogenic probe, DCFH-DA for 30 min. 
Data are presented as percentage of the untreated cells. The figure represents means ± SEM of 3 
independent experiments with 3 wells of cells per treatment condition in each experiment. The 
significant difference between groups was tested with two-way ANOVA followed by Tukey’s 
post-hoc test. * Significantly different from the UT group at p < 0.05. # Significantly different 
from the B[a]P group at p < 0.05. 
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9.2.4.2. Combination effects of resveratrol and cyanidin on mitochondrial superoxide 
generation after 12h, 24h, and 72h 
In measurements after 12 h, the combination of resveratrol and cyanidin in three concentrations 
(1, 5, 10 µM) had no synergistic effect on mitochondrial superoxide generation compared to those 
of polyphenols alone (Fig. 9.5). Only cyanidin alone, at all three concentrations, gave significant 
protection under these conditions. 
To further investigate possible synergistic effects of resveratrol and cyanidin, mitochondrial 
superoxide generation was measured after 24h and 72h in Bhas 42 cells treated with the 
combination of equal concentrations of resveratrol and cyanidin to yield final concentrations of 
1µM (Fig. 9.6A&B). At these time points also, the combination of resveratrol and cyanidin at 1 
µM had no synergistic effect on mitochondrial superoxide generation compared to those of 
cyanidin alone. 
 
Figure 9.5. Combination effect of resveratrol and cyanidin on B[a]P-induced mitochondrial 
superoxide generation after 12h. 
Mitochondrial superoxide generation in Bhas 42 cells was measured with MitoSOX Red after 
treatment with different concentrations of resveratrol and cyanidin as well as their combination for 
2h and exposure to 4 µM B[a]P for 12h. Data are presented as percentage of the untreated cells. 
The figure represents means ± SEM of 3 independent experiments with 3 wells of cells per 
treatment condition in each experiment. The significant difference between groups was tested with 
two-way ANOVA followed by Tukey’s post-hoc test. * Significantly different from the UT group 




Figure 9.6. Combination effect of resveratrol and cyanidin on B[a]P-induced mitochondrial 
superoxide generation after 24 and 72 h. 
Mitochondrial superoxide generation in Bhas 42 cells was measured using MitoSOX Red after 
treatment with different concentrations of resveratrol and cyanidin as well as their combination for 
2h and exposure to 4 µM B[a]P for (A) 24h and (B) 72h. Data are presented as percentage of the 
untreated cells. The figure represents means ± SEM of 3 independent experiments with 3 wells of 
cells per treatment condition in each experiment. The significant difference between groups was 
tested with two-way ANOVA followed by Tukey’s post-hoc test. * Significantly different from 
the UT group at p < 0.05. # Significantly different from the B[a]P group at p < 0.05. 
 
